<SEC-DOCUMENT>0001140361-25-026428.txt : 20250718
<SEC-HEADER>0001140361-25-026428.hdr.sgml : 20250718
<ACCEPTANCE-DATETIME>20250718170557
ACCESSION NUMBER:		0001140361-25-026428
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		18
FILED AS OF DATE:		20250718
DATE AS OF CHANGE:		20250718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Jefferies Financial Group Inc.
		CENTRAL INDEX KEY:			0000096223
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				132615557
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-271881
		FILM NUMBER:		251135126

	BUSINESS ADDRESS:	
		STREET 1:		520 MADISON AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		2124601900

	MAIL ADDRESS:	
		STREET 1:		520 MADISON AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEUCADIA NATIONAL CORP
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TALCOTT NATIONAL CORP
		DATE OF NAME CHANGE:	19800603
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20052252_424b2.htm
<DESCRIPTION>DEAL 733
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <div>
    <div>
      <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: right;"> <font style="font-weight: bold;">Filed Pursuant to Rule 424(b)(2)<br>
        <font style="font-weight: bold;">Registration No. </font></font><font style="font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: bold; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">333-271881</font></div>
    <div style="text-align: right;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9720946f9e2e4725ad0471e191d6e8be">

        <tr>
          <td style="width: 99.88%; vertical-align: top;">
            <div>PRICING SUPPLEMENT dated July 16, 2025</div>
            <div>(To Product Supplement No. 2 dated June 30, 2023</div>
            <div>Prospectus Supplement dated May 12, 2023</div>
            <div style="margin-bottom: 0.75pt;">and Prospectus dated May 12, 2023)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 99.88%; vertical-align: top; background-color: rgb(237, 239, 238);">
            <div style="color: rgb(187, 8, 38); font-size: 15pt; font-weight: bold; margin-left: 9pt;">Jefferies Financial Group Inc.</div>
            <div style="color: rgb(187, 8, 38); font-size: 11pt; margin-left: 9pt;"><font style="font-size: 2.5pt;">&#160;</font><font style="font-weight: bold;">Medium-Term Notes, Series A</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 99.88%; vertical-align: top; background-color: rgb(213, 217, 216);">
            <div style="color: rgb(187, 8, 38); font-size: 12pt; font-weight: bold; margin-left: 9pt;">Market Linked Securities&#8212; Auto-Callable with Contingent Coupon and Contingent Downside</div>
            <div style="color: rgb(187, 8, 38); font-weight: bold; margin-left: 9pt;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional Banking ETF and
              the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF due July 19, 2029</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 95%; vertical-align: top; background-color: rgb(94, 138, 180);">
            <div style="text-indent: -18pt; margin-left: 27pt; text-align: justify;"><font style="font-size: 8pt; color: rgb(255, 255, 255);">&#9632;</font><font style="font-size: 5.36pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">Linked to the lowest performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF (each referred to as a &#8220;<u>Market






                  Measure</u>&#8221;)</font></div>
            <div style="text-indent: -18pt; margin-left: 27pt; text-align: justify;"><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">&#9632;</font><font style="font-size: 5.36pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">Unlike ordinary debt securities, the securities do not provide for fixed payments of interest, do not repay a fixed amount of principal at stated maturity and are subject to potential automatic call prior to
                stated maturity upon the terms described below. Whether the securities pay a contingent coupon, whether the securities are automatically called prior to stated maturity and, if they are not automatically called, whether you receive the face
                amount of your securities at stated maturity will depend, in each case, on the fund closing price of the lowest performing Market Measure on the relevant calculation day. The lowest performing Market Measure on any calculation day is the
                Market Measure that has the lowest fund closing price on that calculation day as a percentage of its starting price</font></div>
            <div style="text-indent: -18pt; margin-left: 27pt; text-align: justify;"><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">&#9632;</font><font style="font-size: 5.36pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 7.5pt; color: rgb(255, 255, 255);"><font style="font-weight: bold;">Contingent Coupon. </font>The securities will pay a contingent coupon on a monthly basis until the earlier of stated maturity or automatic call if, and only if, the fund closing
                price of the lowest performing Market Measure on the calculation day for that month is greater than or equal to its threshold price. However, if the fund closing price of the lowest performing Market Measure on a calculation day is less
                than its threshold price, you will not receive any contingent coupon for the relevant month. If the fund closing price of the lowest performing Market Measure is less than its threshold price on every calculation day, you will not receive
                any contingent coupons throughout the entire term of the securities. The threshold price for each Market Measure is equal to 70% of its starting price. The contingent coupon rate is 13.40% per annum</font></div>
            <div style="text-indent: -18pt; margin-left: 27pt; text-align: justify;"><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">&#9632;</font><font style="font-size: 5.36pt;" class="TRGRRTFtoHTMLTab">&#160;&#160; &#160; &#160; </font><font style="font-size: 7.5pt; color: rgb(255, 255, 255);"><font style="font-weight: bold;">Automatic Call.</font>&#160; If the fund closing price of the lowest performing Market Measure on any of the calculation days occurring in January, April, July and October from January
                2026 to April 2029, inclusive, is greater than or equal to its starting price, the securities will be automatically called for the face amount plus a final contingent coupon payment</font></div>
            <div style="text-indent: -18pt; margin-left: 27pt; text-align: justify;"><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">&#9632;</font><font style="font-size: 5.36pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 7.5pt; color: rgb(255, 255, 255);"><font style="font-weight: bold;">Potential Loss of Principal.</font>&#160; If the securities are not automatically called prior to stated maturity, you will receive the face amount at stated maturity if, <font style="font-weight: bold;">and only if</font>, the fund closing price of the lowest performing Market Measure on the final calculation day is greater than or equal to its threshold price. If the fund closing price of the lowest performing
                Market Measure on the final calculation day is less than its threshold price, you will lose more than 30%, and possibly all, of the face amount of your securities.</font></div>
            <div style="text-indent: -18pt; margin-left: 27pt; text-align: justify;"><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">&#9632;</font><font style="font-size: 5.36pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">If the securities are not automatically called prior to stated maturity, you will have full downside exposure to the lowest performing Market Measure from its starting price if its fund closing price on the final
                calculation day is less than its threshold price, but you will not participate in any appreciation of any Market Measure and will not receive any dividends on any Market Measure or the securities included in any Market Measure</font></div>
            <div style="text-indent: -18pt; margin-left: 27pt; text-align: justify;"><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">&#9632;</font><font style="font-size: 5.36pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">Your return on the securities will depend solely on the performance of the Market Measure that is the lowest performing Market Measure on each calculation day. You will not benefit in any way from the performance
                of the better performing Market Measures. Therefore, you will be adversely affected if any Market Measure performs poorly, even if the other Market Measures perform favorably</font></div>
            <div style="text-indent: -18pt; margin-left: 27pt; text-align: justify;"><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">&#9632;</font><font style="font-size: 5.36pt;" class="TRGRRTFtoHTMLTab">&#160;&#160; &#160; &#160; </font><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">All payments on the securities are subject to our credit risk, and you will have no ability to pursue any Market Measure or any securities included in any Market Measure for payment; if we default on our
                obligations under the securities, you could lose some or all of your investment</font></div>
            <div style="margin-left: 9pt; text-align: justify;"><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">&#9632;</font><font style="font-size: 5.36pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 7.5pt; color: rgb(255, 255, 255);">No exchange listing; designed to be held to maturity</font></div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(94, 138, 180);" colspan="1">&#160;</td>
        </tr>

    </table>
    <div style="text-align: justify; margin-right: 9pt; font-size: 7pt; font-weight: bold;">
      <div style="margin-right: 9pt; font-weight: bold;">We estimate that the value of each security on the pricing date is $952.30 per security. See &#8220;Estimated Value of the Securities&#8221; in this pricing supplement.</div>
    </div>
    <div style="text-align: justify; margin-right: 9pt; font-size: 7pt; font-weight: bold;">The securities have complex features and investing in the securities involves risks not associated with an investment in conventional debt securities. See &#8220;Selected
      Risk Considerations&#8221; beginning on page PRS-9 herein and &#8220;Risk Factors&#8221; beginning on page PS-5 of the accompanying product supplement.</div>
    <div style="text-align: justify; margin-right: 9pt; font-size: 7pt; font-weight: bold;">The securities are senior unsecured obligations of Jefferies Financial Group Inc. and, accordingly, all payments are subject to our credit risk. If we default on
      our obligations under the securities, you could lose some or all of your investment. The securities are not savings accounts, deposits or other obligations of a depository institution and are not insured by the Federal Deposit Insurance Corporation,
      the Deposit Insurance Fund or any other governmental agency.</div>
    <div style="text-align: justify; margin-right: 9pt; font-size: 7pt; font-weight: bold;">Neither the Securities and Exchange Commission nor any state securities commission or other regulatory body has approved or disapproved of these securities or
      passed upon the accuracy or adequacy of this pricing supplement or the accompanying product supplement, prospectus supplement and prospectus. Any representation to the contrary is a criminal offense.</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf72ca6776f124c0ca9f8d8e949fb16bb">

        <tr>
          <td style="width: 25.39%; vertical-align: bottom; padding-bottom: 1px;">&#160;</td>
          <td nowrap="nowrap" style="width: 24.87%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-size: 7.5pt; font-weight: bold;">Original Offering Price</div>
          </td>
          <td nowrap="nowrap" style="width: 24.87%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-size: 12pt;"><font style="font-size: 7.5pt; font-weight: bold;">Agent Discount</font><font style="font-size: 7.5pt;"><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(2)</sup></font></div>
          </td>
          <td nowrap="nowrap" style="width: 24.87%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center;"><font style="font-size: 7.5pt;">Proceeds to the Issuer </font><br>
            </div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 25.39%; vertical-align: bottom; font-size: 4pt;"><br>
          </td>
          <td nowrap="nowrap" rowspan="1" style="width: 24.87%; vertical-align: bottom; font-size: 4pt;"><br>
          </td>
          <td nowrap="nowrap" rowspan="1" style="width: 24.87%; vertical-align: bottom; font-size: 4pt;"><br>
          </td>
          <td nowrap="nowrap" rowspan="1" style="width: 24.87%; vertical-align: bottom; font-size: 4pt;"><br>
          </td>
        </tr>
        <tr>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: top; width: 25.39%;">
            <div style="text-align: right; font-size: 9.5pt; font-weight: bold;">Per Security</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; white-space: nowrap; width: 24.87%;">
            <div style="text-align: center; font-size: 9.5pt;">$1,000.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; white-space: nowrap; width: 24.87%;">
            <div style="text-align: center; font-size: 9.5pt;">$23.25</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; white-space: nowrap; width: 24.87%;">
            <div style="text-align: center; font-size: 9.5pt;">$976.75</div>
          </td>
        </tr>
        <tr>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: top; width: 25.39%;">
            <div style="text-align: right;"><font style="font-size: 9.5pt; font-weight: bold;">Total</font><font style="font-size: 5.13pt;" class="TRGRRTFtoHTMLTab"> <br>
              </font></div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; white-space: nowrap; width: 24.87%;">
            <div style="text-align: center; font-size: 9.5pt;">$2,150,000.00</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); vertical-align: bottom; white-space: nowrap; width: 24.87%; text-align: center;">
            <div style="font-size: 9.5pt;">$49,987.50</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; white-space: nowrap; width: 24.87%;">
            <div style="text-align: center; font-size: 9.5pt;">$2,100,012.50</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9e650a9b87e54f47869555693d244e12">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 8pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 7pt;">Jefferies LLC and Wells Fargo Securities, LLC are the agents for the distribution of the securities and are acting as principal.&#160; See &#8220;Terms of the Securities&#8212;Agents&#8221; and &#8220;Estimated Value of the Securities&#8221; in this
              pricing supplement for further information.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb51d08d8fb874516ab0c77ec74544b96">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 8pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 7.5pt;">In respect of certain securities sold in this offering, <font style="font-size: 7pt;">Jefferies LLC, the broker-dealer subsidiary of Jefferies Financial Group Inc.,</font> may pay a fee of up to $3.00 per
              security to selected securities dealers in consideration for marketing and other services in connection with the distribution of the securities to other securities dealers.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; font-size: 11pt; font-weight: bold;">
      <table cellspacing="0" cellpadding="0" border="0" id="z7ed50bc9be4b4eb083f3937e779c9ddb" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50%; font-size: 11pt; font-weight: bold; text-align: center;">Jefferies</td>
            <td style="width: 50%; font-size: 11pt; font-weight: bold; text-align: center;">Wells Fargo Securities</td>
          </tr>

      </table>
    </div>
    <div style="font-weight: 400;"><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <!--PROfilePageNumberReset%Num%2%PRS-%%-->
    <div> </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze153b575cfa54cdf801c0856ad8af2ee">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="color: #FFFFFF; font-size: 10pt; font-weight: bold; text-align: center;">Terms of the Securities</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z6f28063f217d43e0826b77e21812a703">

        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Issuer:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">Jefferies Financial Group Inc.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Market Measures:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">The Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF (each referred to as a &#8220;<u>Market










                Measure</u>,&#8221; and collectively as the &#8220;<u>Market Measures</u>&#8221;).</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin: 3pt 0px 0px; font-weight: bold;">Fund Underlying</div>
            <div style="margin: 0px 0px 3pt; font-weight: bold;">Index:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">With respect to the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund, the <font style="color: rgb(0, 0, 0);">Utilities Select Sector Index.</font></div>
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">With respect to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional Banking ETF, the S&amp;P Regional Banks Select Industry Index.</div>
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">With respect to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF, the <font style="color: rgb(0, 0, 0);">S&amp;P</font><sup style="color: rgb(0, 0, 0); vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Biotechnology Select Industry<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index.</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Pricing Date:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">July 16, 2025</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Issue Date:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">July 21, 2025</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; font-weight: bold;">Original Offering</div>
            <div style="margin-bottom: 3pt; font-weight: bold;">Price:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">$1,000 per security.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Face Amount:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">$1,000 per security. References in this pricing supplement to a &#8220;<u>security</u>&#8221; are to a security with a face amount of $1,000.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; font-weight: bold;">Contingent</div>
            <div style="font-weight: bold;">Coupon Payment:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">On each contingent coupon payment date, you will receive a contingent coupon payment at a per annum rate equal to the contingent coupon rate if, <font style="font-weight: bold;">and only if</font>, the fund closing price of the lowest performing Market Measure on the related calculation day is greater than or equal to its threshold price. Each &#8220;<u>contingent coupon payment</u>,&#8221; if any, will be calculated
              per security as follows: ($1,000 &#215; contingent coupon rate)/12. Any contingent coupon payment will be rounded to the nearest cent, with one-half cent rounded upward.</div>
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">If the fund closing price of the lowest performing Market Measure on any calculation day is less than its threshold price, you will not receive any
              contingent coupon payment on the related contingent coupon payment date. If the fund closing price of the lowest performing Market Measure is less than its threshold price on all calculation days, you will not receive any contingent coupon
              payments over the term of the securities.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="font-weight: bold;">Contingent Coupon</div>
            <div style="margin-bottom: 3pt; font-weight: bold;">Payment Dates:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">Monthly, on the third business day following each calculation day (as each such calculation day may be postponed pursuant to &#8220;-Market Disruption Events and Postponement
              Provisions&#8221; below, if applicable); <font style="font-style: italic;">provided</font> that the contingent coupon payment date with respect to the final calculation day will be the stated maturity date.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; font-weight: bold;">Contingent Coupon</div>
            <div style="margin-bottom: 3pt; font-weight: bold;"> Rate:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">The &#8220;<u>contingent coupon rate</u>&#8221; is 13.40% per annum.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt;"><font style="font-weight: bold;">Automatic Call</font>:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">If the fund closing price of the lowest performing Market Measure on any of the calculation days occurring in January, April, July and October from January 2026 to April
              2029, inclusive, is greater than or equal to its starting price, the securities will be automatically called, and on the related call settlement date you will be entitled to receive a cash payment per security in U.S. dollars equal to the
              face amount plus a final contingent coupon payment. The securities will not be subject to automatic call until the sixth calculation day, which is approximately six months after the issue date.</div>
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">If the securities are automatically called, they will cease to be outstanding on the related call settlement date and you will have no further rights under the securities
              after such call settlement date. You will not receive any notice from us if the securities are automatically called.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Calculation Days:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">Monthly, on the 16th day of each month, commencing August 2025 and ending June 2029, and the final calculation day, each subject to postponement as described below under
              &#8220;-Market Disruption Events and Postponement Provisions.&#8221; We refer to July 16, 2029 as the &#8220;<u>final calculation day</u>.&#8221;</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; font-weight: bold;">Call Settlement</div>
            <div style="margin-bottom: 3pt; font-weight: bold;">Date:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">Three business days after the applicable calculation day (as each such calculation day may be postponed as described below in &#8220;&#8212;Market Disruption Events and Postponement
              Provisions&#8221;, if applicable).</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; font-weight: bold;">Stated Maturity</div>
            <div style="margin-bottom: 3pt; font-weight: bold;">Date:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">July 19, 2029, subject to postponement. The securities are not subject to repayment at the option of any holder of the securities prior to the stated maturity date.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td colspan="1" rowspan="2" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td rowspan="2" style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; font-weight: bold;">Maturity Payment</div>
            <div style="margin-bottom: 3pt; font-weight: bold;">Amount:</div>
          </td>
          <td style="vertical-align: top; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: top; width: 80%;">
            <div style="margin: 3pt 0px 12pt; text-align: justify;">If the securities are not automatically called prior to the stated maturity date, then on the stated maturity date, you will be entitled to receive a cash payment per security in U.S.
              dollars equal to the maturity payment amount (in addition to the final contingent coupon payment, if any). The &#8220;<u>maturity payment amount</u>&#8221; per security will equal:</div>
            <div style="margin-top: 3pt; margin-bottom: 12pt; text-indent: -18pt; margin-left: 18pt;">&#8226;<font style="font-size: 6.12pt;" class="TRGRRTFtoHTMLTab">&#160; &#160; &#160;&#160; &#160;&#160; </font>if the ending price of the lowest performing Market Measure on the final
              calculation day is greater than or equal to its threshold price: $1,000; or</div>
            <div style="margin-top: 3pt; margin-bottom: 6pt; text-indent: -18pt; margin-left: 18pt;">&#8226;<font style="font-size: 6.12pt;" class="TRGRRTFtoHTMLTab"> &#160; &#160; &#160; &#160;&#160; </font>if the ending price of the lowest performing Market Measure on the final
              calculation day is less than its threshold price:</div>
            <div style="margin-top: 3pt; margin-bottom: 3pt; margin-left: 36pt;">$1,000 &#215; performance factor of the lowest performing Market Measure on the final calculation day</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: bottom; width: 80%;">
            <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-weight: bold;">If the securities are not automatically called prior to stated maturity and the ending price of the lowest performing Market Measure on the final
              calculation day is less than its threshold price, you will lose more than 30%, and possibly all, of the face amount of your securities at stated maturity.</div>
            <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-weight: bold;">Any return on the securities will be limited to the sum of your contingent coupon payments, if any. You will not participate in any appreciation of any
              Market Measure, but you will have full downside exposure to the lowest performing Market Measure on the final calculation day if the ending price of that Market Measure is less than its threshold price.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; font-weight: bold;">Lowest Performing</div>
            <div style="margin-bottom: 3pt; font-weight: bold;">Market Measure:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">For any calculation day, the &#8220;<u>lowest performing Market Measure</u>&#8221; will be the Market Measure with the lowest performance factor on that calculation day.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; font-weight: bold;">Performance</div>
            <div style="margin-bottom: 3pt; font-weight: bold;">Factor:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">With respect to a Market Measure on any calculation day, its fund closing price on such calculation day <font style="font-style: italic;">divided by</font> its starting
              price (expressed as a percentage).</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; font-weight: bold;">Fund Closing</div>
            <div style="margin-bottom: 3pt; font-weight: bold;">Price:</div>
          </td>
          <td style="vertical-align: top; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: top; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">With respect to each Market Measure, fund closing price, closing price and adjustment factor have the meanings set forth under &#8220;General Terms of the Securities&#8212;Certain Terms
              for Securities Linked to a Fund&#8212;Certain Definitions&#8221; in the accompanying product supplement.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Starting Price:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">With respect to the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund: $82.03, its fund closing price on the pricing date.</div>
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">With respect to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional Banking ETF: $61.91, its fund closing price on the pricing date.</div>
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">With respect to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF: $87.82, its fund closing price on the pricing date.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Ending Price:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">The &#8220;<u>ending price</u>&#8221; of a Market Measure will be its fund closing price on the final calculation day.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Threshold Price:</div>
            <div>&#160;</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">With respect to the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund: $57.421, which is equal to 70% of its starting price.</div>
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">With respect to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional Banking ETF: $43.337, which is equal to 70% of its starting price.</div>
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">With respect to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF: $61.474, which is equal to 70% of its starting price.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; font-weight: bold;">Market Disruption</div>
            <div style="font-weight: bold;">Events and</div>
            <div style="font-weight: bold;">Postponement</div>
            <div style="font-weight: bold;">Provisions:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">Each calculation day (including the final calculation day) is subject to postponement due to non-trading days and the occurrence of a market disruption event. In addition,
              the stated maturity date will be postponed if the final calculation day is postponed, and will be adjusted for non-business days. For more information regarding adjustments to the calculation days and the stated maturity date, see &#8220;General
              Terms of the Securities&#8212;Consequences of a Market Disruption Event; Postponement of a Calculation Day&#8212;Securities Linked to Multiple Market Measures&#8221; and &#8220;&#8212;Payment Dates&#8221; in the accompanying product supplement. For purposes of the accompanying
              product supplement, each call settlement date and the stated maturity date is a &#8220;payment date.&#8221; In addition, for information regarding the circumstances that may result in a market disruption event, see &#8220;General Terms of the
              Securities&#8212;Certain Terms for Securities Linked to an Index&#8212;Market Disruption Events&#8221; and &#8220;General Terms of the Securities&#8212;Certain Terms for Securities Linked to a Fund&#8212;Market Disruption Events&#8221; in the accompanying product supplement.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Calculation Agent:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">Jefferies Financial Services Inc. (&#8220;<u>JFSI</u>&#8221;), a wholly owned subsidiary of Jefferies Financial Group Inc.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="text-align: justify; margin-top: 3pt; font-weight: bold;">Material Tax</div>
            <div style="font-weight: bold;">Consequences:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">For a discussion of the material U.S. federal income and certain estate tax consequences of the ownership and disposition of the securities, see &#8220;Supplemental Discussion of
              U.S. Federal Income Tax Consequences.&#8221;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Agents:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">Jefferies LLC and Wells Fargo Securities, LLC (&#8220;<u>WFS</u>&#8221;) are the agents for the distribution of the securities. The agents will receive an agent discount of up to $23.25
              per security. The agents may resell the securities to other securities dealers at the original offering price of the securities less a concession not in excess of $17.50 per security. Such securities dealers may include Wells Fargo Advisors
              (&#8220;<u>WFA</u>&#8221;) (the trade name of the retail brokerage business of WFS&#8217;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC). In addition to the concession allowed to WFA, WFS may pay $0.75 per
              security of the underwriting discount to WFA as a distribution expense fee for each security sold by WFA.</div>
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">In addition, in respect of certain securities sold in this offering, Jefferies LLC may pay a fee of up to $3.00 per security to selected securities dealers in consideration
              for marketing and other services in connection with the distribution of the securities to other securities dealers.</div>
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">The agents and/or one or more of their respective affiliates expects to realize hedging profits projected by their proprietary pricing models to the extent they assume the
              risks inherent in hedging our obligations under the securities.&#160; If the agents or any other dealer participating in the distribution of the securities or any of their affiliates conduct hedging activities for us in connection with the
              securities, that dealer or its affiliates will expect to realize a profit projected by its proprietary pricing models from those hedging activities. Any such projected profit will be in addition to any discount, concession or fee received in
              connection with the sale of the securities to you.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Denominations:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">$1,000 and any integral multiple of $1,000.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="background-color: #D9D9D6; border-bottom: 1px solid #FFFFFF; vertical-align: middle; width: 1%;">&#160;</td>
          <td style="background-color: rgb(217, 217, 214); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 18%;">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">CUSIP:</div>
          </td>
          <td style="vertical-align: middle; width: 1%;" colspan="1">&#160;</td>
          <td style="vertical-align: middle; width: 80%;">
            <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt;">47233YKT1</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; font-size: 7.5pt;"> <br>
    </div>
    <div style="text-align: justify; font-size: 7.5pt;">
      <hr noshade="noshade" align="left" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto 0px 0px; height: 1px; width: 15%; color: #000000; text-align: left;"></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd028368dc209492ca9463df8096a475a">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="color: #FFFFFF; font-size: 10pt; font-weight: bold; text-align: center;">Additional Information about the Issuer and the Securities</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify;">You should read this pricing supplement together with product supplement No. 2 dated June 30, 2023, the prospectus supplement dated May 12, 2023 and the prospectus dated May 12, 2023 for additional information about
      the securities. Information included in this pricing supplement supersedes information in the product supplement, prospectus supplement and prospectus to the extent it is different from that information. Certain defined terms used but not defined
      herein have the meanings set forth in the product supplement, prospectus supplement or prospectus.</div>
    <div style="text-align: justify; margin-top: 9pt;">As used in this pricing supplement, &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Jefferies Financial Group Inc., unless the context requires otherwise.</div>
    <div style="text-align: justify; margin-top: 9pt;">You may access the product supplement, prospectus supplement and prospectus on the SEC website www.sec.gov as follows (or if such address has changed, by reviewing our filing for the relevant date on
      the SEC website):</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zbaaa11a9fb1c492496a92a44396de78a">

        <tr>
          <td style="width: 12.25pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Product Supplement No. 2 dated June 30, 2023:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-left: 12.2pt;"><a href="https://www.sec.gov/Archives/edgar/data/96223/000114036123032428/brhc20055267_424b2.htm">https://www.sec.gov/Archives/edgar/data/96223/000114036123032428/brhc20055267_424b2.htm</a></div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z3ecbf851038443f49dd3689defa434cb">

        <tr>
          <td style="width: 12.25pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Prospectus Supplement dated May 12, 2023 and Prospectus dated May 12, 2023:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-left: 12.25pt;"><a href="https://www.sec.gov/Archives/edgar/data/96223/000114036123024421/ny20009069x3_424b2.htm">https://www.sec.gov/Archives/edgar/data/96223/000114036123024421/ny20009069x3_424b2.htm</a></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7a68a4beab4f4be9ab2b481b4dd7880a">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="color: #FFFFFF; font-size: 10pt; font-weight: bold; text-align: center;">Estimated Value of the Securities</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 9pt;">
      <div style="margin-top: 9pt;">The face amount of each security is $1,000.&#160; The original issue price will equal 100% of the face amount per security.&#160; This price includes costs associated with issuing, selling, structuring and hedging the securities,
        which are borne by you, and, consequently, the estimated value of the securities on the pricing date is less than the original offering price.&#160; We estimate that the value of each security on the pricing date is $952.30 per security.</div>
    </div>
    <div style="text-align: justify; margin-top: 9pt; font-style: italic;">Valuation of the Securities</div>
    <div style="text-align: justify; margin-top: 9pt;">Jefferies LLC calculated the estimated value of the securities set forth on the cover page of this pricing supplement based on its proprietary pricing models at that time. Jefferies LLC&#8217;s proprietary
      pricing models generated an estimated value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on the securities, which consists of a fixed-income bond (the &#8220;bond component&#8221;)
      and one or more derivative instruments underlying the economic terms of the securities (the &#8220;derivative component&#8221;). In calculating the estimated value of the derivative component, Jefferies LLC estimated future cash flows based on a proprietary
      derivative-pricing model that is in turn based on various inputs, including the factors described under &#8220;Selected Risk Considerations&#8212;The estimated value of the securities was determined for us by our subsidiary using proprietary pricing models&#8221;
      below. These inputs may be market-observable or may be based on assumptions made by Jefferies LLC in its discretionary judgment. Estimated cash flows on the bond and derivative components were discounted using a discount rate based on our internal
      funding rate.</div>
    <div style="text-align: justify; margin-top: 9pt;">The estimated value of the securities is a function of the terms of the securities and the inputs to Jefferies LLC&#8217;s proprietary pricing models.<br>
    </div>
    <div style="text-align: justify; margin-top: 9pt;">Since the estimated value of the securities is a function of the underlying assumptions and construction of Jefferies LLC&#8217;s proprietary derivative-pricing model, modification to this model will impact
      the estimated value calculation.&#160; Jefferies LLC&#8217;s proprietary models are subject to ongoing review and modification, and Jefferies LLC may change them at any time and for a variety of reasons.&#160; In the event of a model change, prior descriptions of
      the model and computations based on the older model will be superseded, and calculations of estimated value under the new model may differ significantly from those under the older model.&#160; Further, model changes may cause a larger impact on the
      estimated value of a note with a particular return formula than on a similar note with a different return formula.&#160; For example, to the extent a return formula contains leverage, model changes may cause a larger impact on the estimated value of that
      note than on a similar note without such leverage.</div>
    <div style="text-align: justify; margin-top: 9pt;">WFS has advised us that if it, WFA or any of their affiliates makes a secondary market in the securities at any time up to the issue date or during the 4-month period following the issue date, the
      secondary market price offered by it, WFA or any of their affiliates will be increased by an amount reflecting a portion of the costs associated with selling, structuring and hedging the securities that are included in their original offering price.&#160;
      Because this portion of the costs is not fully deducted upon issuance, WFS has advised us that any secondary market price it, WFA or any of their affiliates offers during this period will be higher than it otherwise would be after this period, as any
      secondary market price offered after this period will reflect the full deduction of the costs as described above. WFS has advised us that the amount of this increase in the secondary market price will decline steadily to zero over this 4-month
      period.</div>
    <div style="text-align: justify; margin-top: 9pt; font-style: italic; font-weight: bold;">The relationship between the estimated value on the pricing date and the secondary market price of the securities</div>
    <div style="text-align: justify; margin-top: 9pt;">The price at which the agents or any of their respective affiliates purchase the securities in the secondary market, absent changes in market conditions, including those related to interest rates and
      the Market Measure, may vary from, and be lower than, the estimated value on the pricing date, because the secondary market price takes into account our secondary market credit spread as well as a bid-offer spread that would be charged in a secondary
      market transaction of this type, the costs of unwinding the related hedging transactions and other factors.</div>
    <div style="text-align: justify; margin-top: 9pt;">The agents and/or their respective affiliates may, but are not obligated to, make a market in the securities and, if it once chooses to make a market, may cease doing so at any time.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5733345e8dec4b0da7dd806f13b056c0">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt; color: rgb(255, 255, 255); font-size: 10pt; font-weight: bold;">Investor Considerations</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 9pt; font-weight: bold;">The securities are not appropriate for all investors. The securities may be an appropriate investment for investors who:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zad715ecc553c433abe0c92213386dce9">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>seek an investment with contingent coupon payments at a rate of 13.40% per annum until the earlier of stated maturity or automatic call, if,<font style="font-weight: bold;"> and only if</font>, the fund closing price of the lowest
              performing Market Measure on the applicable calculation day is greater than or equal to 70% of its starting price;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z304efa32bce74916bcce0669fba8872b">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>understand that if the ending price of the lowest performing Market Measure on the final calculation day has declined by more than 30% from its starting price, they will be fully exposed to the decline in the lowest performing Market
              Measure from its starting price and will lose more than 30%, and possibly all, of the face amount at stated maturity;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zbcbde83cc09841ec9ff34fff36c1b6cb">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are willing to accept the risk that they may receive few or no contingent coupon payments over the term of the securities;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zc2b6897d6df14131b8bfe155a4e48f8e">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>understand that the securities may be automatically called prior to stated maturity and that the term of the securities may be as short as approximately six months;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zc51fb3e2e6ec4f93871ef275d4f2134a">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>understand that the return on the securities will depend solely on the performance of the Market Measure that is the lowest performing Market Measure on each calculation day and that they will not benefit in any way from the performance of
              the better performing Market Measures;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z0e806b7d428c4de4b07e5d0ac06c0bf1">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>understand that the securities are riskier than alternative investments linked to only one of the Market Measures or linked to a basket composed of each Market Measure;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zb39af03c73894b739ea1c99fccedd1d8">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>understand and are willing to accept the full downside risks of each Market Measure;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z9530b9f7a8494304991b6db8a31750c2">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are willing to forgo participation in any appreciation of any Market Measure and dividends on the Market Measures and the securities included in the Market Measures; and</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z6c8a093635634c0bb6eebf87de152a7a">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are willing to hold the securities until maturity.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 9pt; font-weight: bold;">The securities may not be an appropriate investment for investors who:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z2ea015a9bc5e46d49601c82264e5c739">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>seek a liquid investment or are unable or unwilling to hold the securities to maturity or any earlier automatic call;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z7f7be293ea20496793aa673def37e341">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>require full payment of the face amount of the securities at stated maturity;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z84220fb1b461403cb9177f93b5eb3382">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>seek a security with a fixed term;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zf0c3c3a94ba1445baf6a9d15ad63e8ec">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are unwilling to purchase securities with an estimated value as of the pricing date that is lower than the original offering price;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zf893c34d8690499e9bba3336edc3fdfd">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are unwilling to accept the risk that the fund closing price of the lowest performing Market Measure on the final calculation day may decline by more than 30% from its starting price;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z146e064ad6f34b8e9db4cd83c9df1b1a">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>seek the certainty of current income over the term of the securities;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z640ea2c90fee4dbd8f58c45470678183">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>seek exposure to the upside performance of any or each Market Measure;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zfbc9c9e5ef5c4f0db8097461071076df">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>seek exposure to a basket composed of each Market Measure or a similar investment in which the overall return is based on a blend of the performances of the Market Measures, rather than solely on the lowest performing Market Measure;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z9266db462fe6467fae3fb5cb1b5ecf9b">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are unwilling to accept the risk of exposure to the Market Measures;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z928e8046bf5846399c237da7e6cf88c3">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are unwilling to accept our credit risk; or</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z7e3e604c8fd142fc960c6b93096dd5cd">

        <tr>
          <td style="width: 12.25pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>prefer the lower risk of fixed income investments with comparable maturities issued by companies with comparable credit ratings.</div>
          </td>
        </tr>

    </table>
    <div style="margin: 14pt 0px 0px; font-weight: bold; text-align: justify;"><font style="color: rgb(0, 0, 0);">The considerations identified above are not exhaustive. Whether or not the securities are an </font>appropriate <font style="color: rgb(0, 0, 0);">investment for you will depend on your individual circumstances, and you should reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered the </font>appropriateness
      <font style="color: rgb(0, 0, 0);">of an investment in the securities in light of your particular circumstances. You should also review carefully the &#8220;Selected Risk Considerations&#8221; herein and the &#8220;Risk Factors&#8221; in the accompanying product supplement
        for risks related to an investment in the securities. For more information about the Market Measures, please see the section titled &#8220;The Market Measures&#8221; below.</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze1eb60676a914345870eea75fc72e459">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="color: #FFFFFF; font-size: 10pt; font-weight: bold; text-align: center;">Determining Payment On A Contingent Coupon Payment Date and at Maturity</div>
          </td>
        </tr>

    </table>
    <div style="margin-top: 12pt; margin-bottom: 12pt; color: rgb(0, 0, 0);">If the securities have not been previously automatically called, on each contingent coupon payment date, you will either receive a contingent coupon payment or you will not
      receive a contingent coupon payment, depending on the fund closing price of the lowest performing Market Measure on the related calculation day.</div>
    <div style="margin-top: 12pt; margin-bottom: 12pt; color: rgb(0, 0, 0);"><font style="font-weight: bold;">Step 1</font>: Determine which Market Measure is the lowest performing Market Measure on the relevant calculation day. The lowest performing
      Market Measure on any calculation day is the Market Measure with the lowest performance factor on that calculation day. The performance factor of an Market Measure on a calculation day is its fund closing price on that calculation day as a percentage
      of its starting price (i.e., its fund closing price on that calculation day <font style="font-style: italic;">divided by</font> its starting price).</div>
    <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);"><font style="font-weight: bold;">Step 2</font>: Determine whether a contingent coupon is paid on the applicable contingent coupon payment date based on the fund closing price of
      the lowest performing Market Measure on the relevant calculation day, as follows:</div>
    <div><br>
    </div>
    <div><img src="image00001.jpg"></div>
    <br>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 12pt; color: rgb(0, 0, 0);">If the securities have not been automatically called prior to the stated maturity date, then at maturity you will receive (in addition to the final contingent coupon payment, if
      any) a cash payment per security (the maturity payment amount) calculated as follows:</div>
    <div style="margin-top: 12pt; margin-bottom: 12pt; color: rgb(0, 0, 0);"><font style="font-weight: bold;">Step 1</font>: Determine which Market Measure is the lowest performing Market Measure on the final calculation day. The lowest performing Market
      Measure on the final calculation day is the Market Measure with the lowest performance factor on the final calculation day. The performance factor of an Market Measure on the final calculation day is its ending price as a percentage of its starting
      price (i.e., its ending price divided by its starting price).</div>
    <div style="margin-top: 12pt; margin-bottom: 12pt; color: rgb(0, 0, 0);"><font style="font-weight: bold;">Step 2</font>: Calculate the maturity payment amount based on the ending price of the lowest performing Market Measure, as follows:</div>
    <img src="image00003.jpg">
    <div style="text-align: justify;"><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcdfe0e9079d84971811afb42afb8ecba">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="color: #FFFFFF; font-size: 10pt; font-weight: bold; text-align: center;">Hypothetical Payout Profile</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; color: rgb(0, 0, 0);">The following profile illustrates the potential maturity payment amount on the securities (excluding the final contingent coupon payment, if any) for a range of hypothetical performances of the
      lowest performing Market Measure on the final calculation day from its starting price to its ending price, assuming the securities have not been automatically called prior to the stated maturity date. As this profile illustrates, in no event will you
      have a positive rate of return based solely on the maturity payment amount received at maturity; any positive return will be based solely on the contingent coupon payments, if any, received during the term of the securities. This graph has been
      prepared for purposes of illustration only. Your actual return will depend on whether the securities are automatically called, the actual ending price of the lowest performing Market Measure on the final calculation day and whether you hold your
      securities to stated maturity. The performance of the better performing Market Measures is not relevant to your return on the securities.</div>
    <div style="margin: 12pt 0px 0px; text-align: center;"><img src="image00002.jpg"></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-10</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z43fc1749cafb487e809b828c61746cad">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="color: #FFFFFF; font-size: 10pt; font-weight: bold; text-align: center;">Selected Risk Considerations</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 6pt;">The securities have complex features and investing in the securities will involve risks not associated with an investment in conventional debt securities. Some of the risks that apply to an investment
      in the securities are summarized below, but we urge you to read the more detailed explanation of the risks relating to the securities generally in the &#8220;Risk Factors&#8221; section of the accompanying product supplement. You should reach an investment
      decision only after you have carefully considered with your advisors the appropriateness of an investment in the securities in light of your particular circumstances.</div>
    <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt; font-weight: bold;"><u>Risks Relating To The Securities Generally</u></div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">If The Securities Are Not Automatically Called Prior To Stated Maturity, You May Lose Some Or All Of The Face Amount Of Your Securities At Stated Maturity.</div>
    <div style="text-align: justify; margin-top: 6pt;">We will not repay you a fixed amount on the securities at stated maturity. If the securities are not automatically called prior to stated maturity, you will receive a maturity payment amount that will
      be equal to or less than the face amount, depending on the ending price of the lowest performing Market Measure on the final calculation day.</div>
    <div style="text-align: justify; margin-top: 6pt;">If the ending price of the lowest performing Market Measure on the final calculation day is less than its threshold price, the maturity payment amount will be reduced by an amount equal to the decline
      in the value of the lowest performing Market Measure from its starting price (expressed as a percentage of its starting price). The threshold price for each Market Measure is 70% of its starting price. For example, if the securities are not
      automatically called and the lowest performing Market Measure on the final calculation day has declined by 30.1% from its starting price to its ending price, you will not receive any benefit of the contingent downside protection feature and you will
      lose 30.1% of the face amount. As a result, you will not receive any protection if the value of the lowest performing Market Measure on the final calculation day declines significantly and you may lose some, and possibly all, of the face amount at
      stated maturity, even if the value of the lowest performing Market Measure is greater than or equal to its starting price or its threshold price at certain times during the term of the securities.</div>
    <div style="text-align: justify; margin-top: 6pt;">Even if the ending price of the lowest performing Market Measure on the final calculation day is greater than its threshold price, the maturity payment amount will not exceed the face amount, and your
      yield on the securities, taking into account any contingent coupon payments you may have received during the term of the securities, may be less than the yield you would earn if you bought a traditional interest-bearing debt security of ours or
      another issuer with a similar credit rating with the same stated maturity date.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Securities Do Not Provide For Fixed Payments Of Interest And You May Receive No Coupon Payments On One Or More Contingent Coupon Payment Dates, Or Even Throughout The Entire Term
      Of The Securities.</div>
    <div style="text-align: justify; margin-top: 6pt;">On each contingent coupon payment date you will receive a contingent coupon payment if,<font style="font-weight: bold;"> and only if</font>, the fund closing price of the lowest performing Market
      Measure on the related calculation day is greater than or equal to its threshold price. The threshold price for each Market Measure is 70% of its starting price. If the fund closing price of the lowest performing Market Measure on any calculation day
      is less than its threshold price, you will not receive any contingent coupon payment on the related contingent coupon payment date, and if the fund closing price of the lowest performing Market Measure is less than its threshold price on each
      calculation day over the term of the securities, you will not receive any contingent coupon payments over the entire term of the securities.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Securities Are Subject To The Full Risks Of Each Market Measure And Will Be Negatively Affected If Any Market Measure Performs Poorly, Even If The Other Market Measures Perform
      Favorably.</div>
    <div style="text-align: justify; margin-top: 6pt;">You are subject to the full risks of each Market Measure. If any Market Measure performs poorly, you will be negatively affected, even if the other Market Measures perform favorably. The securities are
      not linked to a basket composed of the Market Measures, where the better performance of some Market Measures could offset the poor performance of others. Instead, you are subject to the full risks of whichever Market Measure is the lowest performing
      Market Measure on each calculation day. As a result, the securities are riskier than an alternative investment linked to only one of the Market Measures or linked to a basket composed of each Market Measure. You should not invest in the securities
      unless you understand and are willing to accept the full downside risks of each Market Measure.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Your Return On The Securities Will Depend Solely On The Performance Of The Market Measure That Is The Lowest Performing Market Measure On Each Calculation Day, And You Will Not
      Benefit In Any Way From The Performance Of The Better Performing Market Measures.</div>
    <div style="text-align: justify; margin-top: 6pt;">Your return on the securities will depend solely on the performance of the Market Measure that is the lowest performing Market Measure on each calculation day. Although it is necessary for each Market
      Measure to close at or above its respective threshold price on the relevant calculation day in order for you to receive a contingent coupon payment and at or above its respective threshold price on the final calculation day for you to receive the
      face amount of your securities at maturity, you will not benefit in any way from the performance of the better performing Market Measures. The securities may underperform an alternative investment linked to a basket composed of the Market Measures,
      since in such case the performance of the better performing Market Measures would be blended</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-11</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;">with the performance of the lowest performing Market Measure, resulting in a better return than the return of the lowest performing Market Measure alone.</div>
    <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0); font-weight: bold;">You Will Be Subject To Risks Resulting From The Relationship Among The Market Measures.</div>
    <div style="text-align: justify; margin-top: 6pt;">It is preferable from your perspective for the Market Measures to be correlated with each other so that their values will tend to increase or decrease at similar times and by similar magnitudes. By
      investing in the securities, you assume the risk that the Market Measures will not exhibit this relationship. The less correlated the Market Measures, the more likely it is that any one of the Market Measures will be performing poorly at any time
      over the term of the securities. All that is necessary for the securities to perform poorly is for one of the Market Measures to perform poorly; the performance of the better performing Market Measures is not relevant to your return on the
      securities. It is impossible to predict what the relationship among the Market Measures will be over the term of the securities. To the extent the Market Measures represent a different equity market, such equity markets may not perform similarly over
      the term of the securities.</div>
    <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0); font-weight: bold;">You May Be Fully Exposed To The Decline In The Lowest Performing Market Measure On The Final Calculation Day From Its Starting price, But Will Not Participate In
      Any Positive Performance Of Any Market Measure.</div>
    <div style="text-align: justify; margin-top: 6pt;">Even though you will be fully exposed to a decline in the value of the lowest performing Market Measure on the final calculation day if its ending price is below its threshold price, you will not
      participate in any increase in the value of any Market Measure over the term of the securities. Your maximum possible return on the securities will be limited to the sum of the contingent coupon payments you receive, if any. Consequently, your return
      on the securities may be significantly less than the return you could achieve on an alternative investment that provides for participation in an increase in the value of any or each Market Measure.</div>
    <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0); font-weight: bold;">Higher Contingent Coupon Rates Are Associated With Greater Risk.</div>
    <div style="text-align: justify; margin-top: 6pt;">The securities offer contingent coupon payments at a higher rate, if paid, than the fixed rate we would pay on conventional debt securities of the same maturity. These higher potential contingent
      coupon payments are associated with greater levels of expected risk as of the pricing date as compared to conventional debt securities, including the risk that you may not receive a contingent coupon payment on one or more, or any, contingent coupon
      payment dates and the risk that you may lose a substantial portion, and possibly all, of the face amount at maturity. The volatility of the Market Measures and the correlation among the Market Measures are important factors affecting this risk.
      Volatility is a measurement of the size and frequency of daily fluctuations in the value of an Market Measure, typically observed over a specified period of time. Volatility can be measured in a variety of ways, including on a historical basis or on
      an expected basis as implied by option prices in the market. Correlation is a measurement of the extent to which the values of the Market Measures tend to fluctuate at the same time, in the same direction and in similar magnitudes. Greater expected
      volatility of the Market Measures or lower expected correlation among the Market Measures as of the pricing date may result in a higher contingent coupon rate, but it also represents a greater expected likelihood as of the pricing date that the fund
      closing price of at least one Market Measure will be less than its threshold price on one or more calculation days, such that you will not receive one or more, or any, contingent coupon payments during the term of the securities, and that the fund
      closing price of at least one Market Measure will be less than its threshold price on the final calculation day such that you will lose a substantial portion, and possibly all, of the face amount at maturity. In general, the higher the contingent
      coupon rate is relative to the fixed rate we would pay on conventional debt securities, the greater the expected risk that you will not receive one or more, or any, contingent coupon payments during the term of the securities and that you will lose a
      substantial portion, and possibly all, of the face amount at maturity.</div>
    <div style="text-align: justify; margin-top: 10pt; margin-bottom: 3pt; font-weight: bold;">The Securities Are Subject To A Potential Automatic Call, Which Would Limit Your Ability To Receive Further Payment On The Securities.</div>
    <div style="text-align: justify; margin-top: 10pt; margin-bottom: 3pt;">The securities are subject to a potential automatic call. If your securities are automatically called early, the term of the securities may be reduced to as short as approximately
      six months. The securities will be automatically called if, on any calculation day occurring in January, April, July and October from January 2026 to April 2029, inclusive, the fund closing price of the lowest performing Market Measure is greater
      than or equal to its starting price. If the securities are automatically called, you will be entitled to receive the face amount plus a final contingent coupon payment, and no further amounts will be payable with respect to the securities. In this
      case, you will lose the opportunity to receive payment of any contingent coupon payments that otherwise would be payable after the date of the automatic call. If the securities are called, you may be unable to invest in other securities with a
      similar level of risk that could provide a return that is similar to the securities.</div>
    <div style="text-align: justify; margin-top: 4.5pt; font-weight: bold;">A Contingent Coupon Payment Date, A Call Settlement Date Or The Stated Maturity Date May Be Postponed If A Calculation Day Is Postponed.</div>
    <div style="text-align: justify; margin-top: 6pt;">A calculation day (including the final calculation day) with respect to an Market Measure will be postponed if the applicable originally scheduled calculation day is not a trading day with respect to
      any Market Measure or if the calculation agent determines that a market disruption event has occurred or is continuing with respect to that Market Measure on that calculation day. If such a postponement occurs with respect to a calculation day other
      than the final calculation day, then the related contingent coupon payment date or call settlement date, as applicable, will be postponed. If such a postponement occurs with respect to the final calculation day, the stated maturity date will be the
      later of (i) the initial stated maturity date and (ii) three business days after the last final calculation day as postponed.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-12</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Tax Consequences Of An Investment In Your Securities Are Uncertain.</div>
    <div style="text-align: justify; margin-top: 6pt;">The tax consequences of an investment in your securities are uncertain, both as to the timing and character of any inclusion in income in respect of your securities.</div>
    <div style="text-align: justify; margin-top: 6pt;">The Internal Revenue Service (&#8220;IRS&#8221;) announced on December 7, 2007 that it is considering issuing guidance regarding the tax treatment of an instrument such as your securities, and any such guidance
      could adversely affect the value and the tax treatment of your securities. Among other things, the IRS may decide to require the holders to accrue ordinary income on a current basis and recognize ordinary income on payment at maturity, and could
      subject non-U.S. investors to withholding tax. Furthermore, in 2007, legislation was introduced in Congress that, if enacted, would have required holders that acquired instruments such as your securities after the bill was enacted to accrue interest
      income over the term of such instruments. It is not possible to predict whether a similar or identical bill will be enacted in the future, or whether any such bill would affect the tax treatment of your securities. We describe these developments in
      more detail under &#8220;Supplemental Discussion of U.S. Federal Income Tax Consequences &#8211; U.S. Holders &#8211; Possible Change in Law&#8221; below. You should consult your tax advisor about this matter. Except to the extent otherwise provided by law, we intend to
      continue treating the securities for U.S. federal income tax purposes in accordance with the treatment described under &#8220;Supplemental Discussion of U.S. Federal Income Tax Consequences&#8221; below unless and until such time as Congress, the Treasury
      Department or the IRS determine that some other treatment is more appropriate. Please also consult your tax advisor concerning the U.S. federal income tax and any other applicable tax consequences to you of owning your securities in your particular
      circumstances.</div>
    <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt; font-weight: bold;">Your Securities may be subject to the constructive ownership rules.</div>
    <div style="text-align: justify; margin-top: 6pt;">There exists a risk that the constructive ownership rules of Section 1260 of the Internal Revenue Code could apply to your securities. If your securities were
      subject to the constructive ownership rules, then any long-term capital gain that you realize upon the sale, exchange, redemption or maturity of your securities would be re-characterized as ordinary income (and you would be subject to an interest
      charge on deferred tax liability with respect to such re-characterized capital gain) to the extent that such capital gain exceeds the amount of &#8220;net underlying long-term capital gain&#8221; (as defined in Section 1260 of the Internal Revenue Code). Because
      the application of the constructive ownership rules is unclear you are strongly urged to consult your tax advisor with respect to the possible application of the constructive ownership rules to your investment in the securities.</div>
    <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt; font-weight: bold;"><u>Risks Relating To An Investment In Our Debt Securities, Including The Securities</u></div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Securities Are Subject To Our Credit Risk.</div>
    <div style="text-align: justify; margin-top: 6pt;">The securities are our obligations and are not, either directly or indirectly, an obligation of any other third party. Any amounts payable under the securities are subject to our creditworthiness and
      you will have no ability to pursue any Market Measure or any securities included in any Market Measure for payment. As a result, our actual and perceived creditworthiness may affect the value of the securities and, in the event we were to default on
      our obligations under the securities, you may not receive any amounts owed to you under the terms of the securities.</div>
    <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt; font-weight: bold;"><u>Risks Relating To The Estimated Value Of The Securities And Any Secondary Market</u></div>
    <div style="text-align: justify; margin-bottom: 10pt; font-weight: bold;">The Estimated Value Of The Securities On The Pricing Date, Based On Jefferies LLC Proprietary Pricing Models At That Time And Our Internal Funding Rate, Will Be Less Than The
      Original Offering Price.</div>
    <div style="text-align: justify; margin-bottom: 12pt;">The difference is attributable to certain costs associated with selling, structuring and hedging the securities that are included in the original offering price.&#160; These costs include (i) the
      selling concessions paid in connection with the offering of the securities, (ii) hedging and other costs incurred by us and our subsidiaries in connection with the offering of the securities and (iii) the expected profit (which may be more or less
      than actual profit) to Jefferies LLC or other of our subsidiaries in connection with hedging our obligations under the securities.&#160; These costs adversely affect the economic terms of the securities because, if they were lower, the economic terms of
      the securities would be more favorable to you.&#160; The economic terms of the securities are also likely to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities.&#160; See &#8220;The estimated
      value of the securities would be lower if it were calculated based on our secondary market rate&#8221; below.</div>
    <div style="text-align: justify; margin-bottom: 10pt; font-weight: bold;">The Estimated Value Of The Securities Was Determined For Us By Our Subsidiary Using Proprietary Pricing Models.</div>
    <div style="text-align: justify;">Jefferies LLC derived the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models at that time.&#160; In doing so, it may have made discretionary judgments about the inputs
      to its models, such as the volatility of the Market Measures.&#160; Jefferies LLC&#8217;s views on these inputs and assumptions may differ from your or others&#8217; views, and as an agent in this offering, Jefferies LLC&#8217;s interests may conflict with yours.&#160; Both the
      models and the inputs to the models may prove to be wrong and therefore not an accurate reflection of the value of the securities.&#160; Moreover, the estimated value of the securities set forth on the cover page of</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-13</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">this pricing supplement may differ from the value that we or our subsidiaries may determine for the securities for other purposes, including for accounting purposes.&#160; You should not invest in the
      securities because of the estimated value of the securities.&#160; Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.</div>
    <div style="text-align: justify; margin-bottom: 12pt;">Since the estimated value of the securities is a function of the underlying assumptions and construction of Jefferies LLC&#8217;s proprietary derivative-pricing model, modifications to this model will
      impact the estimated value calculation.&#160; Jefferies LLC&#8217;s proprietary models are subject to ongoing review and modification, and Jefferies LLC may change them at any time and for a variety of reasons.&#160; In the event of a model change, prior
      descriptions of the model and computations based on the older model will be superseded, and calculations of estimated value under the new model may differ significantly from those under the older model.&#160; Further, model changes may cause a larger
      impact on the estimated value of a note with a particular return formula than on a similar note with a different return formula.&#160; For example, to the extent a return formula contains leverage, model changes may cause a larger impact on the estimated
      value of that note than on a similar note without such leverage.</div>
    <div style="text-align: justify; margin-bottom: 10pt; font-weight: bold;">The Estimated Value Of The Securities Would Be Lower If It Were Calculated Based On Our Secondary Market Rate.</div>
    <div style="text-align: justify; margin-bottom: 12pt;">The estimated value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which we are willing to borrow funds through the
      issuance of the securities.&#160; Our internal funding rate is generally lower than our secondary market rate, which is the rate that Jefferies LLC will use in determining the value of the securities for purposes of any purchases of the securities from
      you in the secondary market.&#160; If the estimated value included in this pricing supplement were based on our secondary market rate, rather than our internal funding rate, it would likely be lower.&#160; We determine our internal funding rate based on
      factors such as the costs associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity needs and preferences.&#160; Our internal funding rate is not the same as the interest that
      is payable on the securities.</div>
    <div style="text-align: justify; margin-bottom: 12pt;">Because there is not an active market for traded instruments referencing our outstanding debt obligations, Jefferies LLC determines our secondary market rate based on the market price of traded
      instruments referencing our debt obligations, but subject to adjustments that Jefferies LLC makes in its sole discretion.&#160; As a result, our secondary market rate is not a market-determined measure of our creditworthiness, but rather reflects the
      market&#8217;s perception of our creditworthiness as adjusted for discretionary factors such as Jefferies LLC&#8217;s preferences with respect to purchasing the securities prior to maturity.</div>
    <div style="text-align: justify; margin-bottom: 10pt; font-weight: bold;">The Estimated Value Of The Securities Is Not An Indication Of The Price, If Any, At Which WFS, Jefferies LLC Or Any Other Person May Be Willing To Buy The Securities From You In
      The Secondary Market.</div>
    <div style="text-align: justify; margin-bottom: 12pt;">Any such secondary market price will fluctuate over the term of the securities based on the market and other factors described in the next risk factor.&#160; In addition, any secondary market price for
      the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount of the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging
      transactions.&#160; As a result, it is likely that any secondary market price for the securities will be less than the original offering price.</div>
    <div style="text-align: justify; margin-top: 6pt;">WFS has advised us that if it, WFA or any of their affiliates makes a secondary market in the securities at any time, the secondary market price offered by it, WFA or any of their affiliates will be
      affected by changes in market conditions and other factors described in the next risk factor. WFS has advised us that if it, WFA or any of their affiliates makes a secondary market in the securities at any time up to the issue date or during the
      4-month period following the issue date, the secondary market price offered by it, WFA or any of their affiliates will be increased by an amount reflecting a portion of the costs associated with selling, structuring and hedging the securities that
      are included in their original offering price.&#160; Because this portion of the costs is not fully deducted upon issuance, WFS has advised us that any secondary market price it, WFA or any of their affiliates offers during this period will be higher than
      it otherwise would be after this period, as any secondary market price offered after this period will reflect the full deduction of the costs as described above. WFS has advised us that the amount of this increase in the secondary market price will
      decline steadily to zero over this 4-month period.&#160; WFS has advised us that, if you hold the securities through an account with WFS, WFA or any of their affiliates, WFS expects that this increase will also be reflected in the value indicated for the
      securities on your brokerage account statement.&#160; If you hold your securities through an account at a broker-dealer other than WFS, WFA or any of their affiliates, the value of the securities on your brokerage account statement may be different than
      if you held your securities at WFS, WFA or any of their affiliates.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Value Of The Securities Prior To Stated Maturity Will Be Affected By Numerous Factors, Some Of Which Are Related In Complex Ways.</div>
    <div style="text-align: justify; margin-top: 6pt;">The value of the securities prior to stated maturity will be affected by the then-current value of the Market Measures, interest rates at that time and a number of other factors, some of which are
      interrelated in complex ways. The effect of any one factor may be offset or magnified by the effect of another factor. The following factors, which we refer to as the &#8220;<u>derivative component factors</u>,&#8221; and which are described in more detail in
      the accompanying product supplement, are expected to affect the value of the securities: Market Measure performance of each Market Measure; interest rates; volatility of the Market Measures; correlation among the Market Measures; time</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-14</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;">remaining to maturity; and dividend yields on the Market Measures and the securities included in each Market Measure.&#160; When we refer to the &#8220;<u>value</u>&#8221; of your security, we mean the value you could
      receive for your security if you are able to sell it in the open market before the stated maturity date.</div>
    <div style="text-align: justify; margin-top: 6pt;">In addition to the derivative component factors, the value of the securities will be affected by actual or anticipated changes in our creditworthiness. The value of the securities will also be limited
      by the automatic call feature because if the securities are automatically called, you will not receive the contingent coupon payments that would have been paid, if any, had the securities been called on a later calculation day or held until the
      stated maturity date. You should understand that the impact of one of the factors specified above, such as a change in interest rates, may offset some or all of any change in the value of the securities attributable to another factor, such as a
      change in the value of any or all of the Market Measures.&#160; Because numerous factors are expected to affect the value of the securities, changes in the values of the Market Measures may not result in a comparable change in the value of the securities.</div>
    <div style="text-align: justify; margin-top: 4.5pt; font-weight: bold;">The Securities Will Not Be Listed On Any Securities Exchange And We Do Not Expect A Trading Market For The Securities To Develop.</div>
    <div style="text-align: justify; margin-top: 6pt;">The securities will not be listed or displayed on any securities exchange or any automated quotation system. Although the agents and/or their respective affiliates may purchase the securities from
      holders, they are not obligated to do so and are not required to make a market for the securities. There can be no assurance that a secondary market will develop. Because we do not expect that any market makers will participate in a secondary market
      for the securities, the price at which you may be able to sell your securities is likely to depend on the price, if any, at which the agents are willing to buy your securities. If a secondary market does exist, it may be limited. Accordingly, there
      may be a limited number of buyers if you decide to sell your securities prior to stated maturity. This may affect the price you receive upon such sale. Consequently, you should be willing to hold the securities to stated maturity.</div>
    <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt; font-weight: bold;"><u>Risks Relating To The Market Measures</u></div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Any Payments On The Securities And Whether The Securities Are Automatically Called Will Depend Upon The Performance Of Each Market Measure And Therefore The Securities Are Subject To
      The Following Risks, Each As Discussed In More Detail In The Accompanying Product Supplement.</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z2b5bf1da1b51424fa14e4f2d77e51b24">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="font-weight: bold;">Investing In The Securities Is Not The Same As Investing In The Market Measures. </font><font style="color: rgb(0, 0, 0);">Investing in the securities is not equivalent to investing in the Market Measures.
                As an investor in the securities, your return will not reflect the return you would realize if you actually owned and held the Market Measures or the securities included in the Market Measures for a period similar to the term of the
                securities because you will not receive any dividend payments, distributions or any other payments paid on those securities. As a holder of the securities, you will not have any voting rights or any other rights that holders of the Market
                Measures or the securities included in the Market Measures would have.</font></div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zea9a842c395643b8841ac4ac122f7f81">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">Historical Values Of A Market Measure Should Not Be Taken As An Indication Of The Future Performance Of Such Market Measure During The Term Of The Securities.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z97f6fec5c8a548298209f089d9d9734a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">Changes That Affect A Market Measure Or Its Fund Underlying Index May Adversely Affect The Value Of The Securities And Any Payments On The Securities.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z76ae307eb786413ca087559791b7c67d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">We Cannot Control Actions By Any Of The Unaffiliated Companies Whose Securities Are Included In A Market Measure Or Its Fund Underlying Index,.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zb0e28a65686944f2910d970403c0d124">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">We And Our Subsidiaries Have No Affiliation With Any Market Measure Sponsor Or the Sponsor of each Fund Underlying Index, And Have Not Independently Verified Their Public Disclosure Of Information.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z8c6829a7c3824a50bf4e2bfb1090c2a4">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">An Investment Linked To The Shares Of The Market Measures Is Different From An Investment Linked To Their Underlying Indices.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="z55a9c538a2114c6fa68c919f5d345e48">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">There Are Risks Associated With A Fund.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 4.5pt;" class="DSPFListTable" id="zc7f5e2e6272e417f8161639c7d8087e0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">Anti-dilution Adjustments Relating To The Shares Of A Fund Do Not Address Every Event That Could Affect Such Shares.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: -25.8pt; margin-right: 28.05pt; margin-left: 25.8pt; font-size: 8pt;"><font style="font-size: 9pt; font-weight: bold;">The Stocks Held By The Market Measures Are Concentrated In A Few Sectors.</font><font style="color: rgb(88, 89, 91);">&#160;</font></div>
    <div style="margin-right: 28.1pt;">The Market Measures hold securities issues by companies in the utilities, regional banking and biotechnology sectors. As a result, the stocks that will determine the performance of the securities are concentrated in
      just a few sectors. Although an investment in the securities will not give holders any ownership or other direct interests in the securities held by the Market Measures, the return on an investment in the securities will be subject to certain risks
      associated with a direct equity investment in these sectors. Accordingly, by investing in the securities, you will not benefit from the diversification which could result from an investment linked to companies that operate in multiple sectors.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin-right: 28.05pt; font-weight: bold;">Adverse Conditions In The Utilities Sector May Reduce Your Return On The Securities.</div>
    <div style="margin-right: 28.05pt;">All of the stocks held by the XLU are issued by companies whose primary lines of business are directly associated with the utilities sector. Utility companies are affected by supply and demand, operating costs,
      government regulation, environmental factors, liabilities for environmental damage and general civil liabilities. Due to the capital intensive nature of utilities, many of these companies tend to be more greatly impacted by interest rates due to
      their relatively high debt ratios. Additionally, certain utility companies have experienced full or partial deregulation in recent years, and are therefore subject to greater competition.&#160; As a result of these factors, the value of the securities may
      be subject to greater volatility and be more adversely affected by economic, political, or regulatory events relating to the utilities sector.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">The Securities Are Subject To Risks Associated With The Banking Industry.</div>
    <div>All of the stocks held by the KRE are issued by companies in the banking industry. The performance of companies in the banking industry are influenced by many complex and unpredictable factors, including industry competition, interest rates,
      geopolitical events, the ability of borrowers to repay loans, government regulation, and supply and demand for the products and services offered by such companies. Any adverse development in the banking industry may have a material adverse effect on
      the stocks held by the KRE, and as a result, on the value of the securities. The securities may be subject to greater volatility and be more adversely affected by a single positive or negative economic, political or regulatory occurrence affecting
      this industry than a different investment linked to securities of a more broadly diversified group of issuers.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Adverse Conditions In The Biotechnology Sector May Reduce Your Return On The Securities.</div>
    <div style="margin-bottom: 12pt;">All of the stocks held by the XBI are issued by companies whose primary lines of business are directly associated with the biotechnology sector. The profitability of these companies is largely dependent on, among other
      things, demand for the companies&#8217; products, regulatory influences on the biotechnology market (including healthcare reform and receipt of regulatory approvals and compliance with complex regulatory requirements), pricing and reimbursement from third
      party payors, continued innovation and successful development of new products, talent attraction and retention, maintaining intellectual property rights and industry competition. Any adverse developments affecting the biotechnology sector could
      adversely affect the price of the XBI and, in turn, the value of the securities.</div>
    <div style="margin-bottom: 12pt; font-weight: bold;"><u>Risks Relating To Conflicts Of Interest</u></div>
    <div style="text-align: justify; font-weight: bold;">Our Economic Interests And Those Of Any Dealer Participating In The Offering Are Potentially Adverse To Your Interests.</div>
    <div style="text-align: justify; margin-top: 6pt;">You should be aware of the following ways in which our economic interests and those of any dealer participating in the distribution of the securities, which we refer to as a &#8220;<u>participating dealer</u>,&#8221;










      are potentially adverse to your interests as an investor in the securities.&#160; In engaging in certain of the activities described below and as discussed in more detail in the accompanying product supplement, our subsidiaries or any participating dealer
      or its affiliates may take actions that may adversely affect the value of and your return on the securities, and in so doing they will have no obligation to consider your interests as an investor in the securities.&#160; Our subsidiaries or any
      participating dealer or its affiliates may realize a profit from these activities even if investors do not receive a favorable investment return on the securities.</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 9pt; margin-top: 6pt;" class="DSPFListTable" id="ze2ac668c4c2b43c48f7d68eedf9732a5">

        <tr>
          <td style="width: 18pt;">&#160;</td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="font-weight: bold; font-style: italic;">The calculation agent is our subsidiary and may be required to make discretionary judgments that affect the return you receive on the securities.</font><font style="font-style: italic;">&#160;
              </font>JFSI, a wholly owned subsidiary of Jefferies Financial Group Inc., will be the calculation agent for the securities.&#160; As calculation agent, JFSI will determine any values of the Market Measures and make any other determinations
              necessary to calculate any payments on the securities. In making these determinations, JFSI may be required to make discretionary judgments that may adversely affect any payments on the securities.&#160; See the sections entitled &#8220;General Terms of
              the Securities&#8212; Certain Terms for Securities Linked to an Fund&#8212;Market Disruption Events,&#8221;&#8212;Adjustments to an Fund&#8221; and &#8220;&#8212;Discontinuance of an Fund&#8221; in the accompanying product supplement. In making these discretionary judgments, the fact that
              JFSI is our subsidiary may cause it to have economic interests that are adverse to your interests as an investor in the securities, and JFSI&#8217;s determinations as calculation agent may adversely affect your return on the securities.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 9pt; margin-top: 6pt;" class="DSPFListTable" id="zbd362d22cfb14819bc2e62cd1794f72a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-style: italic; font-weight: bold;">Research reports by our subsidiaries or any participating dealer or its affiliates may be inconsistent with an investment in the securities and may adversely affect the value of A Market
              Measure. </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 9pt; margin-top: 6pt;" class="DSPFListTable" id="z9e87d2d6f0f04713908006fc4d04f850">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="font-weight: bold; font-style: italic;">Business activities of our subsidiaries or any participating dealer or its affiliates with the companies whose securities are included in A Market Measure may adversely affect the value
                of such Market Measure. </font></div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 9pt; margin-top: 6pt;" class="DSPFListTable" id="z6dc5584a1f2c414ca9785ad64e6aeda4">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="font-weight: bold; font-style: italic;">Hedging activities by our subsidiaries or any participating dealer or its affiliates may adversely affect the value of A Market Measure.</font></div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z9ee9f3d68c7f41feb4c918fdaeefba4a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="font-weight: bold; font-style: italic;">Trading activities by our subsidiaries or any participating dealer or its affiliates may adversely affect the value of A Market Measure. </font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-16</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="zc821997e9c394f4e811d7f4bba1b7b9d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-style: italic; font-weight: bold;">A participating dealer or its affiliates may realize hedging profits projected by its proprietary pricing models in addition to any selling concession and/or distribution expense fee, creating
              a further incentive for the participating dealer to sell the securities to you.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
  <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageFooter" style="width: 100%;"></div>
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-17</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    <div class="BRPFPageHeader" style="width: 100%;">
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 99.88%; vertical-align: top;">
              <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
              <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                  S&amp;P Biotech ETF due July 19, 2029</font></div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z88a8a4175ac6429a8c747e4e1b61936e">

          <tr>
            <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
              <div style="color: rgb(255, 255, 255); font-size: 10pt; font-weight: bold; text-align: center;">Hypothetical Returns</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="margin-top: 6pt; margin-bottom: 6pt; font-weight: bold;">If the securities are automatically called:</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">If the securities are automatically called prior to stated maturity, you will receive the face amount of your securities plus a final contingent coupon payment on the call settlement date. In the event
      the securities are automatically called, your total return on the securities will equal any contingent coupon payments received prior to the call settlement date and the contingent coupon payment received on the call settlement date.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt; font-weight: bold;">If the securities are not automatically called:</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">If the securities are not automatically called prior to stated maturity, the following table illustrates, for a range of hypothetical performance factors of the lowest performing Market Measure on the
      final calculation day, the hypothetical maturity payment amount payable at stated maturity per security (excluding the final contingent coupon payment, if any). The performance factor of the lowest performing Market Measure on the final calculation
      day is its ending price expressed as a percentage of its starting price (i.e., its ending price <font style="font-style: italic;">divided by </font>its starting price).</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zaf4e2dbdc23d4310b5bede255a5d4557">

        <tr>
          <td nowrap="nowrap" style="width: 70%; vertical-align: middle; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="margin-right: 3.6pt; margin-left: 3.6pt; color: rgb(0, 0, 0);"><font style="font-weight: bold;">Hypothetical</font>&#160;<font style="font-weight: bold;">performance factor of lowest performing Market Measure</font></div>
            <div style="margin-right: 3.6pt; margin-left: 3.6pt; color: rgb(0, 0, 0); font-weight: bold;">on final calculation day</div>
          </td>
          <td nowrap="nowrap" style="width: 30%; vertical-align: middle; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; margin-right: 3.6pt; margin-left: 3.6pt; color: rgb(0, 0, 0); font-weight: bold;">Hypothetical Maturity Payment</div>
            <div style="text-align: center; margin-right: 3.6pt; margin-left: 3.6pt; color: rgb(0, 0, 0); font-weight: bold;">Amount per Security</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">175.00%</div>
          </td>
          <td style="width: 30%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">160.00%</div>
          </td>
          <td style="width: 30%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">150.00%</div>
          </td>
          <td style="width: 30%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">140.00%</div>
          </td>
          <td style="width: 30%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">130.00%</div>
          </td>
          <td style="width: 30%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">120.00%</div>
          </td>
          <td style="width: 30%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">110.00%</div>
          </td>
          <td style="width: 30%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00%</div>
          </td>
          <td style="width: 30%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">90.00%</div>
          </td>
          <td style="width: 30%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">80.00%</div>
          </td>
          <td style="width: 30%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">75.00%</div>
          </td>
          <td style="width: 30%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00%</div>
          </td>
          <td style="width: 30%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$1,000.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">69.00%</div>
          </td>
          <td style="width: 30%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$690.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">50.00%</div>
          </td>
          <td style="width: 30%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$500.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">40.00%</div>
          </td>
          <td style="width: 30%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$400.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">30.00%</div>
          </td>
          <td style="width: 30%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">$300.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt; color: rgb(0, 0, 0);">25.00%</div>
          </td>
          <td style="width: 30%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt; color: rgb(0, 0, 0);">$250.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt; color: rgb(0, 0, 0);">0.00%</div>
          </td>
          <td style="width: 30%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt; color: rgb(0, 0, 0);">$0.00</div>
          </td>
        </tr>

    </table>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">The above figures do not take into account contingent coupon payments, if any, received during the term of the securities. As evidenced above, in no event will you have a positive rate of return based
      solely on the maturity payment amount received at maturity; any positive return will be based solely on the contingent coupon payments, if any, received during the term of the securities.</div>
    <div style="margin-top: 6pt;">The above figures are for purposes of illustration only and may have been rounded for ease of analysis. If the securities are not automatically called prior to stated maturity, the actual amount you will receive at stated
      maturity will depend on the actual ending price of the lowest performing Market Measure on the final calculation day. The performance of the better performing Market Measures is not relevant to your return on the securities.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-18</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1bd02b62eeb242159c784131440940ac">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="color: rgb(255, 255, 255); font-size: 10pt; font-weight: bold; text-align: center;">Hypothetical Contingent Coupon Payments</div>
          </td>
        </tr>

    </table>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">
      <div style="margin-top: 6pt; margin-bottom: 6pt;">Set forth below are examples that illustrate how to determine whether a contingent coupon payment will be paid and whether the securities will be automatically called, if applicable, on a contingent
        coupon payment date prior to the stated maturity date. The examples do not reflect any specific contingent coupon payment date. The following examples assume that the securities are subject to automatic call on the applicable calculation day. The
        securities will not be subject to automatic call until the sixth calculation day, which is approximately six months after the issue date. The following examples reflect a hypothetical contingent coupon rate of 13.40% per annum and assume the
        hypothetical starting price, threshold price and fund closing prices for each Market Measure indicated in the examples. The terms used for purposes of these hypothetical examples do not represent any actual starting price or threshold price. The
        hypothetical starting price of 100.00 for each Market Measure has been chosen for illustrative purposes only and does not represent the actual starting price for any Market Measure. The actual starting price and threshold price for each Market
        Measure is set forth under &#8220;Terms of the Securities&#8221; above. For historical data regarding the actual fund closing prices of the Market Measures, see the historical information provided below. These examples are for purposes of illustration only and
        the values used in the examples may have been rounded for ease of analysis.</div>
    </div>
    <div style="font-weight: bold;">Example 1. The fund closing price of the lowest performing Market Measure on the relevant calculation day is greater than or equal to its threshold price and less than its starting price. As a result, investors receive a
      contingent coupon payment on the applicable contingent coupon payment date and the securities are not automatically called.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zfbfe7fbeccb843689413400813358bda">

        <tr>
          <td style="vertical-align: bottom; width: 35%;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(104, 143, 207); vertical-align: middle; white-space: nowrap; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fund</div>
          </td>
          <td style="border-bottom: 1px solid rgb(104, 143, 207); vertical-align: middle; white-space: nowrap; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Banking ETF</div>
          </td>
          <td style="border-bottom: 1px solid rgb(104, 143, 207); vertical-align: bottom; white-space: nowrap; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF</div>
          </td>
        </tr>
        <tr>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); vertical-align: top; width: 35%;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical starting price:</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); vertical-align: bottom; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); vertical-align: bottom; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
        </tr>
        <tr>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); vertical-align: top; width: 35%;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical fund closing price on relevant calculation day:</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); vertical-align: bottom; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">90.00</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">95.00</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); vertical-align: bottom; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">80.00</div>
          </td>
        </tr>
        <tr>
          <td style="background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); vertical-align: top; width: 35%; padding-bottom: 1px;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical threshold price:</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid; vertical-align: bottom; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-bottom: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid; vertical-align: bottom; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
        </tr>
        <tr>
          <td style="background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); vertical-align: top; width: 35%;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Performance factor (fund closing price on calculation day <font style="font-style: italic;">divided by</font> starting price):</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">90.00%</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">95.00%</div>
          </td>
          <td style="background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">80.00%</div>
          </td>
        </tr>

    </table>
    <div style="margin: 15pt 0px 6pt;"><u>Step 1</u>: Determine which Market Measure is the lowest performing Market Measure on the relevant calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">In this example, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF has the lowest performance factor and is, therefore, the lowest performing Market Measure on the relevant calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;"><u>Step 2</u>: Determine whether a contingent coupon payment will be paid and whether the securities will be automatically called on the applicable contingent coupon payment date.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">Since the hypothetical fund closing price of the lowest performing Market Measure on the relevant calculation day is greater than or equal to its threshold price, but less than its starting price, you
      would receive a contingent coupon payment on the applicable contingent coupon payment date and the securities would not be automatically called. The contingent coupon payment would be equal to $11.17 per security, determined as follows: (i) $1,000 <font style="font-style: italic;">multiplied by</font> 13.40% per annum <font style="font-style: italic;">divided by</font> (ii) 12, rounded to the nearest cent.</div>
    <div style="margin: 0px 0px 15pt; font-weight: bold; text-align: justify;">Example 2. The fund closing price of the lowest performing Market Measure on the relevant calculation day is less than its threshold price. As a result, investors do not receive
      a contingent coupon payment on the applicable contingent coupon payment date and the securities are not automatically called.</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2fd61784bb1048139be25e966e6f58ff">

        <tr>
          <td style="width: 35%; vertical-align: bottom;">&#160;</td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: middle; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Utilities Select Sector </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund</div>
          </td>
          <td nowrap="nowrap" style="width: 25.26%; vertical-align: middle; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Banking ETF</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: bottom; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical starting price:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical fund closing price on relevant calculation day:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">60.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">105.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">102.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical threshold price:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; border-top: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Performance factor (fund closing price on calculation day <font style="font-style: italic;">divided by</font> starting price):</div>
          </td>
          <td style="width: 20%; vertical-align: middle; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">60.00%</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; border-top: 1px solid #FFFFFF; vertical-align: middle; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">105.00%</div>
          </td>
          <td style="width: 20%; vertical-align: middle; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">102.00%</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-19</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;"><u>Step 1</u>: Determine which Market Measure is the lowest performing Market Measure on the relevant calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">In this example, the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund has the lowest performance factor and is, therefore, the lowest performing Market Measure on the relevant calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;"><u>Step 2</u>: Determine whether a contingent coupon payment will be paid and whether the securities will be automatically called on the applicable contingent coupon payment date.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">Since the hypothetical fund closing price of the lowest performing Market Measure on the relevant calculation day is less than its threshold price, you would not receive a contingent coupon payment on
      the applicable contingent coupon payment date. In addition, the securities would not be automatically called, even though the fund closing prices of the better performing Market Measures on the relevant calculation day are greater than their starting
      prices. As this example illustrates, whether you receive a contingent coupon payment and whether the securities are automatically called on a contingent coupon payment date will depend solely on the fund closing price of the lowest performing Market
      Measure on the relevant calculation day. The performance of the better performing Market Measures is not relevant to your return on the securities.</div>
    <div style="text-align: justify; font-weight: bold;">Example 3. The fund closing price of the lowest performing Market Measure on the relevant calculation day is greater than or equal to its starting price. As a result, the securities are automatically
      called on the applicable contingent coupon payment date for the face amount plus a final contingent coupon payment.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z88b3788e302e45dd9dc0b3ab37334d74">

        <tr>
          <td style="width: 35%; vertical-align: bottom;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(104, 143, 207); vertical-align: middle; white-space: nowrap; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Utilities Select Sector </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund</div>
          </td>
          <td nowrap="nowrap" style="width: 25.26%; vertical-align: middle; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Banking ETF</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: bottom; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical starting price:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical fund closing price on relevant calculation day:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">115.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">105.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">115.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical threshold price:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; border-top: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Performance factor (fund closing price on calculation day <font style="font-style: italic;">divided by</font> starting price):</div>
          </td>
          <td style="width: 20%; vertical-align: middle; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">115.00%</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; border-top: 1px solid #FFFFFF; vertical-align: middle; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">105.00%</div>
          </td>
          <td style="width: 20%; vertical-align: middle; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">115.00%</div>
          </td>
        </tr>

    </table>
    <div style="margin: 15pt 0px 6pt;"><u>Step 1</u>: Determine which Market Measure is the lowest performing Market Measure on the relevant calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">In this example, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional Banking ETF has the lowest performance factor and is, therefore, the lowest performing Market Measure on the relevant calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;"><u>Step 2</u>: Determine whether a contingent coupon payment will be paid and whether the securities will be automatically called on the applicable contingent coupon payment date.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">Since the hypothetical fund closing price of the lowest performing Market Measure on the relevant calculation day is greater than or equal to its starting price, the securities would be automatically
      called and you would receive the face amount plus a final contingent coupon payment on the applicable contingent coupon payment date, which is also referred to as the call settlement date. On the call settlement date, you would receive $1,011.17 per
      security.</div>
    <div>You will not receive any further payments after the call settlement date.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-20</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2e73fe1cfa61425188e56e9e90b1eca2">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="color: rgb(255, 255, 255); font-size: 10pt; font-weight: bold; text-align: center;">Hypothetical Payment at Stated Maturity</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify;">Set forth below are examples of calculations of the maturity payment amount payable at stated maturity, assuming that the securities have not been automatically called prior to stated maturity and assuming the
      hypothetical starting price, threshold price and ending prices for each Market Measure indicated in the examples. The terms used for purposes of these hypothetical examples do not represent any actual starting price or threshold price. The
      hypothetical starting price of 100.00 for each Market Measure has been chosen for illustrative purposes only and does not represent the actual starting price for any Market Measure. The actual starting price and threshold price for each Market
      Measure is set forth under &#8220;Terms of the Securities&#8221; above. For historical data regarding the actual fund closing prices of the Market Measures, see the historical information provided below. These examples are for purposes of illustration only and
      the values used in the examples may have been rounded for ease of analysis.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;">Example 1. The ending price of the lowest performing Market Measure on the final calculation day is greater than its starting price, the maturity payment amount is equal to the face amount of your
      securities at maturity and you receive a final contingent coupon payment:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5e2031cf3baf4685a1cca8ac52c73f00">

        <tr>
          <td style="width: 35%; vertical-align: bottom;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(104, 143, 207); vertical-align: middle; white-space: nowrap; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Utilities Select Sector </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund</div>
          </td>
          <td nowrap="nowrap" style="width: 25.26%; vertical-align: middle; border-bottom: #688FCF 1px solid;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Banking ETF</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: bottom; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: #E0E3E2; border-right: #FFFFFF 1px solid; border-bottom: #FFFFFF 1px solid;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical starting price:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: #E0E3E2; border-right: #FFFFFF 1px solid; border-bottom: #FFFFFF 1px solid;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical fund closing price on relevant calculation day:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">115.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">115.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">110.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: #E0E3E2; border-right: #FFFFFF 1px solid;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical threshold price:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; border-top: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: #E0E3E2; border-right: #FFFFFF 1px solid; border-bottom: #FFFFFF 1px solid;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Performance factor (fund closing price on calculation day <font style="font-style: italic;">divided by</font> starting price):</div>
          </td>
          <td style="width: 20%; vertical-align: middle; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">115.00%</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; border-top: 1px solid #FFFFFF; vertical-align: middle; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">115.00%</div>
          </td>
          <td style="width: 20%; vertical-align: middle; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">110.00%</div>
          </td>
        </tr>

    </table>
    <div style="margin: 15pt 0px 6pt;"><u>Step 1</u>: Determine which Market Measure is the lowest performing Market Measure on the final calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">In this example, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF has the lowest performance factor and is, therefore, the lowest performing Market Measure on the final calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;"><u>Step 2</u>: Determine the maturity payment amount based on the ending price of the lowest performing Market Measure on the final calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">Since the hypothetical ending price of the lowest performing Market Measure on the final calculation day is greater than its hypothetical threshold price, the maturity payment amount would equal the
      face amount. Although the hypothetical ending price of the lowest performing Market Measure on the final calculation day is significantly greater than its hypothetical starting price in this scenario, the maturity payment amount will not exceed the
      face amount.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">In addition to any contingent coupon payments received during the term of the securities, on the stated maturity date you would receive $1,000 per security. In addition, because the hypothetical ending
      price of the lowest performing Market Measure on the final calculation day is greater than its threshold price, you would receive a final contingent coupon payment on the stated maturity date.</div>
    <div style="text-align: justify; font-weight: bold;">Example 2. The ending price of the lowest performing Market Measure on the final calculation day is less than its starting price but greater than its threshold price, the maturity payment amount is
      equal to the face amount of your securities at maturity and you receive a final contingent coupon payment:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z81f943cdc51a4bef96e2aa228918f67c">

        <tr>
          <td style="width: 35%; vertical-align: bottom;">&#160;</td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: middle; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Utilities Select Sector </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund</div>
          </td>
          <td nowrap="nowrap" style="width: 25.26%; vertical-align: middle; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Banking ETF</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: bottom; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical starting price:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical fund closing price on relevant calculation day:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">80.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">85.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">95.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical threshold price:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; border-top: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Performance factor (fund closing price on calculation day <font style="font-style: italic;">divided by</font> starting price):</div>
          </td>
          <td style="width: 20%; vertical-align: middle; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">80.00%</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; border-top: 1px solid #FFFFFF; vertical-align: middle; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">85.00%</div>
          </td>
          <td style="width: 20%; vertical-align: middle; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">95.00%</div>
          </td>
        </tr>

    </table>
    <div style="margin: 15pt 0px 0px;"><u>Step 1</u>: Determine which Market Measure is the lowest performing Market Measure on the final calculation day.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-21</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin: 0px 0px 6pt;">In this example, the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund has the lowest performance factor and is, therefore, the lowest performing Market Measure on the final calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;"><u>Step 2</u>: Determine the maturity payment amount based on the ending price of the lowest performing Market Measure on the final calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">Since the hypothetical ending price of the lowest performing Market Measure is less than its hypothetical starting price, but not by more than 30%, you would receive the face amount of your securities
      at maturity.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">In addition to any contingent coupon payments received during the term of the securities, on the stated maturity date you would receive $1,000 per security. In addition, because the hypothetical ending
      price of the lowest performing Market Measure on the final calculation day is greater than its threshold price, you would receive a final contingent coupon payment on the stated maturity date.</div>
    <div style="text-align: justify; font-weight: bold;">Example 3. The ending price of the lowest performing Market Measure on the final calculation day is less than its threshold price, the maturity payment amount is less than the face amount of your
      securities at maturity and you do not receive a final contingent coupon payment:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb83ce97e86e545b98837b6c99ce58034">

        <tr>
          <td style="width: 35%; vertical-align: bottom;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(104, 143, 207); vertical-align: middle; white-space: nowrap; width: 20%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Utilities Select Sector </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund</div>
          </td>
          <td nowrap="nowrap" style="width: 25.26%; vertical-align: middle; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Regional </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Banking ETF</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: bottom; border-bottom: 1px solid rgb(104, 143, 207);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical starting price:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">100.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical fund closing price on relevant calculation day:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">105.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">45.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">110.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Hypothetical threshold price:</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; border-top: 1px solid #FFFFFF; vertical-align: bottom; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
          <td style="width: 20%; vertical-align: bottom; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">70.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: top; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Performance factor (fund closing price on calculation day <font style="font-style: italic;">divided by</font> starting price):</div>
          </td>
          <td style="width: 20%; vertical-align: middle; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">105.00%</div>
          </td>
          <td style="background-color: #E0E3E2; border-bottom: 1px solid #FFFFFF; border-right: 1px solid #FFFFFF; border-top: 1px solid #FFFFFF; vertical-align: middle; width: 25.26%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">45.00%</div>
          </td>
          <td style="width: 20%; vertical-align: middle; background-color: rgb(224, 227, 226); border-right: 1px solid rgb(255, 255, 255); border-top: 1px solid rgb(255, 255, 255); border-bottom: 1px solid rgb(255, 255, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">110.00%</div>
          </td>
        </tr>

    </table>
    <div style="margin: 15pt 0px 6pt;"><u>Step 1</u>: Determine which Market Measure is the lowest performing Market Measure on the final calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">In this example, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional Banking ETF has the lowest performance factor and is, therefore, the lowest performing Market Measure on the final calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;"><u>Step 2</u>: Determine the maturity payment amount based on the ending price of the lowest performing Market Measure on the final calculation day.</div>
    <div style="margin-top: 6pt; margin-bottom: 6pt;">Since the hypothetical ending price of the lowest performing Market Measure on the final calculation day is less than its hypothetical starting price by more than 30%, you would lose a portion of the
      face amount of your securities and receive the maturity payment amount equal to $450.00 per security, calculated as follows:</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">= $1,000 &#215; performance factor of the lowest performing Market Measure on the final calculation day</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">= $1,000 &#215; 45.00%</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">= $450.00</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">In addition to any contingent coupon payments received during the term of the securities, on the stated maturity date you would receive $450.00 per security. Because the
      hypothetical ending price of the lowest performing Market Measure on the final calculation day is less than its threshold price, you would not receive a final contingent coupon payment on the stated maturity date.</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">These examples illustrate that you will not participate in any appreciation of any Market Measure, but will be fully exposed to a decrease in the lowest performing Market Measure if
      the ending price of the lowest performing Market Measure on the final calculation day is less than its threshold price, even if the ending prices of the other Market Measures have appreciated or have not declined below their respective threshold
      price.</div>
    <div style="text-align: justify; margin-top: 6pt;">To the extent that the starting price, threshold price&#160; and ending price of the lowest performing Market Measure differ from the values assumed above, the results indicated above would be different.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-22</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zeb6c423fa1fb4614a12ee70dfe2ace61">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="font-size: 10pt; text-align: center;">&#160;<font style="font-weight: bold; color: #FFFFFF;">The Market Measures</font></div>
          </td>
        </tr>

    </table>
    <div style="margin-top: 4.5pt;">All disclosures contained in this pricing supplement regarding the Market Measures, including, without limitation, their make-up, method of calculation, and changes in their components, have been derived from publicly
      available sources.&#160; The information reflects the policies of, and is subject to change by, SSGA Funds Management, Inc. (&#8220;SSGA&#8221;), the investment advisor of each of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P
      Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF.&#160; The investment advisor, which licenses the copyright and all other rights to the respective Market Measures, has no obligation to continue to publish, and may discontinue publication
      of, the Market Measures.&#160; The consequences of the investment advisor discontinuing publication of a Market Measure are discussed in &#8220;General Terms of the Securities&#8212;Discontinuance of an Fund&#8221; in the accompanying product supplement.&#160; None of us, the
      calculation agent, or Jefferies LLC accepts any responsibility for the calculation, maintenance or publication of any Market Measure or any successor fund.&#160; None of us, the calculation agent, Jefferies LLC or any of our other affiliates makes any
      representation to you as to the future performance of the Market Measures.&#160; You should make your own investigation into the Market Measures.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z82bb20f588514756bbcd2f0aa9306c02">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="font-size: 10pt; text-align: center;">&#160;<font style="font-weight: bold; color: #FFFFFF;">The Utilities Select Sector SPDR</font><sup style="color: #FFFFFF; font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold; color: #FFFFFF;">
                Fund</font></div>
          </td>
        </tr>

    </table>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">The shares of the XLU are issued by Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Trust, a registered investment company. The XLU seeks investment results that correspond generally to the price and yield performance,
      before fees and expenses, of the Utilities Select Sector Index. The XLU measures the performance of the utilities sector of the U.S. equity market. The XLU is composed of equity securities of companies in the electric utilities, water utilities,
      multi-utilities, independent power producers and energy traders, and gas utilities industries. The XLU trades on the NYSE Arca under the ticker symbol &#8220;XLU.&#8221;</div>
    <div style="font-style: italic; font-weight: bold;">Investment Approach</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">The XLU utilizes a &#8220;passive&#8221; or &#8220;indexing&#8221; investment approach in attempting to track the performance of the Utilities Select Sector Index. The XLU will invest in substantially all of the securities
      which comprise the Utilities Select Sector Index. The XLU will normally invest at least 95% of its total assets in common stocks that comprise the Utilities Select Sector Index.</div>
    <div style="font-style: italic; font-weight: bold;">Investment Objective and Strategy</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">The XLU seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Utilities Select Sector Index. The investment manager of the
      XLU uses a replication strategy to try to achieve the XLU&#8217;s investment objective, which means that the XLU generally invests in substantially all of the securities represented in the Utilities Select Sector Index in approximately the same proportions
      as the Utilities Select Sector Index. Under normal market conditions, the XLU generally invests at least 95% of its total assets in the securities comprising the Utilities Select Sector Index. In certain situations or market conditions, the XLU may
      temporarily depart from its normal investment policies and strategies provided that the alternative is consistent with the XLU&#8217;s investment objective and is in the best interest of the XLU. For example, if the XLU is unable to invest directly in a
      component security or if a derivative investment may provide higher liquidity than other types of investments, it may make larger than normal investments in derivatives to maintain exposure to the Utilities Select Sector Index that it tracks.
      Consequently, under such circumstances, the XLU may invest in a different mix of investments than it would under normal circumstances. The XLU will provide shareholders with at least 60 days&#8217; notice prior to any material change in its investment
      policies. The XLU is managed with a passive investment strategy, attempting to track the performance of an unmanaged index of securities. This differs from an actively managed underlying, which typically seeks to outperform a benchmark index.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">Notwithstanding the XLU&#8217;s investment objective, the return on your Notes will not reflect any dividends paid on shares of the XLU, on the securities purchased by the XLU or on the securities that
      comprise the Utilities Select Sector Index.</div>
    <div style="font-style: italic; font-weight: bold;">The Select Sector Indices</div>
    <div style="margin-top: 8pt;">The Underlying Index of the XLU is part of the Select Sector Indices. The Select Sector Indices are sub-indices of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (&#8220;SPX&#8221;). Each stock in the SPX is allocated to at least one Select Sector
      Index, and the combined companies of the eleven Select Sector Indices represent all of the companies in the SPX. The industry indices are sub-categories within each Select Sector Index and represent a specific industry segment of the overall Select
      Sector Index. The eleven Select Sector Indices seek to represent the eleven SPX sectors. The index compilation agent for these indices (the &#8220;Index Compilation Agent&#8221;) determines the composition of the Select Sector Indices based on S&amp;P&#8217;s sector
      classification methodology. (Sector designations are determined by the index sponsor using criteria it has selected or developed. Index sponsors may use very different standards for determining sector designations. In addition, many companies operate
      in a number of sectors, but are listed in only one sector and the basis on which that sector is selected may also differ. As a result, sector comparisons between indices with different index sponsors may reflect differences in methodology as well as
      actual differences in the sector composition of the indices.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-23</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin: 0px 0px 8pt;">Each Select Sector Index was developed and is maintained in accordance with the following criteria:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z45178eb0c1684fc8a77b1d1c63026aad">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Each of the component stocks in a Select Sector Index (the &#8220;Component Stocks&#8221;) is a constituent company of the SPX.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z195f40d71a554495af367277b6731248">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>The eleven Select Sector Indices together will include all of the companies represented in the SPX and each of the stocks in the SPX will be allocated to at least one of the Select Sector Indices.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z26a9acfe620545d9931c148fbe90ac48">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Index Compilation Agent assigns each constituent stock of the SPX to a Select Sector Index. The Index Compilation Agent assigns a company&#8217;s stock to a particular Select Sector Index based on S&amp;P Dow Jones Indices&#8217;s sector
              classification methodology as set forth in its Global Industry Classification Standard.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z25d04e194266404fae106f0bb5d84274">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Each Select Sector Index is calculated by S&amp;P Dow Jones Indices using a modified &#8220;market capitalization&#8221; methodology. This design ensures that each of the component stocks within a Select Sector Index is represented in a proportion
              consistent with its percentage with respect to the total market capitalization of that Select Sector Index.</div>
          </td>
        </tr>

    </table>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">For reweighting purposes, each Select Sector Index is rebalanced quarterly after the close of business on the second to last calculation day of March, June, September and December using the following
      procedures: (1) The rebalancing reference date is two business days prior to the last calculation day of each quarter; and (2) With prices reflected on the rebalancing reference date, and membership, shares outstanding, additional weight factor
      (capping factor) and investable weight factors (as described in the section &#8220;Computation of the S&amp;P 500 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221; below) as of the rebalancing effective date, each company is weighted using the modified market capitalization methodology.
      Modifications are made as defined below.</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 8pt; margin-top: 8pt;" class="DSPFListTable" id="z49910a1134f8496ba2fb285bc57c2143">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(i)</td>
          <td style="width: auto; vertical-align: top;">
            <div>The indices are first evaluated to ensure none of the indices breach the maximum allowable limits defined in rules (ii) and (v) below. If any of the allowable limits are breached, the component stocks are reweighted based on their
              float-adjusted market capitalization weights.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 8pt; margin-top: 8pt;" class="DSPFListTable" id="z48f1e5bd98614bebafd53aa00f179e7f">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(ii)</td>
          <td style="width: auto; vertical-align: top;">
            <div>If any component stock has a weight greater than 24%, that component stock has its float-adjusted market capitalization weight capped at 23%. The 23% weight cap creates a 2% buffer to ensure that no component stock exceeds 25% as of the
              quarter-end diversification requirement date.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 8pt; margin-top: 8pt;" class="DSPFListTable" id="zb5ec6b71826e4b7c814bc630bfb82d1c">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(iii)</td>
          <td style="width: auto; vertical-align: top;">
            <div>All excess weight is equally redistributed to all uncapped component stocks within the relevant Select Sector Index.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 8pt; margin-top: 8pt;" class="DSPFListTable" id="zc037e7c36e1d4ba8870dae23ff4fd125">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(iv)</td>
          <td style="width: auto; vertical-align: top;">
            <div>After this redistribution, if the float-adjusted market capitalization weight of any other component stock(s) then breaches 23%, the process is repeated iteratively until no component stock breaches the 23% weight cap.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 8pt; margin-top: 8pt;" class="DSPFListTable" id="z9a24c55cf8fd4ddc8374be604ec4edad">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(v)</td>
          <td style="width: auto; vertical-align: top;">
            <div>The sum of the component stocks with weight greater than 4.8% cannot exceed 50% of the total index weight. These caps are set to allow for a buffer below the 5% limit.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 8pt; margin-top: 8pt;" class="DSPFListTable" id="zd16c5c32cee141a6af061be3e7f211e7">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(vi)</td>
          <td style="width: auto; vertical-align: top;">
            <div>If the rule in step (v) is breached, all the component stocks are ranked in descending order of their float-adjusted market capitalization weights and the first component stock that causes the 50% limit to be breached has its weight
              reduced to 4.6%.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 8pt; margin-top: 8pt;" class="DSPFListTable" id="zebf54ec2651c46839a097c82165bd086">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(vii)</td>
          <td style="width: auto; vertical-align: top;">
            <div>This excess weight is equally redistributed to all component stocks with weights below 4.6%. This process is repeated iteratively until step (v) is satisfied.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 8pt; margin-top: 8pt;" class="DSPFListTable" id="zd645ab17d1fb43cc826a35df2938b23c">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(viii)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Index share amounts are assigned to each component stock to arrive at the weights calculated above. Since index shares are assigned based on prices one business day prior to rebalancing, the actual weight of each component stock at the
              rebalancing differs somewhat from these weights due to market movements.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 8pt; margin-top: 8pt;" class="DSPFListTable" id="z752bdeb20cf14f2c8c9175b208e01cca">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(ix)</td>
          <td style="width: auto; vertical-align: top;">
            <div>If necessary, the reweighting process may take place more than once prior to the close on the last business day of March, June, September or December to ensure conformity with all diversification requirements.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1b2ff482d4a643f798331ae9c9001886">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Each Select Sector Index is calculated using the same methodology utilized by S&amp;P Dow Jones Indices in calculating the SPX, using a base-weighted aggregate methodology. The daily calculation of each Select Sector Index is computed by
              dividing the total market value of the companies in the Select Sector Index by a number called the index divisor.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z66c173f031aa4ed89f74f416bc4a06cf">

        <tr>
          <td style="width: 12.25pt;"><br>
          </td>
          <td style="width: 13.7pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Index Compilation Agent at any time may determine that a Component Stock which has been assigned to one Select Sector Index has undergone such a transformation in the composition of its business, and should be removed from that Select
              Sector Index and assigned to a different Select Sector Index. In the event that the Index Compilation Agent notifies S&amp;P Dow Jones Indices that a Component Stock&#8217;s Select Sector Index assignment should be changed, S&amp;P Dow Jones
              Indices will disseminate notice of the change following its standard procedure for announcing index changes and will implement the change in the affected Select Sector Indices on a date no less than one week after the initial dissemination of
              information on the sector change to the maximum extent practicable. It is not anticipated that Component Stocks will change sectors frequently.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-24</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zca29254a735a44b4a06b303d9dd4bbf0">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Component Stocks removed from and added to the SPX will be deleted from and added to the appropriate Select Sector Index on the same schedule used by S&amp;P Dow Jones Indices for additions and deletions from the SPX insofar as
              practicable.</div>
          </td>
        </tr>

    </table>
    <div style="margin: 20pt 0px 0px; font-style: italic; font-weight: bold;">The S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
    <div style="margin-top: 6pt;">The S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (the &#8220;SPX) includes a representative sample of 500 companies in leading industries of the U.S. economy. The SPX is intended to provide an indication of the pattern of common stock price
      movement. The calculation of the level of the SPX is based on the relative value of the aggregate market value of the common stocks of 500 companies as of a particular time compared to the aggregate average market value of the common stocks of 500
      similar companies during the base period of the years 1941 through 1943.</div>
    <div style="margin-top: 6pt;">The SPX includes companies from eleven main groups: Communication Services; Consumer Discretionary; Consumer Staples; Energy; Financials; Health Care; Industrials; Information Technology; Real Estate; Materials; and
      Utilities. SPDJI may from time to time, in its sole discretion, add companies to, or delete companies from, the SPX to achieve the objectives stated above.</div>
    <div style="margin-top: 6pt;">Company additions to the SPX must have an unadjusted company market capitalization of $18.0 billion or more (an increase from the previous requirement of an unadjusted company market capitalization of $15.8 billion or
      more).</div>
    <div style="margin: 6pt 0px 20pt;">SPDJI calculates the SPX by reference to the prices of the constituent stocks of the SPX without taking account of the value of dividends paid on those stocks. As a result, the return on the Notes will not reflect the
      return you would realize if you actually owned the SPX constituent stocks and received the dividends paid on those stocks.</div>
    <div style="margin-bottom: 12pt; font-style: italic;">Computation of the SPX</div>
    <div style="margin-bottom: 12pt;">While SPDJI currently employs the following methodology to calculate the SPX, no assurance can be given that SPDJI will not modify or change this methodology in a manner that may affect payment on the notes.</div>
    <div style="margin-bottom: 12pt;">Historically, the market value of any component stock of the SPX was calculated as the product of the market price per share and the number of then outstanding shares of such component stock. In March 2005, SPDJI began
      shifting the SPX halfway from a market capitalization weighted formula to a float-adjusted formula, before moving the SPX to full float adjustment on September 16, 2005. SPDJI&#8217;s criteria for selecting stocks for the SPX did not change with the shift
      to float adjustment. However, the adjustment affects each company&#8217;s weight in the SPX.</div>
    <div style="margin-bottom: 12pt;">Under float adjustment, the share counts used in calculating the SPX reflect only those shares that are available to investors, not all of a company&#8217;s outstanding shares. Float adjustment excludes shares that are
      closely held by control groups, other publicly traded companies or government agencies.</div>
    <div style="margin-bottom: 12pt;">In September 2012, all shareholdings representing more than 5% of a stock&#8217;s outstanding shares, other than holdings by &#8220;block owners,&#8221; were removed from the float for purposes of calculating the SPX. Generally, these
      &#8220;control holders&#8221; will include officers and directors, private equity, venture capital and special equity firms, other publicly traded companies that hold shares for control, strategic partners, holders of restricted shares, ESOPs, employee and
      family trusts, foundations associated with the company, holders of unlisted share classes of stock, government entities at all levels (other than government retirement/pension funds) and any individual person who controls a 5% or greater stake in a
      company as reported in regulatory filings. However, holdings by block owners, such as depositary banks, pension funds, mutual funds and ETF providers, 401(k) plans of the company, government retirement/pension funds, investment funds of insurance
      companies, asset managers and investment funds, independent foundations and savings and investment plans, will ordinarily be considered part of the float.</div>
    <div style="margin-bottom: 12pt;">Treasury stock, stock options, restricted shares, equity participation units, warrants, preferred stock, convertible stock, and rights are not part of the float. Shares held in a trust to allow investors in countries
      outside the country of domicile, such as depositary shares and Canadian exchangeable shares are normally part of the float unless those shares form a control block. If a company has multiple classes of stock outstanding, shares in an unlisted or
      non-traded class are treated as a control block.</div>
    <div>For each stock, an investable weight factor (&#8220;IWF&#8221;) is calculated by dividing the available float shares by the total shares outstanding. Available float shares are defined as the total shares outstanding less shares held by control holders. This
      calculation is subject to a 5% minimum threshold for control blocks. For example, if a company&#8217;s officers and directors hold 3% of the company&#8217;s shares, and no other control group holds 5% of the company&#8217;s shares, SPDJI would assign that company an
      IWF of 1.00, as no control group meets the 5% threshold. However, if a company&#8217;s officers and directors hold 3% of the company&#8217;s shares and another control group holds 20% of the company&#8217;s shares, SPDJI would assign an IWF of 0.77, reflecting the
      fact that 23% of the company&#8217;s outstanding shares are considered to be held for control. As of July 31, 2017, companies with multiple share class lines are no longer eligible for inclusion in the</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-25</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin-bottom: 12pt;">SPX. Constituents of the SPX prior to July 31, 2017 with multiple share class lines will be grandfathered in and continue to be included in the SPX. If a constituent company of the SPX reorganizes into a multiple share
      class line structure, that company will remain in the SPX at the discretion of the S&amp;P Index Committee in order to minimize turnover.</div>
    <div style="margin-bottom: 12pt;">The SPX is calculated using a base-weighted aggregate methodology. The level of the SPX reflects the total market value of all component stocks relative to the base period of the years 1941 through 1943. An indexed
      number is used to represent the results of this calculation in order to make the level easier to work with and track over time. The actual total market value of the component stocks during the base period of the years 1941 through 1943 has been set
      to an indexed level of 10. This is often indicated by the notation 1941- 43 = 10. In practice, the daily calculation of the SPX is computed by dividing the total market value of the component stocks by the &#8220;index divisor.&#8221; By itself, the index
      divisor is an arbitrary number. However, in the context of the calculation of the SPX, it serves as a link to the original base period level of the SPX. The index divisor keeps the SPX comparable over time and is the manipulation point for all
      adjustments to the SPX, which is index maintenance.</div>
    <div style="margin-bottom: 12pt; font-style: italic;">Index Maintenance</div>
    <div style="margin-bottom: 12pt;">Index maintenance includes monitoring and completing the adjustments for company additions and deletions, share changes, stock splits, stock dividends, and stock price adjustments due to company restructuring or
      spinoffs. Some corporate actions, such as stock splits and stock dividends, require changes in the common shares outstanding and the stock prices of the companies in the SPX, and do not require index divisor adjustments.</div>
    <div style="margin-bottom: 12pt;">To prevent the level of the SPX from changing due to corporate actions, corporate actions which affect the total market value of the SPX require an index divisor adjustment. By adjusting the index divisor for the
      change in market value, the level of the SPX remains constant and does not reflect the corporate actions of individual companies in the SPX. Index divisor adjustments are made after the close of trading and after the calculation of the SPX closing
      level.</div>
    <div style="margin-bottom: 12pt;">Changes in a company&#8217;s shares outstanding of 5.00% or more due to mergers, acquisitions, public offerings, tender offers, Dutch auctions, or exchange offers are made as soon as reasonably possible. Share changes due to
      mergers or acquisitions of publicly held companies that trade on a major exchange are implemented when the transaction occurs, even if both of the companies are not in the same headline index, and regardless of the size of the change. All other
      changes of 5.00% or more (due to, for example, company stock repurchases, private placements, redemptions, exercise of options, warrants, conversion of preferred stock, Notes, debt, equity participation units, at-the-market offerings, or other
      recapitalizations) are made weekly and are announced on Fridays for implementation after the close of trading on the following Friday.</div>
    <div style="margin-bottom: 12pt;">Changes of less than 5.00% are accumulated and made quarterly on the third Friday of March, June, September, and December, and are usually announced two to five days prior.</div>
    <div style="margin-bottom: 12pt;">If a change in a company&#8217;s shares outstanding of 5.00% or more causes a company&#8217;s IWF to change by five percentage points or more, the IWF is updated at the same time as the share change. IWF changes resulting from
      partial tender offers are considered on a case by case basis.</div>
    <div style="text-align: justify; margin-top: 9pt; font-weight: bold;">Historical Information</div>
    <div style="text-align: justify; margin-top: 9pt;">We obtained the closing prices of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Fund in the graph below from Bloomberg L.P., without independent verification.</div>
    <div style="text-align: justify; margin-top: 9pt;">The following graph sets forth daily closing prices of the Market Measure for the period from January 1, 2018 to July 16, 2025. The fund closing price on July 16, 2025 was $82.03. The historical
      performance of the Market Measure should not be taken as an indication of the future performance of the Market Measure during the term of the securities.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-26</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: center; margin-top: 12pt; margin-bottom: 12pt;">
      <div>
        <div><img src="image0.jpg"></div>
      </div>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z99f2aa5db66640eb8e0e477ef07838ce">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="font-size: 10pt; text-align: center;">&#160;<font style="font-weight: bold; color: #FFFFFF;">The SPDR</font><sup style="color: #FFFFFF; font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold; color: #FFFFFF;"> S&amp;P Regional Banking
                ETF</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>The KRE seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the S&amp;P Regional Banks Select Industry Index (the &#8220;Underlying Index&#8221;). The Underlying Index represents the
      regional banks industry portion of the S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Total Market Index (&#8220;S&amp;P TMI&#8221;), an index that measures the performance of the U.S. equity market. The KRE is composed of companies that are regional banks.</div>
    <div style="margin: 9pt 0px 12pt; text-align: justify;">The KRE utilizes a &#8220;replication&#8221; investment approach in attempting to track the performance of the Underlying Index. The KRE typically invests in substantially all of the securities which comprise
      the Underlying Index in approximately the same proportions as the Underlying Index. The KRE will normally invest at least 80% of its total assets in the common stocks that comprise the Underlying Index. The returns of the KRE may be affected by
      certain management fees and other expenses, which are detailed in its prospectus.</div>
    <div style="margin: 0px 0px 15pt; font-style: italic; font-weight: bold;">The S&amp;P Regional Banks Select Industry Index</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">This Underlying Index is an equal-weighted index that is designed to measure the performance of the regional banks portion of the S&amp;P TMI. The S&amp;P TMI includes all U.S. common equities listed on
      the New York Stock Exchange (including NYSE Arca), the NYSE MKT, the NASDAQ Global Select Market, and the NASDAQ Capital Market. Each of the component stocks in the Underlying Index is a constituent company within the regional banks industry portion
      of the S&amp;P TMI.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">To be eligible for inclusion in the Underlying Index, companies must be in the S&amp;P TMI and must be included in the relevant Global Industry Classification Standard (GICS) industry. The GICS was
      developed to establish a global standard for categorizing companies into sectors and industries. In addition to the above, companies must satisfy one of the two following combined size and liquidity criteria:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2bf8683067e14bbdb1e0c6d38fcb7d2f">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>float-adjusted market capitalization above US$500 million and float-adjusted liquidity ratio above 90%; or</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z95c422c3689840df84ef0bbf69ef7e6d">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>float-adjusted market capitalization above US$400 million and float-adjusted liquidity ratio above 150%.</div>
          </td>
        </tr>

    </table>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">All U.S. companies satisfying these requirements are included in the Underlying Index. The total number of companies in the Underlying Index should be at least 35. If there are fewer than 35 stocks,
      stocks from a supplementary list of highly correlated sub-industries that meet the market capitalization and liquidity thresholds above are included in the order of their float-adjusted market capitalization to reach 35 constituents. Minimum market
      capitalization requirements may be relaxed to ensure there are at least 22 companies in the Underlying Index as of each rebalancing effective date.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">Eligibility factors include:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a51a2a58f9f49e79b5f5010a0fad6f1">

        <tr>
          <td style="width: 12.25pt;"><br>
          </td>
          <td style="width: 13.7pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Market Capitalization: Float-adjusted market capitalization should be at least US$400 million for inclusion in the Underlying Index. Existing index components must have a float-adjusted market capitalization of US$300 million to remain in
              the Underlying Index at each rebalancing.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-27</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z527d186177ec4592814c34c401b43ed2">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Liquidity: The liquidity measurement used is a liquidity ratio, defined as dollar value traded over the previous 12-months divided by the float-adjusted market capitalization as of the Underlying Index rebalancing reference date. Stocks
              having a float-adjusted market capitalization above US$500 million must have a liquidity ratio greater than 90% to be eligible for addition to the Underlying Index. Stocks having a float-adjusted market capitalization between US$400 and
              US$500 million must have a liquidity ratio greater than 150% to be eligible for addition to the Underlying Index. Existing index constituents must have a liquidity ratio greater than 50% to remain in the Underlying Index at the quarterly
              rebalancing. The length of time to evaluate liquidity is reduced to the available trading period for IPOs or spin-offs that do not have 12 months of trading history.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc08ef4c845004aa882460c2e7f230398">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Takeover Restrictions: At the discretion of S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, constituents with shareholder ownership restrictions defined in company bylaws may be deemed ineligible for inclusion in the Underlying Index. Ownership restrictions
              preventing entities from replicating the index weight of a company may be excluded from the eligible universe or removed from the Underlying Index.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z936b0b15f8634ba6965511e233e63f1a">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Turnover: S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> believes turnover in index membership should be avoided when possible. At times, a company may appear to temporarily violate one or more of the addition criteria. However, the addition criteria are for
              addition to the Underlying Index, not for continued membership. As a result, an index constituent that appears to violate the criteria for addition to the Underlying Index will not be deleted unless ongoing conditions warrant a change in the
              composition of the Underlying Index.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Computation of the Underlying Index</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">The underlying index is calculated as the underlying index market value divided by the divisor. In an equal-weighted index like the underlying index, the market capitalization of each stock used in the
      calculation of the index market value is redefined so that each stock has an equal weight in the index on each rebalancing date. The adjusted market capitalization for each stock in the index is calculated as the product of the stock price, the
      number of shares outstanding, the stock&#8217;s float factor and the adjustment factor.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">A stock&#8217;s float factor refers to the number of shares outstanding that are available to investors. S&amp;P indices exclude shares closely held by control groups from the underlying index calculation
      because such shares are not available to investors. For each stock, S&amp;P calculates an Investable Weight Factor (IWF) which is the percentage of total shares outstanding that are included in the underlying index calculation.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">The adjustment factor for each stock is assigned at each rebalancing date and is calculated by dividing a specific constant set for the purpose of deriving the adjustment factor (often referred to as
      modified index shares) by the number of stocks in the underlying index multiplied by the float adjusted market value of such stock on such rebalancing date.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">Adjustments are also made to ensure that no stock in the underlying index will have a weight that exceeds the value that can be traded in a single day for a theoretical portfolio of $2 billion.
      Theoretical portfolio values are reviewed annually and any updates are made at the discretion of the underlying index committee, as defined below. The maximum Basket liquidity weight for each stock in the underlying index will be calculated using the
      ratio of its three-month median daily value traded to the theoretical portfolio value of $2 billion. Each stock&#8217;s weight in the underlying index is then compared to its maximum Basket liquidity weight and is set to the lesser of (1) its maximum
      Basket liquidity weight or (2) its initial equal weight. All excess weight is redistributed across the underlying index to the uncapped stocks. If necessary, a final adjustment is made to ensure that no stock in the underlying index has a weight
      greater than 4.5%. No further adjustments are made if the latter step would force the weight of those stocks limited to their maximum Basket liquidity weight to exceed that weight. If the underlying index contains exactly 22 stocks as of the
      rebalancing effective date, the underlying index will be equally weighted without Basket liquidity constraints.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">If a company has more than one share class line in the S&amp;P Total Market Index, such company will be represented once by the designated listing (generally the share class with both (i) the highest
      one-year trading liquidity as defined by median daily value traded and (ii) the largest float-adjusted market capitalization). S&amp;P reviews designated listings on an annual basis and any changes are implemented after the close of the third Friday
      in September. The last trading day in July is used as the reference date for the liquidity and market capitalization data in such determination. Once a listed share class line is added to the underlying index, it may be retained in the underlying
      index even though it may appear to violate certain constituent addition criteria. For companies that issue a second publicly traded share class to underlying index share class holders, the newly issued share class line will be considered for
      inclusion if the event is mandatory and the market capitalization of the distributed class is not considered to be de minimis.</div>
    <div style="margin-top: 8pt;">The underlying index is calculated by using the divisor methodology used in all S&amp;P equity indices. The initial divisor was set to have a base value of 1,000 on June 20, 2003. The underlying index level is the
      underlying index market value divided by the Underlying index divisor. In order to maintain underlying index series continuity, it is also necessary to adjust the divisor at each rebalancing. Therefore, the divisor (after rebalancing) equals the
      underlying index market value (after rebalancing) divided by the underlying index value before</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-28</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin: 0px 0px 8pt;">rebalancing. The divisor keeps the underlying index comparable over time and is one manipulation point for adjustments to the underlying index, which we refer to as maintenance of the underlying index.</div>
    <div style="text-align: justify; margin-top: 9pt; font-weight: bold;">Historical Information</div>
    <div style="text-align: justify; margin-top: 9pt;">We obtained the closing prices of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Regional Banking ETF in the graph below from Bloomberg L.P., without independent verification.</div>
    <div style="text-align: justify; margin-top: 9pt;">
      <div style="margin-top: 9pt;">The following graph sets forth daily closing prices of the Market Measure for the period from January 1, 2018 to July 16, 2025. The closing price on July 16, 2025 was $61.91. The historical performance of the Market
        Measure should not be taken as an indication of the future performance of the Market Measure during the term of the securities.</div>
    </div>
    <div style="text-align: center; margin-top: 12pt; margin-bottom: 12pt;">
      <div>
        <div><img src="image00004.jpg"></div>
      </div>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3999ef9dee724e60a0a98e52883653e5">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="font-size: 10pt; text-align: center;">&#160;<font style="font-weight: bold; color: #FFFFFF;">The SPDR</font><sup style="color: #FFFFFF; font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold; color: #FFFFFF;"> S&amp;P Biotech ETF</font></div>
          </td>
        </tr>

    </table>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">The XBI seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Biotechnology Select Industry<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
      Index (the &#8220;underlying index&#8221;). The underlying index represents the biotechnology sub-industry portion of the Standard &amp; Poor&#8217;s (&#8220;S&amp;P&#8221;) Total Market Index (&#8220;S&amp;P TMI&#8221;), an index that measures the performance of the U.S. equity market. The
      XBI is composed of companies that are in the biotechnology sector. The XBI trades on NYSE Arca under the ticker symbol &#8220;XBI.&#8221;</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">The XBI utilizes a &#8220;replication&#8221; investment approach in attempting to track the performance of its underlying index. The XBI typically invests in substantially all of the securities which comprise the
      underlying index in approximately the same proportions as the underlying index. The XBI will normally invest at least 80% of its total assets in the common stocks that comprise the underlying index.</div>
    <div style="font-style: italic; font-weight: bold;">The S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Biotechnology Select Industry<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">This underlying index is an equal-weighted index that is designed to measure the performance of the biotechnology sub-industry portion of the S&amp;P TMI. The S&amp;P TMI includes all U.S. common
      equities listed on the New York Stock Exchange (the &#8220;NYSE&#8221;) (including NYSE Arca), the NYSE American, the Nasdaq Global Select Market, and the Nasdaq Capital Market. Each of the component stocks in the underlying index is a constituent company within
      the biotechnology sub-industry portion of the S&amp;P TMI.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">To be eligible for inclusion in the underlying index, companies must be in the S&amp;P TMI and must be included in the relevant Global Industry Classification Standard (GICS) sub-industry. The GICS was
      developed to establish a global standard for categorizing companies into sectors and industries. In addition to the above, companies must satisfy one of the two following combined size and liquidity criteria:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 8pt; margin-top: 8pt;" class="DSPFListTable" id="z26a6d6d6a1754a88b1ca41d51a4f15f1">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>float-adjusted market capitalization above US$500 million and float-adjusted liquidity ratio above 90%; or</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 8pt;" class="DSPFListTable" id="z582f46d65b61408fbb4df5c0a9cc5811">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>float-adjusted market capitalization above US$400 million and float-adjusted liquidity ratio above 150%.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-29</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin: 0px 0px 8pt;">All U.S. companies satisfying these requirements are included in the underlying index. The total number of companies in the underlying index should be at least 35. If there are fewer than 35 stocks, stocks from a
      supplementary list of highly correlated sub-industries that meet the market capitalization and liquidity thresholds above are included in order of their float-adjusted market capitalization to reach 35 constituents. Minimum market capitalization
      requirements may be relaxed to ensure there are at least 22 companies in the underlying index as of each rebalancing effective date.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">Eligibility factors include:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc8972afbe93a4a85aadf5a67ecf87602">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Market Capitalization: Float-adjusted market capitalization should be at least US$400 million for inclusion in the underlying index. Existing index components must have a float-adjusted market capitalization of US$300 million to remain in
              the underlying index at each rebalancing.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z238a172e4ac5401a91a6f5bc17d9064e">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Liquidity: The liquidity measurement used is a liquidity ratio, defined as dollar value traded over the previous 12-months divided by the float-adjusted market capitalization as of the underlying index rebalancing reference date. Stocks
              having a float-adjusted market capitalization above US$500 million must have a liquidity ratio greater than 90% to be eligible for addition to the underlying index. Stocks having a float-adjusted market capitalization between US$400 and
              US$500 million must have a liquidity ratio greater than 150% to be eligible for addition to the underlying index. Existing index constituents must have a liquidity ratio greater than 50% to remain in the underlying index at the quarterly
              rebalancing. The length of time to evaluate liquidity is reduced to the available trading period for IPOs or spin-offs that do not have 12 months of trading history.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z40d19c83127145f68498e563d4542079">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Takeover Restrictions: At the discretion of S&amp;P, constituents with shareholder ownership restrictions defined in company bylaws may be deemed ineligible for inclusion in the underlying index. Ownership restrictions preventing entities
              from replicating the index weight of a company may be excluded from the eligible universe or removed from the underlying index.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd15001186db840a9befe90d0899f6a39">

        <tr>
          <td style="width: 12.2pt;"><br>
          </td>
          <td style="width: 13.6pt; vertical-align: top; color: rgb(95, 140, 214); font-size: 12pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Turnover: S&amp;P believes turnover in index membership should be avoided when possible. At times, a company may appear to temporarily violate one or more of the addition criteria. However, the addition criteria are for addition to the
              underlying index, not for continued membership. As a result, an index constituent that appears to violate the criteria for addition to the underlying index will not be deleted unless ongoing conditions warrant a change in the composition of
              the underlying index.</div>
          </td>
        </tr>

    </table>
    <div style="font-style: italic; font-weight: bold;">Computation of the Underlying Index</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">The underlying index is calculated as the underlying index market value divided by the divisor. In an equal-weighted index like the underlying index, the market capitalization of each stock used in the
      calculation of the index market value is redefined so that each stock has an equal weight in the index on each rebalancing date. The adjusted market capitalization for each stock in the index is calculated as the product of the stock price, the
      number of shares outstanding, the stock&#8217;s float factor and the adjustment factor.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">A stock&#8217;s float factor refers to the number of shares outstanding that are available to investors. S&amp;P indices exclude shares closely held by control groups from the underlying index calculation
      because such shares are not available to investors. For each stock, S&amp;P calculates an Investable Weight Factor (IWF) which is the percentage of total shares outstanding that are included in the underlying index calculation.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">The adjustment factor for each stock is assigned at each rebalancing date and is calculated by dividing a specific constant set for the purpose of deriving the adjustment factor (often referred to as
      modified index shares) by the number of stocks in the underlying index multiplied by the float adjusted market value of such stock on such rebalancing date.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">Adjustments are also made to ensure that no stock in the underlying index will have a weight that exceeds the value that can be traded in a single day for a theoretical portfolio of $2 billion.
      Theoretical portfolio values are reviewed annually and any updates are made at the discretion of the underlying index committee, as defined below. The maximum Basket liquidity weight for each stock in the underlying index will be calculated using the
      ratio of its three-month median daily value traded to the theoretical portfolio value of $2 billion. Each stock&#8217;s weight in the underlying index is then compared to its maximum Basket liquidity weight and is set to the lesser of (1) its maximum
      Basket liquidity weight or (2) its initial equal weight. All excess weight is redistributed across the underlying index to the uncapped stocks. If necessary, a final adjustment is made to ensure that no stock in the underlying index has a weight
      greater than 4.5%. No further adjustments are made if the latter step would force the weight of those stocks limited to their maximum Basket liquidity weight to exceed that weight. If the underlying index contains exactly 22 stocks as of the
      rebalancing effective date, the underlying index will be equally weighted without Basket liquidity constraints.</div>
    <div style="margin-top: 8pt;">If a company has more than one share class line in the S&amp;P Total Market Index, such company will be represented once by the designated listing (generally the share class with both (i) the highest one-year trading
      liquidity as defined by median daily value traded and (ii) the largest float-adjusted market capitalization). S&amp;P reviews designated listings on an annual basis and any changes are</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-30</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin: 0px 0px 8pt;">implemented after the close of the third Friday in September. The last trading day in July is used as the reference date for the liquidity and market capitalization data in such determination. Once a listed share class
      line is added to the underlying index, it may be retained in the underlying index even though it may appear to violate certain constituent addition criteria. For companies that issue a second publicly traded share class to underlying index share
      class holders, the newly issued share class line will be considered for inclusion if the event is mandatory and the market capitalization of the distributed class is not considered to be de minimis.</div>
    <div style="margin-top: 8pt; margin-bottom: 8pt;">The underlying index is calculated by using the divisor methodology used in all S&amp;P equity indices. The initial divisor was set to have a base value of 1,000 on June 20, 2003. The underlying index
      level is the underlying index market value divided by the Underlying index divisor. In order to maintain underlying index series continuity, it is also necessary to adjust the divisor at each rebalancing. Therefore, the divisor (after rebalancing)
      equals the underlying index market value (after rebalancing) divided by the underlying index value before rebalancing. The divisor keeps the underlying index comparable over time and is one manipulation point for adjustments to the underlying index,
      which we refer to as maintenance of the underlying index.</div>
    <div style="text-align: justify; margin-top: 9pt; font-weight: bold;">Historical Information</div>
    <div style="text-align: justify; margin-top: 9pt;">We obtained the closing prices of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P Biotech ETF in the graph below from Bloomberg L.P., without independent verification.</div>
    <div style="margin: 9pt 0px 12pt; text-align: justify;">
      <div style="margin-top: 9pt;">The following graph sets forth daily closing prices of the Market Measure for the period from January 1, 2018 to July 16, 2025. The closing price on July 16, 2025 was $87.82. The historical performance of the Market
        Measure should not be taken as an indication of the future performance of the Market Measure during the term of the securities.</div>
    </div>
    <div style="text-align: center; margin-top: 12pt; margin-bottom: 12pt;">
      <div>
        <div><img src="image00008.jpg"></div>
        <div style="text-align: left;"><br>
        </div>
      </div>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-31</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4a8d6ea2550d4fe3a1ac8e73ab108fb5">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="color: rgb(255, 255, 255); font-size: 10pt; font-weight: bold; text-align: center;">SUPPLEMENTAL DISCUSSION OF U.S. FEDERAL INCOME TAX CONSEQUENCES</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-bottom: 9.5pt;">The following section supplements the discussion of U.S. federal income taxation in the accompanying product supplement.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">The following section is the opinion of Sidley Austin LLP, our counsel. In addition, it is the opinion of Sidley Austin LLP that the characterization of the securities for U.S. federal income tax
      purposes that will be required under the terms of the securities, as discussed below, is a reasonable interpretation of current law.</div>
    <div style="text-align: justify;">This section does not apply to you if you are a member of a class of holders subject to special rules, such as:</div>
    <div style="text-align: justify;">
      <div>
        <table cellspacing="0" cellpadding="0" id="z8dbc05a172144a38ae2307aaf25f7b95" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">a dealer in securities or currencies;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z83d93361aa344b4385691ffa03d371f7" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">a trader in securities that elects to use a mark-to-market method of accounting for your securities holdings;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="zf37a59060c95420683773c2d3570ef33" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">a bank;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="zce22adddbaf04ec7963bd99fc8f42b89" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">a life insurance company;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z3ca05198a5f64282a760479a37022bb6" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">a tax exempt organization;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z32213f58cc6942939e70883e0bfabb39" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">a partnership;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z1722c598af104434ba35e3ce397793ca" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">a regulated investment company;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="zc5ed71f1b9ab4ee89c71c981498032c6" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">an accrual method taxpayer subject to special tax accounting rules as a result of its use of financial statements;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z621cf1c790b54433bc6bd89792cf50ef" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">a common trust fund;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="za639863ef2074434bb0c3b3abc0ef527" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">a person that owns a security as a hedge or that is hedged against interest rate risks;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z0f6e46d4a30147758d20c0ec40bcff5c" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">a person that owns a security as part of a straddle or conversion transaction for tax purposes; or</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z05be9d362bd042989ed8ee5af8506619" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">a U.S. holder (as defined below) whose functional currency for tax purposes is not the U.S. dollar.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin: 12pt 0px 9.5pt; text-align: justify;">Although this section is based on the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), its legislative history, existing and proposed regulations under the Code, published rulings
      and court decisions, all as currently in effect, no statutory, judicial or administrative authority directly addresses how your securities should be treated for U.S. federal income tax purposes, and as a result, the U.S. federal income tax
      consequences of your investment in your securities are uncertain. Moreover, these laws are subject to change, possibly on a retroactive basis.</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z2de013b09c1f4a099baab6d634f1bc7f">

        <tr>
          <td style="width: 1%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 98%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);">
            <div style="text-align: justify; margin-top: 9pt;">&#160;<font style="font-style: italic;">You should consult your tax advisor concerning the U.S. federal income tax and any other applicable tax consequences of your investments in the securities,
                including the application of state, local or other tax laws and the possible effects of changes in federal or other tax laws.</font></div>
          </td>
          <td style="width: 1.14%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div style="margin: 10pt 0px 9.5pt; font-weight: bold; text-align: justify;">U.S. Holders</div>
    <div style="text-align: justify;">This section applies to you only if you are a U.S. Holder that holds your securities as a capital asset for tax purposes. You are a &#8220;U.S. Holder&#8221; if you are a beneficial owner of each of your securities and you are:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5515094791444b38b0f59d8bff3984d5">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a citizen or resident of the United States;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" class="DSPFListTable" id="z54c41a33e5fd45d6917cd796e18393a8">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a domestic corporation;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" class="DSPFListTable" id="z92b60c494a9a4abaa7c62a2749d26847">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>an estate whose income is subject to U.S. federal income tax regardless of its source; or</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 9.5pt;" class="DSPFListTable" id="zbed323bfad6d413a81e48da5a641035a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a trust if a United States court can exercise primary supervision over the trust&#8217;s administration and one or more United States persons are authorized to control all substantial decisions of the trust.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-bottom: 9.5pt; font-style: italic; font-weight: bold;">Tax Treatment</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">You will be obligated pursuant to the terms of the securities &#8212; in the absence of a change in law, an administrative determination or a judicial ruling to the contrary &#8212; to characterize your
      securities for all tax purposes as income bearing pre-paid derivative contracts in respect of the Market Measures. Except as otherwise stated below, the discussion herein assumes that the securities will be so treated.</div>
    <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt;">Coupon payments that you receive should be included in ordinary income at the time you receive the payment or when the payment accrues, in accordance with your regular method of
      accounting for U.S. federal income tax purposes.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">
      <div style="margin-bottom: 9.5pt;">Upon the sale, exchange, redemption or maturity of your securities, you should recognize capital gain or loss equal to the difference, if any, between the
        amount of cash you receive at such time (excluding any amounts attributable to accrued and unpaid coupon payments, which will be taxable as described above) and your tax basis in your securities. Your tax basis in the securities will generally be
        equal to the amount that you paid for the securities. If you hold your securities for more than one year, the gain or loss generally will be long-term capital gain or loss. If you hold your securities for one year or less, the gain or loss
        generally will be short-term capital gain or loss. Short-term capital gains are generally subject to tax at the marginal tax rates applicable to ordinary income.</div>
    </div>
    <div>
      <div>In addition, the constructive ownership rules of Section 1260 of the Internal Revenue Code could apply to your securities. If your securities were subject to the constructive
        ownership rules, then any long-term capital gain that you realize upon the sale, exchange,</div>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-32</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin-bottom: 9.5pt;">
      <div>redemption or maturity of your securities would be re-characterized as ordinary income (and you would be subject to an interest charge on deferred tax liability with respect to such
        re-characterized capital gain) to the extent that such capital gain exceeds the amount of &#8220;net underlying long-term capital gain&#8221; (as defined in Section 1260 of the Internal Revenue Code). Because the application of the constructive ownership rules
        is unclear you are strongly urged to consult your tax advisor with respect to the possible application of the constructive ownership rules to your investment in the securities.</div>
    </div>
    <div style="text-align: justify; margin-bottom: 9.5pt; font-weight: bold;">No statutory, judicial or administrative authority directly discusses how your securities should be treated for U.S. federal income tax purposes. As a result, the U.S. federal
      income tax consequences of your investment in the securities are uncertain and alternative characterizations are possible. Accordingly, we urge you to consult your tax advisor in determining the tax consequences of an investment in your securities in
      your particular circumstances, including the application of state, local or other tax laws and the possible effects of changes in federal or other tax laws.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt; font-style: italic; font-weight: bold;">Alternative Treatments</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">There is no judicial or administrative authority discussing how your securities should be treated for U.S. federal income tax purposes. Therefore, the IRS might assert that a treatment other than
      that described above is more appropriate. For example, the IRS could treat your securities as a single debt instrument subject to special rules governing contingent payment debt instruments. Under those rules, the amount of interest you are required
      to take into account for each accrual period would be determined by constructing a projected payment schedule for the securities and applying rules similar to those for accruing original issue discount on a hypothetical noncontingent debt instrument
      with that projected payment schedule. This method is applied by first determining the comparable yield &#8211; i.e., the yield at which we would issue a noncontingent fixed rate debt instrument with terms and conditions similar to your securities &#8211; and
      then determining a payment schedule as of the issue date that would produce the comparable yield. These rules may have the effect of requiring you to include interest in income in respect of your securities prior to your receipt of cash attributable
      to that income.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">If the rules governing contingent payment debt instruments apply, any gain you recognize upon the sale, exchange, redemption or maturity of your securities would be treated as ordinary interest
      income. Any loss you recognize at that time would be treated as ordinary loss to the extent of interest you included as income in the current or previous taxable years in respect of your securities, and, thereafter, as capital loss.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">If the rules governing contingent payment debt instruments apply, special rules would apply to a person who purchases securities at a price other than the adjusted issue price as determined for
      tax purposes.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">
      <div style="margin-bottom: 9.5pt;">It is possible that your securities could be treated in the manner described above, except that (1) any gain or loss that you recognize upon the sale,
        exchange, redemption or maturity of your securities would be treated as ordinary income or loss or (2) you should not include the contingent coupon payment, if any, in income as you receive them but instead you should reduce your basis in your
        securities by the amount of the contingent coupon payment you receive. You should consult your tax advisor as to the tax consequences of such characterization and any possible alternative characterizations of your securities for U.S. federal income
        tax purposes.</div>
    </div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">It is also possible that the IRS could seek to characterize your securities in a manner that results in tax consequences to you that are different from those described above. You should consult
      your tax advisor as to the tax consequences of any possible alternative characterizations of your securities for U.S. federal income tax purposes.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt; font-weight: bold;">Possible Change in Law</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">On December 7, 2007, the IRS released a notice stating that the IRS and the Treasury Department are actively considering issuing guidance regarding the proper U.S. federal income tax treatment of
      an instrument such as the securities, including whether holders should be required to accrue ordinary income on a current basis and whether gain or loss should be ordinary or capital. It is not possible to determine what guidance they will ultimately
      issue, if any. It is possible, however, that under such guidance, holders of the securities will ultimately be required to accrue income currently and this could be applied on a retroactive basis. The IRS and the Treasury Department are also
      considering other relevant issues, including whether foreign holders of such instruments should be subject to withholding tax on any deemed income accruals and whether the special &#8220;constructive ownership rules&#8221; of Section 1260 of the Code might be
      applied to such instruments. Except to the extent otherwise provided by law, we intend to continue treating the securities for U.S. federal income tax purposes in accordance with the treatment described above under &#8220;Tax Treatment&#8221; unless and until
      such time as Congress, the Treasury Department or the IRS determine that some other treatment is more appropriate.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">Furthermore, in 2007, legislation was introduced in Congress that, if enacted, would have required holders that acquired instruments such as your securities after the bill was enacted to accrue
      interest income over the term of such instruments. It is not possible to predict whether a similar or identical bill will be enacted in the future, or whether any such bill would affect the tax treatment of your securities.</div>
    <div style="text-align: justify;">It is impossible to predict what any such legislation or administrative or regulatory guidance might provide, and whether the effective date of any legislation or guidance will affect securities that were issued before
      the date that such legislation or guidance is issued. </div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-33</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify;">You are urged to consult your tax advisor as to the possibility that any legislative or administrative action may adversely affect the tax treatment of your securities.</div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 9.5pt; font-weight: bold;">Backup Withholding and Information Reporting</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">You will be subject to generally applicable information reporting and backup withholding requirements as discussed in the accompanying prospectus supplement under &#8220;United States Federal
      Taxation&#8212;U.S. Holders &#8212; Backup Withholding and Information Reporting&#8221; with respect to payments on your securities and, notwithstanding that we do not intend to treat the securities as debt for tax purposes, we intend to backup withhold on such
      payments with respect to your securities unless you comply with the requirements necessary to avoid backup withholding on debt instruments (in which case you will not be subject to such backup withholding) as set forth under &#8220;United States Federal
      Taxation&#8212;U.S. Holders &#8212; Backup Withholding and Information Reporting&#8221; in the accompanying prospectus supplement. Please see the discussion under &#8220;United States Federal Taxation&#8212;U.S. Holders &#8212; Backup Withholding and Information Reporting&#8221; in the
      accompanying prospectus supplement for a description of the applicability of the backup withholding and information reporting rules to payments made on your securities.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt; font-weight: bold;">Non-U.S. Holders</div>
    <div style="text-align: justify;">This section applies to you only if you are a Non-U.S. Holder. You are a &#8220;Non-U.S. Holder&#8221; if you are the beneficial owner of securities and are, for U.S. federal income tax purposes:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2783a54530e24bc6a342481afdc31277">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a nonresident alien individual;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8ca9b029337e475f9fa23bafb86b4fd4">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a foreign corporation; or</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 9.5pt;" class="DSPFListTable" id="zeec4455b6f6343c0a214bbbcaaa523a2">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>an estate or trust that in either case is not subject to U.S. federal income tax on a net income basis on income or gain from the securities.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify;">The term &#8220;Non-U.S. Holder&#8221; does not include any of the following holders:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2e979f80d3814add9fecefea8d002bda">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a holder who is an individual present in the United States for 183 days or more in the taxable year of disposition and who is not otherwise a resident of the United States for U.S. federal income tax purposes;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6e93252c2e994204a2c673a29866019a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>certain former citizens or residents of the United States; or</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0c542e08bf424ae298d3b9ad33833b0a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a holder for whom income or gain in respect of the securities is effectively connected with the conduct of a trade or business in the United States.</div>
          </td>
        </tr>

    </table>
    <div style="margin: 15pt 0px 9.5pt; text-align: justify;">Such holders should consult their tax advisors regarding the U.S. federal income tax consequences of an investment in the securities.</div>
    <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt;">Because the U.S. federal income tax treatment (including the applicability of withholding) of the coupon payments on the securities is uncertain, in the absence of further
      guidance, we intend to withhold on the coupon payments made to you at a 30% rate or at a lower rate specified by an applicable income tax treaty under an &#8220;other income&#8221; or similar provision. We or our agents, including WFS, will not make payments of
      any additional amounts. To claim a reduced treaty rate for withholding, you generally must provide a valid IRS Form W-8BEN, IRS Form W-8BEN-E, or an acceptable substitute form upon which you certify, under penalty of perjury, your status as a
      non-U.S. Holder and your entitlement to the lower treaty rate. Payments will be made to you at a reduced treaty rate of withholding only if such reduced treaty rate would apply to any possible characterization of the payments (including, for example,
      if the coupon payments were characterized as contract fees). Withholding also may not apply to coupon payments made to you if: (i) the coupon payments are &#8220;effectively connected&#8221; with your conduct of a trade or business in the United States and are
      includable in your gross income for U.S. federal income tax purposes, (ii) the coupon payments are attributable to a permanent establishment that you maintain in the United States, if required by an applicable tax treaty, and (iii) you comply with
      the requisite certification requirements (generally, by providing an IRS Form W-8ECI). If you are eligible for a reduced rate of United States withholding tax, you may obtain a refund of any amounts withheld in excess of that rate by timely filing a
      refund claim with the IRS.</div>
    <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt;">&#8220;Effectively connected&#8221; payments includable in your United States gross income are generally taxed at rates applicable to United States citizens, resident aliens, and domestic
      corporations; if you are a corporate non-U.S. Holder, &#8220;effectively connected&#8221; payments may be subject to an additional &#8220;branch profits tax&#8221; under certain circumstances.</div>
    <div style="text-align: justify;">You will be subject to generally applicable information reporting and backup withholding requirements as discussed in the accompanying prospectus supplement under &#8220;United States Federal Taxation &#8212;Non-U.S. Holders &#8212;
      Backup Withholding and Information Reporting&#8221; with respect to payments on your securities and, notwithstanding that we do not intend to treat the securities as debt for tax purposes, we or the applicable withholding agent intend to backup withhold on
      such payments with respect to your securities unless you comply with the requirements necessary to avoid backup withholding on debt instruments (in which case you will not be subject to such backup withholding) as set forth under &#8220;United States
      Federal Taxation &#8212;Non-U.S. Holders &#8212; Backup Withholding and Information Reporting&#8221; in the accompanying prospectus supplement.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-34</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">As discussed above, alternative characterizations of the securities for U.S. federal income tax purposes are possible. Should an alternative characterization of the securities, by reason of a
      change or clarification of the law, by regulation or otherwise, cause payments with respect to the securities to become subject to withholding tax, we or the applicable withholding agent will withhold tax at the applicable statutory rate and we or
      our agents, including WFS, will not make payments of any additional amounts. Prospective Non-U.S. Holders of the securities should consult their tax advisors in this regard.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">Furthermore, on December 7, 2007, the IRS released Notice 2008-2 soliciting comments from the public on various issues, including whether instruments such as your securities should be subject to
      withholding. It is therefore possible that rules will be issued in the future, possibly with retroactive effect, that would cause payments on your securities to be subject to withholding, even if you comply with certification requirements as to your
      foreign status.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">
      <div style="margin-bottom: 9.5pt;">In addition, the Treasury Department has issued regulations under which amounts paid or deemed paid on certain financial instruments (&#8220;871(m) financial
        instruments&#8221;) that are treated as attributable to U.S.-source dividends could be treated, in whole or in part depending on the circumstances, as a &#8220;dividend equivalent&#8221; payment that is subject to tax at a rate of 30% (or a lower rate under an
        applicable treaty), which in the case of amounts you receive in respect of any coupon payment or upon the sale, exchange, redemption or maturity of your securities, could be collected via withholding. If these regulations were to apply to the
        securities, we or the applicable withholding agent may be required to withhold such taxes if any U.S.-source dividends are paid on the Market Measures during the term of the securities. We could also require you to make certifications (e.g., an
        applicable IRS Form W-8) prior to making any payments in respect of any coupon payment or any payment upon the maturity of the securities in order to avoid or minimize withholding obligations, and we or the applicable withholding agent could
        withhold accordingly (subject to your potential right to claim a refund from the IRS) if such certifications were not received or were not satisfactory. If withholding was required, we or our agents, including WFS, would not be required to pay any
        additional amounts with respect to amounts so withheld. These regulations generally will apply to 871(m) financial instruments (or a combination of financial instruments treated as having been entered into in connection with each other) issued (or
        significantly modified and treated as retired and reissued) on or after January 1, 2027, but will also apply to certain 871(m) financial instruments (or a combination of financial instruments treated as having been entered into in connection with
        each other) that have a delta (as defined in the applicable Treasury regulations) of one and are issued (or significantly modified and treated as retired and reissued) on or after January 1, 2017. In addition, these regulations will not apply to
        financial instruments that reference a &#8220;qualified index&#8221; (as defined in the regulations). We have determined that, as of the issue date of your securities, your securities will not be subject to withholding under these rules. Our determination is
        binding on Non-U.S. Holders and withholding agents, but it is not binding on the IRS. Accordingly, the IRS could challenge our determination and assert that withholding is required in respect of your securities. In certain limited circumstances,
        however, you should be aware that it is possible for Non-U.S. Holders to be liable for tax under these rules with respect to a combination of transactions treated as having been entered into in connection with each other even when no withholding is
        required. You should consult your tax advisor concerning these regulations, subsequent official guidance and regarding any other possible alternative characterizations of your securities for U.S. federal income tax purposes.</div>
    </div>
    <div style="text-align: justify; margin-bottom: 9.5pt;">Under current law, while the matter is not entirely clear, individual Non-U.S. Holders, and entities whose property is potentially includible in those individuals&#8217; gross estates for U.S. federal
      estate tax purposes (for example, a trust funded by such an individual and with respect to which the individual has retained certain interests or powers), should note that, absent an applicable treaty benefit, a security is likely to be treated as
      U.S. situs property, subject to U.S. federal estate tax. These individuals and entities should consult their own tax advisors regarding the U.S. federal estate tax consequences of investing in a security.</div>
    <div style="text-align: justify; margin-bottom: 9.5pt; font-weight: bold;">Foreign Account Tax Compliance Act</div>
    <div style="text-align: justify;">Legislation commonly referred to as &#8220;FATCA&#8221; generally imposes a gross-basis withholding tax of 30% on payments to certain non-U.S. entities (including financial intermediaries) with respect to certain financial
      instruments, unless various U.S. information reporting and due diligence requirements have been satisfied. An intergovernmental agreement between the United States and the non-U.S. entity&#8217;s jurisdiction may modify or supplement these requirements.
      This legislation generally applies to certain financial instruments that are treated as paying U.S.-source interest or other U.S.-source &#8220;fixed or determinable annual or periodical&#8221; (&#8220;FDAP&#8221;) income. Current provisions of the Code and Treasury
      regulations that govern FATCA treat gross proceeds from a sale or other disposition of obligations that can produce U.S.-source interest or FDAP income as subject to FATCA withholding. However, under recently proposed Treasury regulations, such gross
      proceeds would not be subject to FATCA withholding. In its preamble to such proposed regulations, the Treasury Department and the IRS have stated that taxpayers may generally rely on the proposed Treasury regulations until final Treasury regulations
      are issued. We will not be required to pay any additional amounts with respect to amounts withheld. Both U.S. and Non-U.S. Holders should consult their tax advisors regarding the potential application of FATCA to the securities.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">PRS-35</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 99.88%; vertical-align: top;">
                <div style="color: rgb(187, 8, 38); font-size: 14pt; font-weight: bold;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">Market Linked Securities&#8212;</font><font style="font-size: 13pt;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>Auto-Callable with Contingent Coupon and Contingent Downside</font></div>
                <div style="text-align: justify; color: rgb(187, 8, 38); font-size: 4.5pt;"><font style="font-size: 11pt; font-weight: bold;">Principal at Risk Securities Linked to the Lowest Performing of the Utilities Select Sector SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> Fund, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup> S&amp;P Regional Banking ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-weight: bold; color: rgb(187, 8, 38); font-style: normal; font-variant: normal; text-transform: none;">&#174;</font></sup>
                    S&amp;P Biotech ETF due July 19, 2029</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za20871aaafdf45ce92cc7361dd4474db">

        <tr>
          <td style="width: 100%; vertical-align: top; background-color: #5E8AB4;">
            <div style="color: rgb(255, 255, 255); font-size: 10pt; font-weight: bold; text-align: center;">LEGAL MATTERS</div>
          </td>
        </tr>

    </table>
    <div style="margin-top: 9pt;">
      <div style="margin-top: 9pt;">In the opinion of Sidley Austin LLP, as counsel to Jefferies Financial Group Inc., when the securities offered by this pricing supplement have been executed and issued by Jefferies Financial Group Inc. and authenticated
        by the trustee pursuant to the indenture, and delivered against payment as contemplated herein, such securities will be valid and binding obligations of Jefferies Financial Group Inc., enforceable in accordance with their terms, subject to
        applicable bankruptcy, insolvency and similar laws affecting creditors&#8217; rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack
        of bad faith), provided that such counsel expresses no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above. This opinion is given as of the date hereof and
        is limited to the Federal laws of the United States and the laws of the State of New York as in effect on the date hereof. In addition, this opinion is subject to customary assumptions about the trustee&#8217;s authorization, execution and delivery of
        the indenture and the genuineness of signatures and certain factual matters, all as stated in the letter of such counsel dated May 12, 2023, which has been filed as Exhibit 5.1 to Jefferies Financial Group Inc.&#8217;s Registration Statement on Form S-3
        filed with the Securities and Exchange Commission on May 12, 2023.</div>
    </div>
    <div><br>
    </div>
    <br>
    <div style="text-align: center;"><font style="font-size: 8pt;">PRS-36</font><br>
    </div>
  </div>
  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div class="BRPFPageFooter" style="width: 100%;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>EXHIBIT 107
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-221">S-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-222">424B2</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-223">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="ffd:RegnFileNb" contextRef="rc" id="ixv-224">333-271881</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-225">0000096223</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-226">Jefferies Financial Group Inc.</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0000096223</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-07-18</xbrli:startDate>
              <xbrli:endDate>2025-07-18</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_1">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0000096223</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-07-18</xbrli:startDate>
              <xbrli:endDate>2025-07-18</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>
    <div>
      <table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
        <tr>
          <td colspan="4" style="padding-bottom: .5em">
            <p>
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-251">S-3</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-252">Jefferies Financial Group Inc.</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: center; width: 90%; word-wrap: break-word">
            <p style="margin: 0pt; text-align: center;">
              <b>Table 1: Newly Registered and Carry Forward Securities</b>
            </p>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; float: center; width: 100%; text-align: center; border: 1px solid black; font-size: 16px;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 12%;">
            <!-- BLANK -->
          </th>
          <th style="width: 2%;">
            <!-- BLANK -->
          </th>
          <th style="width: 12%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 14%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title </b>
            </p>
          </th>
          <th style="width: 2%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Calculation or Carry Forward Rule</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount Registered</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Proposed Maximum Offering Price Per Unit</b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Rate</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Registration Fee</b>
            </p>
          </th>
          <th style="width: 1%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Form Type</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward File Number</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Initial Effective Date</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b>
            </p>
          </th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Newly Registered Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_1" format="ixt:booleanfalse" id="ixv-253">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		1
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-254">Debt</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-255">Debt Securities</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457rFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-256">457(r)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="Shares" decimals="0" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-257">2,150</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-258">1,000.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-259">2,150,000.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-260">0.0001531</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-261">329.17</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fees Previously Paid
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Carry Forward Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; width: 16%;">
            <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-262">2,150,000.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; border-bottom: 1px black; width: 16%;">
            <p id="TotalFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-263">329.17</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fees Previously Paid:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-264">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fee Offsets:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-265">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Net Fee Due:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="NetFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-266">329.17</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table style="width: 100%; text-indent: 0px;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
            <td>
              <p style="margin:0pt;text-align:left; margin-bottom: 5px;">
                <b>Offering Note</b>
              </p>
            </td>
            <td/>
          </tr>
        </tbody>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="width: 100%; text-indent: 0px;">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_1" id="ixv-267">Fee per Rule 457(r)</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
            <th style="vertical-align: bottom; text-align: center; width: 90%;">
              <b>Narrative Disclosure</b>
            </th>
          </tr>
        </tbody>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; text-align: center; margin-left:auto; margin-right:auto;">
        <tbody>
          <tr>
            <td>
					 The maximum aggregate offering price of the securities to which the prospectus relates is <span>$</span><ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="rc" id="ixv-268">2,150,000.00</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="rc" format="ixt:booleantrue" id="ixv-269">The prospectus is a final prospectus for the related offering.</ix:nonNumeric>
				</td>
          </tr>
          <tr>
            <td>
              <div style="padding-top: 20px;">
                <ix:nonNumeric name="ffd:NrrtvDsclsr" contextRef="rc" escape="1" id="ixv-270">Fee per Rule 457(r)</ix:nonNumeric>
              </div>
            </td>
          </tr>
        </tbody>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $& ; # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*\(_:>\*>*_&_P  /BKX9\#:,OB3QA?^%+N;PYX<.I:?H[^(M6TN:#5K/0+?
M5M7FM=(TZ\UJ2Q&F6-[K%Y8Z1;WEU!+JE_86"W%Y#[O10!^07Q:_9 N_VF]-
M^*OCKXG_ ++6@W^O>,OVM?V2/&O@WP)\;]*^!'C/Q=X4^%'P^U_]FC0_CEJ?
M]JZ1XS^(W@O3=-\5^!O!'Q M-<\-:-XNGU3Q?X5T]M"O=)U&?6[30Y[7AGX)
M_&+X.?&'X\R>%OV;_$VM_#3XC:=\4/!GPY_X5KK_ ,!M#\->"_#VJ^&_@KH?
M@X77ASQ3\5O M[H?A>-/#.NVMCI7AK0M3O-*L]!EC?1+2.YT:/4?USHH _"V
M+_@G--I7A?XK>(-!_9B^%6E?%_7_ -@[]E[X>>&_%^EZ%\(-.\9S_M$:1+\;
M;'X_O#XRMKF#4+'Q-K.A:Y\/].\8>.KC5K6P\=Z<FF6 \1:_#H<T&GPZ/^QK
MJ<?@#XGZ'K/[#*6?BWQ1XZN]0\6^+O!GP[_82T[Q5\6?#+?'B7QB+'7O$/BW
MXK^,K?XY>%?$-K'H'B/QM\/OCGHWPTAUKPM8:K)I/B#PY\2M'\(Z3<?NQ10!
M\I_LS^$_B1X=_9>T;PAXS\ :3\-O&EI9_$FPTCX?Z'K]WH>G>'=#O/%_BZ7X
M>:3!>:=X\^.UK\.F3PG<^'0_AOP7X^^(WA#X8.Q\-?#V>;PGX=T'1;3\A=(_
M8O\ B9'/X0\/ZO\ L%Z=XD^"OAG5O#.JR>$OB!X _8J\4^,=?\93_#OXEZ5X
MH^('C_X6Z=^TYH_[+/C'Q5%J&H^#]*U'XU^%/#?PF^)GC/4+VZ3Q/X U[1_"
MOAKQ+8?T344 ?C%X[^"OQ,UWX2^+/@B/V']?USP+-^T7\//B;IOA:]TK]CS6
M_A/J'PWTJT^'<,_A:S^%NO?M(Z5HWF^%ETZ^@C\(:Q#I_A>W_P"$;DCT36=:
MM5T,ZSTGAS]G)]!\6>&KNZ_8!M=;M]+M?A+_ ,**U'0]0_9X^"FB_LK3Z3XQ
MUF?X@P6.G?#_ .+6OZI\(?[3U2[N/B;XLU/]G*T^(]Y\7=#UU? _C:.[CT>V
M\-6_Z\T4 ?"_[*_[)'PY^ /QB_:U\?>&/@%\)_A9)\1OB]I$_P ._$G@?P1\
M/?#VJZG\*G^!/P$L]=TFWN?"5G#JNC>'+KXS>&?'^L7OA?5!IJWWBE+_ ,8/
MI4[:U;:SJ'S]^US^S_\ %?QG^T-;?$3X;_ *Y^(7B.72/A?X8TCXD^(M3^$!
M\)^"/!MKX@UV;XA)X3\9'XD?"7]I;X/^,)](O]4A\2^&O#ME\;_@;\7-+N_"
M.A>+? X@USXD?V7^M-% 'X<?##]DG_A%OAY\+]&\1?\ !.7P[>>#=.NM'7XX
M? [0OAM^Q/X$B^*FM0_#75=(\,>,?$NC:'^T'K_PU^-EE\,_%$NK;+/XM>)=
M'O[35/&EGX]\-:5K?B+PU;3:9[1>_L0:3XH^*_P%^+^F?LS?"?X9^//"_P"R
M=\;/#D?C/Q9!X+^,/C+X0_')M3_9WC_9GN-=\?ZU'=^-_'7BSX6:!X8\=VVA
M^+-(O]>LO!D.GZ[X>\/>,!IFM:1>Z_\ J_10!^$]]^P]XL^(A^&>A>&_V2?#
MOP&\#1Z)X/LOVF/!_P 5(?@C\5?!OQ_^)5KX]^&NN:9\6?%?A+PM\4?$]I\:
M=0^'FF^%?B=-KOCSXN7'AKXJ>,S\1M!C-CX@E&N6WAG]+/V,?A7XD^"GP,L?
MAEXK\.V?AG5?#'CCXGI'9>'HO#FF?#Z[TG4_B!XBUG0]5^$W@[PQ?W]E\,_A
M9J.CZC93^"OA9>N=:^'.F$>$M8O_ !+?:7+XP\1?5E% 'X':_P#L2_&3QE\0
M?$'AJP_9E\!:=X&\:?$B?QE\6?''[0GA7X*?%+2/B#J\'Q]\.^*]/E\2Z)\*
M_CAX"?\ :?\ A]I_A*V\4WG@N_\ V@?A!\//CO\ #_0)?#NC0^-_$=_K_C[P
MU)VR_L0>*?A=XYU72? ?[/Q\8>/;G4_@K-\(OVNM!TWX$>!_#_[/FCV7Q8\3
M_$'XA>!_!FGZI\4O^%X_#GX+^#-&U.;P/X/^#?@3PUXY\/:G\/;C0/AQK-WX
MCT*;Q7J,'[=T4 ?E-^RK^Q]XO^!7Q^T3XGWOPU^'_AZQ\9>#_CQ:^,M8^%WA
M#X>^ /%$'BWQ)\6-+\5Z%>?M ^(])\0ZCK_[0:^)/#D!G\ :O9BV?X8:S%XF
MA\0Z+K!\:Z;J7@7 UKX$?%/1/CUX\^(7PL_95NO#WQ8N_C[XN^)LW[3UIKG[
M/GA.'XG?">T^#DVCZ1\(M8\46?C'Q+\8-5@\5^)Y[#P_I'A_XB_"34/ /A35
M]*B\?7L4-QX6\*3ZA^O%% 'XL^ _AC^W=XF\=ZGKOQ[&L:%X<\)^/?!>I>#/
MBKXIL?V4]/\ ''A+PAI?PPUA?$_B*YU'P%KGBBTUW3O#7Q%\0>)->L+'Q/86
M6AW#W?VFT^&N@^'T31;3Z<\)S?M'?';]A[Q;X@\4;)OBG\5O#ESK'ASP;X?U
M>R\'6TO@^"QT32!X4\,>-]-AT>\TA/C/HOA_6_%>D>+=3OXM2\)W7Q5CAAUK
M3=*\.Z6=-_0JB@#\CI?@M\5?#AM_$/[+_P"R7J7[)^E>'+GQY-8>"=#\4_L^
M0^()SXFTSX0P^*]<^'OPNTCQCXS_ &</A[XL\2:)HOBW2/!$4NNS^%_$/Q'T
MQ/%_Q@L/#^GZI+J^L\AIFA?\%+];\8W=GXP\/^.O$7PTU/QKJIT/P]\0(/V-
M%L/"OPWL?'\^K^#Y/B!-H?B3QY-\2O'MKH6DZ,L5MX<\,^!%\.SW5MXAG^)/
MC?6K&Y\/M^T%% 'X1?M-_$C_ (*!? 'P1JFN:A\1?BI<7/C/X%>)K?P/%X6@
M_8O/BN']K^ZMOBU>^"O!V@V_Q$T#0O!FM>#H-&T_P- O@73&\2?$/QQX@B\,
M0^!](\:W!^+Y/Z8?&J'XCZ?XT_9Q^('ACX4>-/BTO@S5_&O_  F>C^!M7^%F
MC:[I,7B;X<ZCH]KJSQ_%'XB?#31+NS&LO%9W-OI6KW>I0O=131Z8]FEQ/;_5
MM% 'Y#> ['_@JHU])<^)M<N8HM?U+1_!/B/3/$/AS]G.VT_P7!XQ\1_$&V\2
M_'+X5:SX3\:^*-0UZS^#VB6'@";PQ\.OB#X=TV;QEH=_'<:YI.J^,[WQ/%HG
M#V?@'_@IMJGB[4/%_C*_\2RZUX3\!>/=/\*:EIWA+]F>_73_ !YXD\930W=S
M\,+&/XX^$X]?\%:QX)T?0=,TO2_BF_PZUVTTBTT77KW6]'\>:IXPM;?]L:*
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M1-%TN"UTW2=*TVSAAM+#3K"VM[.SM8HK>WACBC5!\-_#G_E*;^V1_P!F ?\
M!-/_ -:*_P""L5 'W_1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ_+?XKV'BOP_X+U']N.7Q[X@\0^(?#&O>--6^$GA2_-JO@31?AG\35NOA5X
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MVL;-);AT4RROOED.=EK9P7>H73P6-G=7$/S-9>+_ -L._77_ !=8_#7X=?\
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MA_LU_"^7P1\+]/\ $MEXN;3?W5^/OPNG^.'P+^,OP7M?%^M?#ZY^+?PL\?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K^'#Q!X[_P""7O[;7_!8_P 6_L)VGQ0_X+.>'OVGIOVK
M?CW;QZCI_P"U!X1\(_LL_"/Q-\.O 7Q<U+XBVWP3T7P]X_\ '.H:+X+U^2'X
MF_V=H5Y\/K#Q!<3?%WQYI'B+4M%T+5=0\'Q?V:?'D?'AO@]\0!^S#+\)(?C]
M_P (_.?A6_QY@\97'P>/BE9H6MH_B!'\/KBU\:#P_+ +B*>;PY*=1MYGAN(X
M+I(GMIOYKOV=_AUX^N?^"MGAKQ!<^&O^#>;2+"R_:E_:T\3ZC?\ [-5XDO\
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M[0NHZ[XHLM1BUFZU'Q?9>*_#FDZI97^F6%MX(TB?2;K4M: /U7HHHH ****
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MN?"?CSP]J/A?Q%;V&I0AIM/O)](U2[BMKV$&6UF=)XOG137Y<?LU_P#! ?\
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M1._M_P#_ (<;_@EE_P#3+* /O^BOS ^&G_!1KXG_ !@\.:EXL^'7_!+K]O\
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M=KO]C>'?^"CFK^(-7_LCP_I&H:A_9FA:5J>L7_V?[+IFGWM[+!;2 'Z?T5\
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M"CFIWL7_  E'Q-^('A'PU_:<]M'H^B?VO_;/B+4-(\/V&IZK9 'Z?T5\ ?\
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M **_,#3?^"C7Q/U?XI^,O@II_P#P2Z_;_N/B;\/_ (?_  T^*7B[PU_PF?\
MP3*B_LCP)\8/$?Q8\)_#K7?[9G_X*.1^'[__ (2+Q!\#OBEI_P#9FF:K>ZQI
M'_"+_:M=T_3++6_#MSJ_H'_#9'[17_2)W]O_ /\ #C?\$LO_ *990!]_T5\
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MJMEZ!_PV1^T5_P!(G?V__P#PXW_!++_Z990!]_T5\ ?\-D?M%?\ 2)W]O_\
M\.-_P2R_^F65Y_XR_P""C7Q/^'_B/X3^$_%W_!+K]O\ TCQ!\<?B!J7PM^%N
MG_\ "9_\$RK_ /X2CQWI'PL^)?QKU#0OM6F?\%'+VRT3[/\ #+X/_$7Q+_:?
MB*YTC1Y?^$=_L:#4)/$&KZ%I6I@'Z?T5\ ?\-D?M%?\ 2)W]O_\ \.-_P2R_
M^F64?\-D?M%?](G?V_\ _P .-_P2R_\ IEE 'W_17YT>&_V^_'6J?M _"K]G
M#Q;_ ,$\?VU_A;XT^+GA?Q[X_P!$UKQMXH_X)_:IX1T7X;_"KQ3\)/!OQ-\?
M>([SX9?MV_$37(M'\%:Y\<_A?#?:+HGA[7?'&M0>)'N/"'A/Q)'HNOG2_P!%
MZ "BBB@ HHHH **** "BBB@!&;:K-ACM!;"@LQP,X51R6/0 <D\"OS$^!_[?
M/P@^,GQIT[_A$_A1HNC:U\03\.OAAKOQ"?QQ\(=2^)5ZNI> _B-\=O@OX+UO
MPSX.UK7_ !I=Z3X8\*W?Q1UGQ+H?B"^T[_A4_BWQ3KD.AZ1XDLM4^(GB7PU^
MGAS@XX/8D9&>V1D9^F1]17P!X0^'W[7Z_&GP%J'C#XV?L2ZE8>#?&7C+7_B-
MX%^&/[,/C+P/\6I/@EX]M_BK9^"(['X@>+/VD/BU+H]YXG\:Z1X)\1^,9X/A
MUX<T_P 6ZWX+\9V6D^)%BTU[>_ /O^N(^)GBC6?!'PY\?>-/#OA/4?'NO^$?
M!?BCQ-HG@?2'GCU;QCJV@Z)?:IIWA;3'M;#5;I=0U^[M8=*LS;:7J5S]HNH_
ML^GWLVRVE[>LW68]8FTC58?#U[INFZ_+IU['HFH:SIEUK6D6.KO;2KIUYJNC
M6.KZ!>ZMIUM>&&:]TVTUW1KF^MDEMH-5T^65;N( _.O]D;]HSQAXX^(FH_#A
M_@]X-^'_ (.O;CXQ>+!;>!OAW\7? S)K*>/=-\1ZM\9_$*_$/X>?#[2SH_[3
M'BSXB^+/%7AM(=-N-;\1>(/#_C3QDOB[XD7&K>,F^'OZ35\8?!33?VSY/B1H
MEU\:_P!H3]E7XB>#O"_@7Q%X<^*_P^^ _P "_'/PRUO0_C9J]O\ "SQ)X3FF
MU[QM^T'\=KZXT#2?"UUXON(M%N['X?ZQ=Z;XP\):_>6VKVUQ:IIWV?0!Y9\9
M_BIIOP7^'FI_$#5=+O-:AL]7\'^';/3+.]TG2_M6M>//&6@> _#RWVL:]?:=
MHNAZ-'KWB739==UW4[R.UT;1H[[4FCN6MDM)_!OV2/CYX4^)UMXN\$Z=\+?#
M7P?\2^'=;\<>,-8\.^!?$?A'Q?\ #_Q/>>)/C;\7?#GCGQ[X5\4>%+'0#KM[
MXG^+O@SXA:]XTU'7?"7AS7]2\1ZZ^OZQ%?:GKM[=5] ?&70_B!XF^%?CWP]\
M++OX9V7Q!UKPSJFF^%Y?C+X,UKXA_"N74;NW:$67CWP7X=\6>!];U_PSJ,#S
M6&J6>G>*-,G%O<M/_IJ1-I]UXQ^SEX<_:!T37_%G_"P_C%^SC\2?@[IWA7PG
MX(^&'AO]GGX*:S\&--\!^,_ ?B?XB:!\3],U?3=6^,OQS2\CM8(O!?A:STW3
M_%FBV_A;4O".OZ-<>$K"]6>\O0#ZSKY4_;$\=+X-^$;Z5J7A?P!KW@[XG:G?
M_"[XAZK\7_#6L>-/@YX.\$^*?!7B^35=8^*_@S1;*XN/%_@OQ!<Z=8?#FX\+
MWM]X>T;7M4\<Z7I>K>(M.M+IDN?JNO*/C+8?''4O"-O;_L^^+_A1X)\=_P#"
M2>&WN];^,OPZ\7_%#PBO@\:K OC"&W\,^"?BE\(-8/B3^PWNKCPW=R^+ETM=
M5MX+35+-K.\DO;$ X7]F'XK?$_XK> %U'XP?#.Y^&OCC3[7P?-?6\.D^,])\
M.Z_#XL^'WA/QO_:.@6OCK0-!U_39=&O_ !%J/@[Q)X<OUU+4/#7B;PUJFG:C
MJ,ER&AA^D:^=?V<X/CO)H_C/7_C7\8?@U\:],\7>)](\2?!OQ1\#OA[JGPX\
M'VWPMO?A[X)BAM'TC6/B/\7KO5+S4/&EOXQ\26_B&/XD^);+5-$UW2#8_P!E
M6\*:5:?15 'R;^U%\7O#OA:VT?X+:M\/?A[\3;SXY^#_ (DVD_@_XS>-?"OP
M_P#@[XC\$^'K?PUHGC[PSXUUKQ3HOB]-:/B#2_'UI90>"K#P'XM'B'1QXA?6
MK?3M#T^]NSZE\"_C#I'QT^'MMX^T;3GTN$^(/&/A6]M5UC0O$NG'6? OBK5_
M!VMW&@>*?#&H:GX?\3>';O5-%NKG1-:TZ[66>PEA@UG3=!\0V^K^']+\V_:5
M^&?BSXB?V%=M\9;3X.?";P5X5\?>*_&VK3:-\--;@;Q?IL_@^Z\$:OXJL/BO
MX$\8^%+SX:Z!X:MOB:?&MJVH^$M04ZGHVHZ=KEA?Z;::WH/6?LTZ#\7O#7PK
MATGXX-X1_P"$ZB\:_$ZXCA\ ZGJ&J>"[/P7??$;Q1>?#BP\,-JNFZ7J&EZ+9
M> 9_#EO8^&KF"X/A.&-?#,>JZW!I,6LWP![[7P;^U+\7->T7QEIWPYO/#_PQ
MTCP3I>E_#KXLP>-/C5\)?B?\7/"/B_QCX9^(.I^(-&\+^#-.\"V5GI'AOXA_
M##7_  !X.^(FE>*-2U_6/$>A:WJW@_7O"_@6\NM&.KP?>5?*7QC\*?&N7QQ=
M>/?#'[0EA\)_">@>'/A_I'P_\(:Q;>#I_ 7C;XGZUXQ\4:;K_A[XO0^(/!US
MXFGT#QR=2^%'A/P7<_#SQ]X9\9:9KXU9-%AEFU2;3/$X![;\*/%VO>/OAEX!
M\;>*?!VH?#[Q)XK\(Z#K^N^"-4.HF_\ "NJZIIMO>7VB7/\ ;.C>&];#6%Q*
M\"KKWAKPSKR1JB:YX;T#51>:19>@5Y-\!M,^).B_!/X2Z1\8[BUN_BSIGP[\
M(6/Q*N;'7+CQ/93>.+70K&'Q/)9^)+K3-$NM?M6UA+O[/K5UHVDW.IQ;+V?3
M;&69[:+UF@#X<_:)_;#_ &:O@UX@\10_%'P#\;_''C']G7PV_P <;>7P-^QC
M^TG\9;;P>NK>!_B%H-OXF\&?$_PA\&O$7PST3Q)K7@R3XD>"I]5M?'^D2Z?I
M&K>*O#OB?4]'TC4]9BD^V[2Y2\M;:[B#K'=6\-S&L@ <)/&LJ!PK,H<*P#!6
M8 YPQ'-?!?[0G@/]JR1?C%XA^%?[16C>'/&?C2/6/!7[.GP9\4ZEX6\/?#CQ
M-;3?!BUF^P7?B*'X=W'Q2\+_ !@TSQMIOQ-\?Z!XL\(^)O%FF6OAVPTQ_$_@
MW7-$T1K+P[]Y6*W$=C9I=MONTM;=+I\[M]PL*"9MP #;I QR  <YQ0!:KX5\
M<?'_ ,;Z7\4S=:5_P3O_ &C?&.L^!_B!H7P-TGX]2K^RU;>'+/X>?%WQK\(/
M^%B>./!^HQ?'O6OCO+\([6TA\,>-O&UCI'PGCN-8U'X406WB'1+&Z\'QZEHG
MW57Y\^,_ /[6FG:]82>&?VC-&USQ5XV^,\'B76/@SXFU/PKX>T32OV=_"O[0
MWA?4;W7?@[JOA_X=Z9\0K?Q3X8^"EWX7\(?$3PYXJOO&7@3Q?K&OW=@^L>%]
M;\2V_B_5 #]!J1F"*S-G:H+' ). ,G  ))P.@!)Z $TM(V[:VS ?!VE@2N['
MR[@""1G&0"#CH10!^??@/]L/X:^(/B-\&[[4/@3XI^%OCO\ :T7PQX7^&WC7
MQI9_#F#4OBW\*/#OP]^+GQL\'W.G>+/!/B+Q==:G'X$L[KQ/>7/PC\87_A[Q
M5X(U+XC^*?$6BZ#?:'<:]K^H_H+7YX^$OAK^U-H/C_\ 9\TO7_V@?#WQA&A:
MQHWQ#_:6\*>)KWPAI?B;X?W.L?"?XL^&(M5^$$?@SX<>$[W7/A1XS^*4]Q!I
M?AGXCZ=:ZOHT/AZ>\\*^-&T_PY?^!Q^AU '$_$KQ3JW@?X=>/?&F@^$]3\>:
M[X1\&>)_$VB^!]%,ZZQXQU;0M%O=4T[PMI;6MCJERNH:_=VL.E6;6VEZE<+<
M749@T^]E"6TORW\+?B5\2](^/R?";Q]^SMX6^&_B'XD^%OB!\8O'OQ1^&$6N
M^*OAM\2=;\%VWP/^&OA'6KOXCW'@;P+/%\19O"#6WAG6_!GQ&TC_ (2W3O"_
M@7PE9>#O$'C#P=X<N+[3?J3XE67CG4OAUX]T[X8:QIGA[XDW_@SQ/9?#_7]:
MA2YT?1/&MUHM[!X6U?5+>33M8CFT_3=;>QO+R*32-5CDMX9%DTV_0M:2_,OP
MT\'?'OPU\>M.TJ;XZ0_&KX$^#O!?Q"T?Q1/XKUKPQ#\8O"7Q3\13_![7O!G@
MOQII'@'P9X7\)^*=&TWP6NNZ_P"%_%&K6'A[Q_H^F^)XH/$,/C6W\46?B>U
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M.IQ;+V?3;&69[:( ]9KX?^._[4OP<\%_'GX9?L_:EX5\)>/?VEM0N_"GC?\
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M\);[5?#.BZW%\9K;5]=\5VUIK&IZGI&FZG?V-J ?<-%%(3@$X)P"< 9)P,X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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(H **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" #? G<# 2(  A$! Q$!_\0
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M +X'^->2NC1D!U920" PQP>AI*/91#VTCUO_ (3C1_[\W_? _P :/^$XT?\
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MQY/_ -=#_(44>'O^/)_^NA_D**[:?PHEGF'C_P#Y&V__ .V?_HM:Y^N@\?\
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M&TGU&1R*MW&KVN(0DX9H[2>'=%!Y2[F/RX'8>]<]?11P7L\4,@EBCD94<?Q
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M#[)% Y* [B#UZ#I@]:ED\:W=@NH1ZQHH@O(8(+BU@M[H2_:!-)Y:(6V@*V_
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MAK@C ["FJ<GT"Y:T6(Q67/\ $Q;^G]**O@   # ' %%=D596)"BBBF 4444
M%%%% !1110 4444 %%%% !17*KXVLO\ A.KKPO);W$=U# )DG8#RIFV[C&IS
MG<%^;![ ^E36/C31)?#ND:OJ-_:Z5!JD:R6Z7TZ1,Q89V\G!//:@#I** 00"
M""#R"** ,6Q_Y&K4_P#KC%_6MJL2S_Y&W4?^O>+^M;=5(F.P4445)04444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!YOX@\(ZI?:MXIU&SC2.]\RSO-(E9QAIX8V!5N<A6R4.>SFL73_  SK
MVCZ?HDTOABWUF7_A'H])GLWN8A]EE!);)<[6C;< Q7)^0<&O8J* ,?P;I<^B
M>$]'TN[F$]Q9VD4$D@)(9E4 XSSCTK8HHH Q+7_D;[__ *]H_P"9K;K#MO\
MD<;W_KUC_P#0C6Y52)B%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1145X9A:RFU"-.%)C
M#]"W;- &1;_\CE=_]><?_H1K<KADUY3K$MU @:[EM(X5@/7SMY!7\.OTKMXM
M_E)YNWS-HW;>F>^*J2:W(@T]AU%%%26%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUD$C[Y=H9"X&T;1E<GDT60'1V7BK1;R!)8+WY6N4M,21/&RRO]Q65E!7=V)
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MB59R[2$]V+$GTYJM;^#5M7A^R:K=11?V8FEW,7E(PN(T5E1B2,JPWD_+UIZ
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M4U&=-,DUAM0CTZ-8RDV-A1F?&\#<N2F>PHT L_\ "<VR>,H_#MQ:QI<32M!
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M%%%( HHHH **** "BBB@ JYI/_']']1_,53JYI/_ !_1_4?S%-;@==1116Y
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MW<^M7K?2;6$YVLY_VC5\# P.!3C"VK!L****T)"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
%BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &D HX# 2(  A$! Q$!_\0
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MQ^5']I3_ .Q^5 &U16+_ &E/_L?E1_:4_P#L?E0!M45B_P!I3_['Y4?VE/\
M['Y4 ;5%8O\ :4_^Q^5']I3_ .Q^5 &U16+_ &E/_L?E1_:4_P#L?E0!M45B
M_P!I3_['Y4?VE/\ ['Y4 ;5%8O\ :4_^Q^5']I3_ .Q^5 &U16+_ &E/_L?E
M1_:4_P#L?E0!M45B_P!I3_['Y4?VE/\ ['Y4 ;5%8O\ :4_^Q^5']I3_ .Q^
M5 &U16+_ &E/_L?E1_:4_P#L?E0!M45B_P!I3_['Y4?VE/\ ['Y4 ;5%8O\
M:4_^Q^5']I3_ .Q^5 &U16+_ &E/_L?E1_:4_P#L?E0!M45B_P!I3_['Y4?V
ME/\ ['Y4 ;5%8O\ :4_^Q^5']I3_ .Q^5 &U16+_ &E/_L?E1_:4_P#L?E0!
MM45B_P!I3_['Y4?VE/\ ['Y4 ;5%8O\ :4_^Q^5']I3_ .Q^5 &U16+_ &E/
M_L?E1_:4_P#L?E0!M45B_P!I3_['Y4?VE/\ ['Y4 ;5%8O\ :4_^Q^5']I3_
M .Q^5 &U16+_ &E/_L?E1_:4_P#L?E0!M45B_P!I3_['Y4?VE/\ ['Y4 ;5%
M8O\ :4_^Q^5']I3_ .Q^5 &U16+_ &E/_L?E1_:4_P#L?E0!M45B_P!I3_['
MY4?VE/\ ['Y4 ;5%8O\ :4_^Q^5']I3_ .Q^5 &U16+_ &E/_L?E1_:4_P#L
M?E0!M45@W&L301[F7>2<!40DDU9T6YO+J25[SRXU  2)!G'N3Z_2@#5HHHH
M**** "BBB@ HHHH XX?\C/K_ /OP?^BA5NJ@_P"1GU__ 'X/_10JW0(****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **3ZU!#=)
M/*5@#.BCF4#Y,^@/?\* ))IHX5!E<("<#/<^U17"W,DFR)DBBQS)]YOP'0?4
MT06JQR>:[-+.>/,?J!Z =A]*LT 1PQK#&$0L0.[-DGZFM;1>LWX?UK-K2T7K
M-^']: -2BBB@84444 %%%% !1110!QP_Y&?7_P#?@_\ 10JW50?\C/K_ /OP
M?^BA5N@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO6;\/ZT :E%%% PHHHH **** "BBB@#CA_R,^O\ ^_!_Z*%6ZJ#_ )&?7_\
M?@_]%"K= @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **;(Z11EY&5$7JS' %0R-
M)/"C6CJ@?DNRG('L/7ZT 3.VQ6."Q SM7J:KPK<RR+).PA0<B%.2?]X_T%26
M]M';AMF2[<L['+,?<U-0 BJ%SM &3DX'4TM%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M (#O_C1]B^*W_04\-?\ @._^-'L?[R^\/:>3/2J*\U^Q?%;_ *"GAK_P'?\
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MBG@>N/6EMK9(-Q!9Y&^_(YR6_P /I0 R+[3-(LDG[B(<B(<LW^\>WT'YU94
M= !DY.!U-+10!';[/)3RL[,<9J2H;52EM&K#! Y%34 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %:6B]9OP_K6;6
MEHO6;\/ZT :E%%% PHHHH **** "BBB@#CA_R,^O_P"_!_Z*%6ZJ#_D9]?\
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ME&*[\]6Y"YQ]* .]HKD$\=V;:M!;-IVH1V-Q<S6L.I,J?9Y&A5FD/WMP4;&
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MI;1O"KV]W)'))&YW2)(X.75CR<GDUT]% & WA+2#JGV]8IXY=]O)Y:3,(MT
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M **** (HT*S3,>C$8_ 5+4,1)GG!)P"N/;BIJ "BBB@ HHHH **** "BBB@
MHHHH ***!0!';JJPHJ-N4#@^M25#9\6L6?[M34 %%%% !1110 4444 %%%%
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M1110 4444 %%%% !1110!'&5,LH488$;CZ\<5)44:%9IF/1BN/RJ6@ HHHH
M**** "BBB@ HHHH **** "BBB@".W<R0([8RPR<5)4=NH2%%5MR@<'UJ2@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ K2T7K-^']:S:TM%ZS?A_6@#4HHHH&%%%% &18^&-"L+Z\O;+1]/@N[P%;
MB:.W56E!ZACCD'OZ]ZDT/0-(T&UEM]%TVTL()6WNEM$(PQ]3BM.B@#-;0=)8
MV);3K0_80!:_NA^Y Q@+Z=!^(![5I444 <</^1GU_P#WX/\ T4*MU4'_ ",^
MO_[\'_HH5;H$<GXVT^*_NM/5_#NBZU(V](QJ-TL3*>I6,%6W<#)QZ4WX9Z0-
M(T2]6.'3;:&YOI9X[;3I?-BMP<*4WX&X@J<\<9QVK.^)5Y#HVK:1K,-]'!JM
MO%+#%%+8M=H879 \A"LICVG8-^1]['.:UOA_!##8ZJRW8N;V34IFO@MN;=8K
M@;59%C))5<!2#D[L[L\T =31110 4444 %%%% !1110 4444 %%4-4U:STQ,
MW4GSD96)>7;\/ZFN9CFU?Q2"8U-CII. 3QO'\V_05K"BY+F>B(E-)V6YIZQX
MHMK2;[+98N[PG 53E5/OCJ?851A\/7FM3I=>(975!RL"G!_(<*/S/O6YH^AV
M6E#=!'NG(PTSCYC]/0?2M2K]K&G_  OO)Y'+XRO8V=O8P^5:1+$F<D#J3ZD]
MZL445@VV[LT2ML%%%%(84444 %%%% !1110 4444 %%%% $,1)GG!)P"N!Z<
M5-4:%/-EV@[LC=[\<5)0 4444 %%%% !1110 4444 %%%% !0.M%% $%E_QZ
M1?[M3U';N9($=L L,G%24 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %:6B]9OP_K6;6EHO6;\/ZT :E%%% PHHHH
M **** "BBB@#CA_R,^O_ ._!_P"BA5NJ@_Y&?7_]^#_T4*MT"/+_ (CG3]?B
MU$1_VK!<6$B:2EQ:>5B\FE=&-J%?(.&$;%C@+@\G!KI?AT(QIFHB1;Q=6^WR
M?VG]L='D-SA<G*84KLV;=H VXITG@VW/B!M32_O%B^TG4%L3M,"W938)^FXG
M'.W.,\UI^&]&71;.:-KJ6\N[F=KJZNI0%::5L9.!PH    Z "@#6HHHH ***
M* "BBB@ HI"< D\ <DGM7-ZIXHC67[+I"B\NB=NY?F4'V ^\?T]ZN%.4W[I,
MI*.YOW5S!:0F6ZE2*,?Q.<5RVH>(;W49#:>'8&+G@S.,%1ZX_A^I_*EM?#5U
MJ%TMYK]U*S#[L"MT^I' ^@_.NHM;:"TA$5K$D48_A08K7]W2=_B?X?\ !(]Z
M?DC!TKPO#"WGZF_VRY/S,&R4S[YY;\?RKHP,  < < #M2T5E.<IN\BXQ4=@H
MHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH BC4B:9B.&*X]^*EJ*)
MB9YP3D*5P/3BI: "BBB@ HHHH **** "BBB@ HHHH ***!UH CMU"0HH;< ,
M9'>I*@LO^/2+_=J>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY<31HRJ51E^^>3Z#FMR'QE?R>-9=&FBT[3T:5HK6*^6>.:X&S*RHVWRW!/\
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M->YZLWU/>KE-U5%.-+1?B)0<M9C8T6.-4C5411@*HP!3J**P-0HHHH ****
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M$4OH)Y"#:L^R9T4*6SD# !VOSS@UZN^F6$B,LEC:LK0"V*M"I!B'2,C'W?\
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M:+X=M--Q(X%Q==?,<<+_ +H[?7K6U116,IN3O(T45'1!1114C"BBB@ HHHH
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M^ *?XT?\(]JW_0>7_P  4_QKJ** .57PWJJN[#7AEL9_T%.WXT[_ (1[5O\
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M . *?XT?\(]JW_0>7_P!3_&NHHH Y?\ X1[5O^@\O_@"G^-'_"/:M_T'E_\
M %/\:ZBLWQ%K5KH&F->WHE9=ZQ1Q0QF2261B%5$4=6)('_UJ ,G_ (1[5O\
MH/+_ . *?XU2TS2-<NOM?GZP(O*N'B3-@@WJ,8;D]ZD'Q!TO^RYKF2TU..\A
MNELFTQ[;%V9W7<J!,X.5.X'.W&3G@TK?$+1UTR&],=\-WGF: P8EMA 0)C(I
M/&S(SC).1C- %C_A'M6_Z#R_^ *?XT?\(]JW_0>7_P  4_QK;L-3M[^ZO8+;
M<_V1UBDDQ\A<J&V@]R 1GTS5V@#E_P#A'M6_Z#R_^ *?XT?\(]JW_0>7_P
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MNH"P421?W@25&#@_,N0,T =K16%IOBBPU":V@A6X6ZFFF@,#(-\31?ZS?@X
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M@I< CMQZ4 >GT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK;S1O  W$8]<<XZXYKG?#/Q6\,Z[<0QI>PVOVA(3;>?(%,SR%QL ]04QZ98
M5$/!>K_VV(C=:;_8*ZP=;#B)OM9D+%_+_NXW'&_KM^7'>L_2_AWJL.@:E8WM
MSIS3S165O!+&KD>7;S-("V1D$AAP. : .ZE\4:'%K+Z3)JEHNI(AD:W,@W@
M;CQZXYQUQS6+H/Q&T'5]%DU@7EO;:7' DSRS3 ,FYW3:R]N4P.N2<#I6):_#
MBXM_'4NIL]I<:<^HMJBM)<W0ECD/\(B#B$X/1R,XX(/6J]A\/==M;&$F\TMK
M^P^R?8\K(8I/L\D[#S.XW+-VSAAD9H [*\\=^%K.&QEN=?TZ.*^026[&88D4
MG&[V&>,GN#Z5;TKQ!;WL&L32K]F@TRZEMY9)&&"$4,7]A@_I7G/BWX>^+-=T
MZ:T75-)AAO+1XIX(/.MX8I6=W+!(R/-!W ?O#U!.#N(KL+7PO=1>&_$^G//
M9M6>X>-@#MC\R)4&[Z$=NU %O_A.O"XAM)CKM@(KMVC@<R@"0J=IP?3/&>GO
M2Z5XST;4M;U+2H;I%O+*[%DR.<&20Q^9A?7@-_WP:X_Q9\-+K5;ZSN+:2SF0
MZ9%IES#<7-S BJA/S*(77>#N.4;C@<CFM"]\(:[%JEQ=Z3<:9B+48=0M$N/,
MYQ:_9Y$?'08 92,G/!]: .BNO&OAJU,0N-;L8S+&\J!I!RB%@S?0%'R>GRFK
MN@>(-(\0V\L^AZC;7T43^7(T#A@K8S@_@<^]<)9?#O48M U*RN;VRDNKO1WT
MXRK&P7S&FFD+8ZA?WHX]C78:%H4FF^(M9U M#Y-]';(B(N"OE(5.?S&/I0!0
MU;QIX2TR\U22;4=/?5=-M7>>.-E,XC3YF0=S@_P]CUHT[QHMUX9\/:O)8E!K
M%S%;I$DZR>7YA.&+ 8/ Y ^E<Y=?#_6I[=M+-[I:Z1;S7EW:2K$XN7DG24!9
M#G:%!F.6&2P4<#FNGUSPS/J>@:'IPN(T-C-!),_/S*B%6V^_/&: +5CXT\-7
M\L\=EKEA.\$B12".8-M9VV+^!8A<],\5;3Q'HSLX74[0E)I;=OW@PLD0+2*?
M0J 2?2N$M_ &LW%BEKJMWI2KIVEOINFO9PNC,28RDLN3QM,*':N1G)ST%5X/
MA3<R6FJ6U[J4.R^TPPDQ(?EO)0OVB?''#;$XSG&[UH [:/QOX9DT>;5$UNQ-
MA#((I)O,&%<]%QUR>P[TW2O&NB:MXD_L;3KR.YN#9)?H\;!D>-F(X([C'/U'
MO7%0_#:_&BWPEM](.IS30R(3?7[X$0<*PG:0R1N-[8VC &0<YXZ#P7X6UO0]
M6M[G4M1M[]#I_P!EG=BWFJZS22(%./F4"0J6;#':#W- &_;^*]!N-<;1X-6L
MWU12X-J)1O!7[PQZCKCKCFH;?QIX;N+:^N(=;L'@L2!<R"8;8LG )/H3QGI7
M#:7X0UK5M5U>*^-O9:)_;MU?(WE,MU(S1F-2I/R["&)W=<#;TYJ'1?A7?6FE
M7-K</IWG+;P6D,XN+J8R1I-'(=RRNRQ@B,?(@P">N.* .ALOBEX?O-<U.UCN
MK9-,TZVCGGU&2<(FYR-JJIY/4<^I P:VF\=>%U@M)CKM@8[M&D@82@[U7.XC
MZ8.?3'-8^O\ @[4KO6+_ %73[JR%U]MM+ZTCN$9HRT,31E9,<@'>2",X(!P<
M8K.LOA]J>[7KJ^N]/-]K&GW<$H@1A'%+,5QMSR5 49/4G)Q0!U-CX[\+7UU;
MVUGK^G33W$Q@BC28$NX&=H_ \>O:HYO'7A^Q6$:QJVGV$TTDB1H]RIW!)3'G
M/U&#Z'@UB2> KDWDDL4]FBM<Z3, $((6T8%AT[X^7TJ)OA]>-;:O&US9LU[I
MM]8H2I.TW%Q)*">.@#J#[B@#KKOQ5H-GK4>D7.K6<6IR; ELTH#DN<*,>I[#
MKWJMJ7BRVT_QKI7AR>WF\W48))H[@$;%*_P-WR><?2O/=4TW6U\=0:58V#RZ
M?)K-IJEQ<RV,@V^7&@;9-_JRN(QC)#Y)7;CFNM\<>$-0UO5CJ.F7EM;74-CY
M=H\JEO+N%F21'('5<*01[T 36/Q%T29=;FOIAIUGIE]]A^T7+@+.^T'*#J1U
MQW.":LZGX\\.V6EQ7D>J6EQ]HMWN+2*.4%KD*#D)^((]CUKF;OP!K5E!<1^'
MM1@A1[J"7RVEDA,L:6RQ%6D0;E)<;\KUZ$\TGAGX=:EI6CM:W-[9R3G2[ZP$
MB!R-\\YE#?-EL '!R221WH Z]?&.B)I4E_>:A;VL<*Q?:!(X_<O(H94/^U@C
M@<TV#QGHMQXBTS1[6[CGGU&S>]MWC8,CHK <$=S\W_?)KAI?A;?0^'[72[&\
MMWM].O$OK&*2>>,[FB9)HWEC828W,SJP)(S@@BNA\+>#[[0=0T*> V"P6]M=
MPWD*/,^&FD67=&TC,S'<N#N/.2>.E %VT\=6$VH>*;6:">!M ^:5FP1.FS=N
M3\?EQZX]:=I_CW1)/#&D:UJUU%I,>IH'BANY ''J#].YZ"L>?P!=R^(I-0^V
M6ZP7&IO<74>TDRVI6$B+_>\R!3Z;2P[UBZA\+=1DT_0A%<V=Q=65@^GW$<MS
M<V\3JS[]ZF%E8^A5N#[8H ]";Q=X?778]&;6+(:I(0%M_-&XDC('U(YQUQ3+
M'QEX<OYYH;/6K&>6&5('5)02'=MJCWRW (XS7!R?#CQ =?TMO[4LWT?3KZVN
MH(FDG&R.)57RA%G9G@X=BS'OCK3;3X;Z_:-.;*^TVTA@DBFL[%))Y+9I(YED
M!*N285PI7;&2/FSVQ0!Z%?>*]!L54W>JVL6ZX:T4,_+3*0&0#NPR.*ETWQ)H
MVIZI=:=I^IVMQ?6N?.ACD!9<'!^N#P<=#P:Y?P]X.U.TU73]0U2ZL9)X;^^O
MI1 C!?WZX"IGTZ$GK6?\/_AQ<>&==@GN7M)[:R25+6<7-T\S!SWC=S%'QUV@
MY//RT >G4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
<% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $6 E4# 2(  A$! Q$!_\0
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M /Q5'_"PM5_Y]['_ +X?_P"*KCJ*.2/8/:2[G8_\+"U7_GWL?^^'_P#BJ/\
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MI=K/9KNEM)65][ Q89R HSZCOFN6AFD@D$D$KQ..CHVTC\13C<S;U<SR;E!
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MD+N:>.*)[1(8RZ-%,V'8D?(O#$<=3Q7-I<S(\<B32*\8PC!R"H] >U6II;^
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M.&%0D4:A$4=% & *?0 4444 <WK?_'\_X?R%9S*&5E)8!AC*G!'T/K6CK?\
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MUY!(Z^E=W'HUDMUJL[1F0ZH$6Z20[D<*FP #L-O6LVT\(6,%K/:3WFK7UA+
M;86=Y>M+#'&1C:HZ]  "22.QH3B!EZ]XNU3PWI,<_B&PTJUNKJX6WM0EZ[0@
ME2S&5O+RNT+_  @Y[56TCQF^O/H;6\:B>34;BR?[-<M]FE9+=I%8$J"Z'C@@
M$'Z5N#P?9&Q-M/J&M7++(DT%Q-?,TULR@A3$_&W@D=\YYS5FV\-VT3Z?)/>:
ME>SV,[W,4UW<F5R[1F,[CCIM)P!CGFB\0.?3XA1_V='>RV6(X-+EU#455\M;
M.C^6(AQR3(KC)QPN:F\#>./^$DU2YL)4L#+';BY62PG>:,*6VE'+(N'&1TR"
M#QTK:M_"ND0-KF+;>NM.7O4=LJ^1@@?W1R3QW)-2:)H2:3([KJ>KWH*[$2^O
M&F6)?10?YG)]Z5XV Y_5/&&J65YK4J:1:R:/I%W';W,QNB)F5UC)9$VXROF<
M@L,@<52?XF6__"5'38X[)[5=0_LYE\]_M9?=L,@CV;=@;_:S@$UIQ^"(KG7M
M7OM4N[N2UN[Z.[2RBN&6!]D:!3*F/F(9,]<=,YK47PQ:QZL]]:WVK6JR3_:9
M;2"\9+:64G)9D]R,D @'N.M/W0(/">M:IKC3W$^GV=KIJ33VZ.MPSRR-'*4S
MMV@!3M/?.?:J7_"7S_\ ":2Z+);V%K!'*(P;NX>.XG7:&,D*[-CKSC&[)P>*
MZ31],M](LC:V>_RC+)-\[;CND<NWX98UGW7A>TN]8CU"[O-3G6*=;J.RDNBU
MLDJ_=<1XZCKC./:EI<#D="^*MIJ6HQ+)%:"QN(YI8_(G>2YA6-&?,R% J[E4
MXVL<' -:S^*M;M=!CUC4-&L8;2Y>V%ND=XSR!9I$4>8-@ 8*^?E)&1BM73?"
M=EITX^S7FJ?85#!-.DNV:T0-G($9[<G@D@=A5>/P/IB:7<:<]WJTUC(BQQ0R
MWK,MJ%8,GE?W2I P3DC%.\0(-;\6W5C?ZA:6FG17,UOJ-I81AYS&)//3=N)P
M<8_&L3Q-X@\0V*ZPMLMM#JULFFEU%RSVRB:=E(0%,@D  G'<^@STUIX-TVW9
MW:?4;F:2\@OY)KFY,CO-$,(22.F.HZ?2K&K>%]-U1]4>[$^_48H89FCE*E1$
MQ:-D/\+ MG/L*$T@,G4?%M]I4U[8ZGI]J-66*W>SAMYF:.Z:5_+VAF4'Y7Z\
M=#FNIC>]_M*>.:WA6Q6-#%.LF6=SG>I7' 'RX/?/M6'-X9$_B/P_?7$INH]&
MAF\N:Y<O<23287+' ! 4$_7'I6W%8I'J=Q?"6X,D\:1-&TI,2A<X*KT!.[D]
M\#TI.W0"U1114@%%%% !4]C_ ,?MO_UT7^=05/8_\?MO_P!=%_G36X'6T445
MWDGCOC__ )&V_P#^V?\ Z+6N?KH/'_\ R-M__P!L_P#T6M<_79'X4<,_B844
M5-9VTMY=1V\ !DD.!DX ]R?2J)-2+6FM+"TCM,&18)(I Z\ L^58>XZ@U<BU
MBQ+W,4H0Q300*'E@,BAHUP05!!QGO[5070I)'MQ;WEI,DYD"R*S!1L&6SD#%
M-@T5IAN2]M/)+B-)26VN^/NCY<\9&2>*BR+O(T1JMB]S<32O$+C=&$G-EO!1
M5QM5"3M.1U-.;5=/GN[M[J7S+5[EYD@:W);D=4<$;6..]9ECH5S>2311O&MS
M$YC,+*Y.X>X!4?B:>^BA[33FMKF.2ZNP?W!R#G<1P<8P,<Y-%D.\BS#J%AY,
M,TDTR3QV+VGDB+()(8 [L].?2F0ZO!%KEI=$-)#':K V5R5/E[20/8_3-0#0
M9WF@2"XMI4F+J)58A591N(.0".._2HM/TZ*YUJVLFNXFCE8 RQ9Q]!D=?PQ1
MH*[)-<O(9X;6"U>%XH2Q BMC"JYQZDD]*MWFI63_ &^YBFF>:]1$,#1X6+!4
MD[L\XV\8]:CBT>"6P/EWMIYOVL0K.S,%8%>% QG.>^*KV&AW%[+-#')&MS$Y
MC,3*Y)8>X4@?B11H&I-J.I07']M;&<_:YXY(LKU )Z^G!JI8S6QTJ^M+F5H6
MD9)(V$>\$KN^4^F<]:EM=$FN((7$]LDDX?RH78AW*$Y XQVJA8VLE[=)!!MW
MOGEC@* ,DD]@!3T%K<V+C5;=[G4I 799[>*.-67@LI3(/H/E-3:UJ]K=VUX;
M5HE>Z96>,6I5^#GYGW$''L*H+HDLDL2P7-K+#(CNLZL0GR#+ Y&01[BJL=BT
M^H+:6DL5PS=)$)"=,D\@<"E9#NR:UNX8],2!RWF"]2<\<;0N#^-7YM6MVN('
M1Y J:G)='Y2/D)7!^O!XJH=#G,D(BGMY8) [>>I(10GWMV0",<=N_%)-HTJ(
M9([BWFB^SM<AXR<%5;:>H'.:>@>\:VEZMIEK-',"(G$TC2_Z*)'D!)VD,3\H
MP<8'-86H7,<]GIT<9.Z")D?(Q@EV/'X$5)#I3O-!$T\49GA$Z$J[9![84$YX
MJ:?2C96FIK=J#<6YAV,"<8<GG\1CK2T3#5H=<W-A="UN)II@\44<+VHCX8+@
M'#9P 1S]:T9M8T]$BCAD4QK>Q3JL5H(@D:DY'7+'ZUCVVG13:+->M=QQRI,(
MQ&P/S?*3C@=3CCM1>:/-:P2NTUO))!M\^%&)>+/3/&.O'&<4607>Y8N+JRO;
M.-);F:W>!Y60+$6$@=MP/48/8YJ>ZU"QEM[N99I?M-Q9);^3Y7"LNT'YL]#M
MJEH^G)?*GF$1JUU' 9-W*A@>BXYZ=:>VB9:X=;ZU%M%)Y7G-OP6Y^7[O!P.3
MTHT#4O\ ]J:<]Y=W&525Y$9)9+8390* 5 )PIR.IJ#4]0LKY+S$KQM]M:ZBS
M%GS 0!C_ &3Q5#1;"/4-0-O-.L*!';?U!VJ3Z'T_*KT>BQW-C9_9KJU^T2RR
M1JQ9@)B,;0HQ[GDXHT3'=M$UQJ5A>3R^;<SVZ)?-=QLD6XR XXQGAAC@^],_
MMF![RPG.^,17TMS(@&=JLP(QZG -9ZZ1*UK;R^= )+C(A@R?,<AMN,8P.?4X
MJ<^'[EI8DMYK>X+R^2QC8X1\9P<@=@>1GI19!>1#I=W!#>7GGL\<-S%)$)$7
M)3<<@X_#!^M:*7VEJ]O&9/,$%IY,<TUMO59-Y.=F>1@X%5[/2H&-ZCW=M)LM
MO,64,RK&=ZCY@0#T)XQ4!T65)I1)<6T=O'&DIN68^65?[N.,DGTQV-&C$KHU
MX=0M;W6F+YEL#9!;C*"/_5C(('0<@#CUKF;NX>[NIKB7_62N7;\:T_[(=+6[
MC9!)=K/ D)1LA@X8@CU!XHOM,AM-'DE\^"XN%NA$6A8D(-IRIR .HZBA60.[
MW,>BBBK(%C^^OUKW;1_^018_]<$_]!%>$I]]?K7L&FZ5<2:;:.NJWB!H4(4$
M8' XZ5C5V1O1>K.AHK'_ +'N?^@O>_F/\*/['N?^@O>_F/\ "L;+N;W?8V**
MQ_['N?\ H+WOYC_"C^Q[G_H+WOYC_"BR[A=]C8HK'_L>Y_Z"][^8_P */['N
M?^@O>_F/\*++N%WV-BJ4.J6DM])9^9LN4./+<;2WN,]153^Q[G_H+WOYC_"N
M>U;2;S5+H6MK/>2F!\M<W&%1#_L\9)^E-13ZBE)KH:NM_P#'\_X?R%9]37%M
M):,(9KF2Y=0 9'ZG@5#7GS^)FJV"BH8[J"6\GM8Y5:X@"F2,'E0W(_E5;2]9
MT[5I+M-+O8+LVD@BG,+;U1R,[<C@G'I4 7Z*R]>\0:7H$<+ZM=>3YQ*QJL;R
M.^!EB%0$X Y)Q@=ZK:KXNT'2K>SGO=2C6&\C\Z!HT:4/'P3)\@.$&1EC@#/6
MG9@;M%8FK^+-#T>:WBU'48HFGC$R$*SJ(R<!V*@A4)_B; ]ZVZ5@"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J>Q_X_;?\ ZZ+_
M #J"I['_ (_;?_KHO\Z:W ZVBBBN\D\=\?\ _(VW_P#VS_\ 1:US]=#X_'_%
M6WW_ &S_ /1:USU=D?A1PS^)A5O2+DVFI03#R\!L-YF=NTC!SCGH3TJI13)1
MT=WJ5E8K9Q::J2K$)BVV1F&9%V_>8 G'7I532-;DL+(VC"<Q!_,4P7!A8$C!
M!(SD<5CT4N5%<S-^S\1^1Y)>VD=H9FF7%RRAMQS\X_B/N:KV^L^0EDZ6_P#I
M5H[&.3S#@JQ)*E?Q/.:R**.5!S,W9?$!:XAE$5RWEA_EGNFE^\I7C(XQFLG3
MKEK&]M[E%#-"X<*>AQVJ"BG9"<FS2EU&+R5AMK9HHEN1<@-+O.0,8S@5?@\2
M^7('>U<E+E[A%2X9%)8YPP ^;':N>HI<J'S,U8=8,4^GR>0#]D:1L;OO[R3^
M&,U3TV[:QO$G5%D #*R-T92""/R-5J*=D*[-<:Q'$J16EIY5LD<J!&EW,6D&
M"Q;';CC':J6EWLFG7T5U" 73(P21D$8(R.1P:JU?TNUMI[>]GO'F6.V17Q$!
MELL!CGZT620[MLO2Z_YDZ,T-Q+#L>.1+BZ:0LK#! ./EZ>E/FU:TCCLUM[?=
M;FTDMYH/-.Y07)^_CKT/2FRZ38V\=S<33736ZK#)$$5=["0$X.> 1CK1-I]O
MY:W-S)(+6*TAD*Q(H=BY( ].W)-3H5[PBZ\BLRK:/' UNEOMBG*N I)!#XSS
MGD57U#6?M:W:^0$%PL*_?+;?+'OUS5W3=#M;RW%SYEQ]GEE,<?S1JR 8RS;B
M,]>@]*BL]EO9W\=VEG):0%X0X0&224YV%6ZXXSZ8%&G0/>ZE"TODBT^>UF@,
M@=UEC=9-I1P" >AR.>E6+W5TN(;KRK18;B[Q]HE\PL&P<_*O\.2,GK612U5D
M1=EZQU%K.W$:1AF%S'<!B>Z9XQ[YJ]9ZU;V=Y+<6UG<1EWW[1=D GJ0PQ\RY
M[5AT460*31<L+XVFI?:C$K@E]T8.T$,""!Z=>*L1:JD$EAY%L5BLYVF16DW$
M@D'!./;K67119!=F@VJ2"33Y(D"269+*2<[B7+?UQ5R]UX7;1&2*[*K)YC*]
MZ[#OPO\ =Z]>:PZ*+(.9FU>ZZ;E)4\AMKVYMP\DI>3EPV6;'/3 J,:PCQ^1<
MVOFVQ@CB9%DVME,X8'''4\8K)HHY4/F9L-KLGF.\<"(?-A>,9)""($*OOUZU
M%?ZE;SV+VUK9?9U>?SV)E+Y.",=.!S69119"YF%%%%,0L?WU^M>[:/\ \@BQ
M_P"N"?\ H(KPF/[Z_6O=M'_Y!%C_ -<$_P#016-;9&]#=ENBBBN<Z0HHHH *
M*** "BBB@#F];_X_G_#^0J@#@U?UO_C^?\/Y"L^N&?Q,H\;^'MM:V/Q$G@TV
MS_M Y/G7]QI\MM=VP*N<R2-\KY/RGN>".E=/X(U;3#XJ\7):I+!%)-'<1[K*
M2"-D2%5D8$H%X8'W/7FNY6&-)Y9E7$LH4.V?O!<A?RR:6ZB2[M9;:Y'FP2H8
MW1B<,I&"/RH<K@<1>:]:Q:]H'BIH;Y]%NM,FACE2T=WC9W1UW(H+#>JD XQP
M,]:P-%:7PI;V<NM6-_MO-"-I$D-J\S)+YTC^0P0':2LB]>/E(SQ7K$*+!$D<
M($<:*$55X"J!@ ?A3@2.A(HY@/(ECN?#ND:CINJ65[->:GX?M;*V$%NTP>9(
MG1H25!"D,P/S8&"3GBO4]+ADMM+LH)SNFB@CC<YSE@H!_45:!(S@D9ZTE#=P
M"BBBI **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *GL?\
MC]M_^NB_SJ"I['_C]M_^NB_SIK<#K:***[R3S3XG:<\>H17RKF*50C'T8?\
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M3_OXO^-'_"$:S_SQ3_OXO^-'/'N')+L<Q173_P#"$:S_ ,\4_P"_B_XU+;^
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M=']C7'JGYUT-%'L8A<QK?1L,#.X^B\UKQHL:!4&%%.HJXP4=A!1115 %%%%
M!1110 4444 %%%% "2#<C =2,5Y*OPZU>"S\#/:RVB7>FO:PZLA<[9H89/,4
MH<<LK9QD#(=J];HH \RM?"&O)<V6D21Z:-#L]9;5UU 2L;B0>:THC,>W ;<^
MTONY4'C)KTVBB@ HHHH P_#?_']K?_7X?_016Y6'X=_Y"&M_]??_ +**W*J6
MY,=@HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "FR2)& 9&502%&XXR3T%.JIJMDFHV$MM(2N\?*PZJW8T
M(&9FAR)%J&MF1U1?M0Y8X&2HK>KA/#MI?W^M7*ZDH6&WG$LH _UDH4!?PX)_
M'WKNZN:LR(.Z"BBBH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI&GSSK&(5DDMT9@@Z*"1T%6Y-.LI%G62T@99Y%FE!C!$CC&&;U(VKS["K5%
M% Z-IAU?^U3IUF=4QM^U^2OFXZ??QFF6&A:1IU[->:?I5C:W<V?,FA@5'?/7
M) K2HH JS:?9S?:O.M+>3[4H2XWQ@^<H& &]0 3UJO::#H]G:S6UII5A!;S(
M(Y8H[=5211G"L,8(Y/7UK2HH R!X:T(6$-D-%TT6<,GG1P"V38DG]X#'!]ZL
MQZ1IL6JR:G%I]FFI2#:]VL*B5A[MC-7J* (K6WAM+=(+6&.&!!A(XUVJO.>
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MV=O<7EM=SQ![BVW^2[$Y3<,,1VR1Q5BB@ HHHH **** "BBB@ HHHH ****
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MKB9MQ5]H.1\HY&:KZ+X-N/"=O?WVFP:1<W\5D\-H+331!-*Y V^8Y<@\@9
M!HT [/6M2AT?2;K4;I)7M[5/,D$2[F"CJ<>PY/L#6?J/BK3;"2\C?[1,UL(
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M.M.U*[LX$LM6MUNIGM%GN;79$MPH):%FS]X;6Z97C&:V-6TLZAJ>BW8F\O\
MLZZ:X*E<^9F-TQGM][/X5DP^%#'#9QM=AEM]8EU4_N\;PY?]WUXQOZ^W2EH
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M[>7S69OFCW#YEW<'/KQS2T T1XVTV;3].N=.M]0U&2_$C0VMI 'FQ&<2%@2
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M4Q26[(,(48<@@<?2LX^"=)^PS6XDU)6DNUOS<B\?[0LX4+O60\@X&#VY-)6
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M=P_&NKJMJ%FEY#M;AA]T^E3)70TSCJ*L75I+;2;9%/U]:KUB4%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6IH$!DNQ(
M1\J<G_/^>E5;.QFNI %4@=R>U=39VR6L(C3\3ZU<8W=Q-D]%%%:DA1110 UT
M61<.H8>A&:JR:79NV6A&?9B/ZT44K(!O]D67_/#_ ,?;_&C^R++_ )X?^/M_
MC1119!</[(LO^>'_ (^W^-']D67_ #P_\?;_ !HHHL@N']D67_/#_P ?;_&C
M^R++_GA_X^W^-%%%D%P_LBR_YX?^/M_C1_9%E_SP_P#'V_QHHHL@N']D67_/
M#_Q]O\:/[(LO^>'_ (^W^-%%%D%P_LBR_P">'_C[?XT?V19?\\/_ !]O\:**
M+(+A_9%E_P \/_'V_P :/[(LO^>'_C[?XT44607#^R++_GA_X^W^-']D67_/
M#_Q]O\:**+(+A_9%E_SP_P#'V_QH_LBR_P">'_C[?XT44607#^R++_GA_P"/
MM_C1_9%E_P \/_'V_P :**+(+A_9%E_SP_\ 'V_QH_LBR_YX?^/M_C1119!<
M/[(LO^>'_C[?XT?V19?\\/\ Q]O\:**+(+A_9%E_SP_\?;_&C^R++_GA_P"/
MM_C1119!</[(LO\ GA_X^W^-']D67_/#_P ?;_&BBBR"X?V19?\ /#_Q]O\
M&C^R++_GA_X^W^-%%%D%P_LBR_YX?^/M_C1_9%E_SP_\?;_&BBBR"X?V19?\
M\/\ Q]O\:/[(LO\ GA_X^W^-%%%D%P_LBR_YX?\ C[?XT?V19?\ /#_Q]O\
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I_P"/M_C3H],LXVRL(S[DG^9HHHL@N6U4(N% 4#L!BEHHI@%%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $& ; # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;U%?-/C7XA>(=,_:-^%?A'3[M+7PF=#U>T\;P7-T8X;VY\<>'/B)XH\&:A!
M8&A+^'O^&?\ Q?!>7<UU;O;P>)X$@CFCFO##[5X&\<^%/B3X6TOQKX(U>+7O
M#&M?;?[,U:&WO;6.[_L[4;O2;W;!J%M:7D?D:A87=L?.MX]S0EX]\3([:U*%
M2G"G4DFXU(1G=)M0YY55",W:RG.-*4XQO=PUZ.V-/$4ZM2K3BTITZDX6;2<_
M9QI.I.$;\SA3E6C3E*UE/3[46^LHHHK$W"BBB@ HHHH **** "BBB@ HHHH
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M%<AV!1110 5\V_\ ""^%?'_QR^,FI:YHHU:QB^#'@GX(ZC<O=WELCVWB2_\
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M([\3?_4*UNO8J\>_:'!/P ^.8 ))^#WQ-  &22?!6MX 'K6V'_WBA_U^I?\
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M* "BBB@ HHHH **** "BBB@ HHHH \D^//PD3X\?![X@?!^3XD_%SX/KX_\
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M=W&@Z5+*UE#\V_&/PI\:Y?'%UX]\,?M"6'PG\)Z!X<^'^D?#_P (:Q;>#I_
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MF@L)[\6\5Y-"#+%;M(\8+J*^6?V2)_'W_".ZW:^/9+^SUEFMO$&O^&I?AWX
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MHD\^ONWB'4M,U&VT6VT_0$&I7/B+P]]75^9'[?7P^M/CQJ/A3X97O[*'Q_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image00008.jpg
<TEXT>
begin 644 image00008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $& ; # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,>IVGX"_L<:I_P %)?\ AO+PKX-_:"_X*F?'_P#:&^#WP=_:"\8?"7Q7X/\
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M\<M;^/\ '+):ZGX0^,'C:S\/WUK:V7E^*]&A^#/@KX,>)]+U662%-51/"OQ
M\*^+(-'+SK;0W-IKDMM97-IK\&IKX1_P4>^&%[X_L?A7JB7;V&F>%M*^.M[>
M726GVO-YI/PNNOB1IMDZ^? (DU4?#&]TIKDNWV7[9]J6&Y: 6TWV]\"]%O\
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M9XH^$,_@3X=IKW@CPIX%\'_$'XPVOQ,\#^(?&2:%H?@C4HET"\\4VNH^'M-
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M<?(/PY_Y2F_MD?\ 9@'_  33_P#6BO\ @K%0!]_T444 %%%% !1110 4444
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M-;0SPZI:WFJ:=H7B"71?(OQ!=>'+J]DUC1I(+?1;J]:[OKB..T6QF-W!'/\
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M\3>-? <VN3S>';O2(M:TWQ);^%?#_B35=$OM,?QIX6\.Q:C>Q:9K4[0#WO\
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M5RMMMMMMMMMN[;;U;;>[;W9V)**48I)))))622T226B26B2V"BBBD,XGXE>
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MMK/4)?#GB"UD@407QL+V%H7FMKFTN+:>6)_Q&^%?[/7['WA__@I1X;\61?\
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M=ZMX@\2>(M5U3Q#XBUJ^O]:UW4]0U:_O+R;XR^'/_*4W]LC_ +, _P"":?\
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M*U?[1X[^./Q3\&_!3X6Z%]ET+_@HYJ=[%_PE'Q-^('A'PU_:<]M'H^B?VO\
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MNE:8 ?I_17P!_P -D?M%?](G?V__ /PXW_!++_Z991_PV1^T5_TB=_;_ /\
MPXW_  2R_P#IEE 'W_17Y@?#3_@HU\3_ (P>'-2\6?#K_@EU^W_XB\/Z1\0/
MBQ\+=0U#_A,_^"96D?9_'?P.^*?C+X*?%+0OLNN_\%'-,O9?^$7^)OP_\7>&
MO[3@MI-'UO\ LC^V?#NH:OX?O],U6]] _P"&R/VBO^D3O[?_ /X<;_@EE_\
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M;?%7PW\:/A5#X-\#^!OAW\1+6\\.P>/=9\5>"/'?QCA^)&F?%3PWX)\,>'?
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M>(_#NI6VFZ]#H>D 'T_7QS^VI\>_#OP.^%MU%XW_ &;_ ![^TAX$^(^F>*_
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M--U._L;7[AH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Jul. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000096223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Jefferies Financial Group Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-271881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Jul. 18, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">2,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 2,150,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 329.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Fee per Rule 457(r)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Jul. 18, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 2,150,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">329.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text">Fee per Rule 457(r)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 329.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 2,150,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 4,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 23,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001140361-25-026428-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-026428-xbrl.zip
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-  $ /@   !@*      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000096223</identifier>
        </entity>
        <period>
            <startDate>2025-07-18</startDate>
            <endDate>2025-07-18</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000096223</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-18</startDate>
            <endDate>2025-07-18</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-221">S-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-222">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-223">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:RegnFileNb contextRef="rc" id="ixv-224">333-271881</ffd:RegnFileNb>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-225">0000096223</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-226">Jefferies Financial Group Inc.</dei:EntityRegistrantName>
    <ffd:FormTp contextRef="rc" id="ixv-251">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-252">Jefferies Financial Group Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-253">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-254">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-255">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="offrl_1" id="ixv-256">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_1"
      decimals="0"
      id="ixv-257"
      unitRef="Shares">2150</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">1000.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-259"
      unitRef="USD">2150000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-260"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-261"
      unitRef="USD">329.17</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="INF" id="ixv-262" unitRef="USD">2150000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="INF" id="ixv-263" unitRef="USD">329.17</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="INF" id="ixv-264" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="INF" id="ixv-265" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="INF" id="ixv-266" unitRef="USD">329.17</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_1" id="ixv-267">Fee per Rule 457(r)</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="rc" decimals="INF" id="ixv-268" unitRef="USD">2150000.00</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="rc" id="ixv-269">true</ffd:FnlPrspctsFlg>
    <ffd:NrrtvDsclsr contextRef="rc" id="ixv-270">Fee per Rule 457(r)</ffd:NrrtvDsclsr>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
